diff --git a/annotated-projects/MSV000078494/MSV000078494.sdrf.tsv b/annotated-projects/MSV000078494/MSV000078494.sdrf.tsv
index a5cd4ee6..a4283788 100644
--- a/annotated-projects/MSV000078494/MSV000078494.sdrf.tsv
+++ b/annotated-projects/MSV000078494/MSV000078494.sdrf.tsv
@@ -1,97 +1,97 @@
 source name	characteristics[biological replicate]	characteristics[organism]	characteristics[organism part]	characteristics[xenograft]	characteristics[cell type]	characteristics[cell line]	characteristics[age]	characteristics[disease]	characteristics[enrichment process]	assay name	technology type	comment[cleavage agent details]	comment[cleavage agent details]	comment[cleavage agent details]	comment[fractionation method]	comment[fraction identifier]	comment[fragment mass tolerance]	comment[precursor mass tolerance]	comment[technical replicate]	comment[instrument]	comment[label]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[tool metadata]	comment[file uri]	comment[data file]	factor value[disease]
-colon sample 1	1	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 1	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	not applicable	not applicable	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091103_CO_5555_FP/W091103_nCO_5555_FP_rafkt_ft8_cc_01.RAW	W091103_nCO_5555_FP_rafkt_ft8_cc_01.RAW	normal
-lung sample 1	1	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 2	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	not applicable	not applicable	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091103_LU_5555_FP/W091103_nLU_5555_FP_rafkt_ft8_cc_01.RAW	W091103_nLU_5555_FP_rafkt_ft8_cc_01.RAW	normal
-lung sample 1	1	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 3	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091119_LU_5555_OGE/W091119_LU_5555_01_OGE_raflt_ft8_cc_01.RAW	W091119_LU_5555_01_OGE_raflt_ft8_cc_01.RAW	normal
-lung sample 1	1	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 4	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091119_LU_5555_OGE/W091119_LU_5555_02_OGE_raflt_ft8_cc_01.RAW	W091119_LU_5555_02_OGE_raflt_ft8_cc_01.RAW	normal
-lung sample 1	1	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 5	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091119_LU_5555_OGE/W091119_LU_5555_03_OGE_raflt_ft8_cc_01.RAW	W091119_LU_5555_03_OGE_raflt_ft8_cc_01.RAW	normal
-lung sample 1	1	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 6	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091119_LU_5555_OGE/W091119_LU_5555_04_OGE_raflt_ft8_cc_01.RAW	W091119_LU_5555_04_OGE_raflt_ft8_cc_01.RAW	normal
-lung sample 1	1	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 7	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091119_LU_5555_OGE/W091119_LU_5555_05_OGE_raflt_ft8_cc_01.RAW	W091119_LU_5555_05_OGE_raflt_ft8_cc_01.RAW	normal
-lung sample 1	1	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 8	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091119_LU_5555_OGE/W091119_LU_5555_06_OGE_raflt_ft8_cc_01.RAW	W091119_LU_5555_06_OGE_raflt_ft8_cc_01.RAW	normal
-lung sample 1	1	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 9	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091119_LU_5555_OGE/W091119_LU_5555_07_OGE_raflt_ft8_cc_01.RAW	W091119_LU_5555_07_OGE_raflt_ft8_cc_01.RAW	normal
-lung sample 1	1	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 10	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091119_LU_5555_OGE/W091119_LU_5555_08_OGE_raflt_ft8_cc_01.RAW	W091119_LU_5555_08_OGE_raflt_ft8_cc_01.RAW	normal
-lung sample 1	1	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 11	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091119_LU_5555_OGE/W091119_LU_5555_09_10_OGE_raflt_ft8_cc_01.RAW	W091119_LU_5555_09_10_OGE_raflt_ft8_cc_01.RAW	normal
-lung sample 1	1	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 12	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091119_LU_5555_OGE/W091119_LU_5555_11_OGE_raflt_ft8_cc_02.RAW	W091119_LU_5555_11_OGE_raflt_ft8_cc_02.RAW	normal
-lung sample 1	1	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 13	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091119_LU_5555_OGE/W091119_LU_5555_12_OGE_raflt_ft8_cc_01.RAW	W091119_LU_5555_12_OGE_raflt_ft8_cc_01.RAW	normal
-colon sample 1	1	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 14	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091121_CO_5555_OGE/W091121_CO_5555_01_OGE_raflt_ft8_cc_01.RAW	W091121_CO_5555_01_OGE_raflt_ft8_cc_01.RAW	normal
-colon sample 1	1	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 15	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091121_CO_5555_OGE/W091121_CO_5555_02_OGE_raflt_ft8_cc_01.RAW	W091121_CO_5555_02_OGE_raflt_ft8_cc_01.RAW	normal
-colon sample 1	1	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 16	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091121_CO_5555_OGE/W091121_CO_5555_03_OGE_raflt_ft8_cc_01.RAW	W091121_CO_5555_03_OGE_raflt_ft8_cc_01.RAW	normal
-colon sample 1	1	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 18	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091121_CO_5555_OGE/W091121_CO_5555_05_OGE_raflt_ft8_cc_01.RAW	W091121_CO_5555_05_OGE_raflt_ft8_cc_01.RAW	normal
-colon sample 1	1	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 17	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091121_CO_5555_OGE/W091123_CO_5555_04_OGE_raflt_ft8_cc_01.RAW	W091123_CO_5555_04_OGE_raflt_ft8_cc_01.RAW	normal
-colon sample 1	1	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 19	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091121_CO_5555_OGE/W091123_CO_5555_06_OGE_raflt_ft8_cc_01.RAW	W091123_CO_5555_06_OGE_raflt_ft8_cc_01.RAW	normal
-colon sample 1	1	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 20	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091121_CO_5555_OGE/W091123_CO_5555_07_OGE_raflt_ft8_cc_01.RAW	W091123_CO_5555_07_OGE_raflt_ft8_cc_01.RAW	normal
-colon sample 1	1	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 21	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091121_CO_5555_OGE/W091123_CO_5555_08_OGE_raflt_ft8_cc_01.RAW	W091123_CO_5555_08_OGE_raflt_ft8_cc_01.RAW	normal
-colon sample 1	1	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 22	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091121_CO_5555_OGE/W091123_CO_5555_09_10_OGE_raflt_ft8_cc_01.RAW	W091123_CO_5555_09_10_OGE_raflt_ft8_cc_01.RAW	normal
-colon sample 1	1	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 23	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091121_CO_5555_OGE/W091123_CO_5555_11_OGE_raflt_ft8_cc_01.RAW	W091123_CO_5555_11_OGE_raflt_ft8_cc_01.RAW	normal
-colon sample 1	1	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 24	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091121_CO_5555_OGE/W091123_CO_5555_12_OGE_raflt_ft8_cc_01.RAW	W091123_CO_5555_12_OGE_raflt_ft8_cc_01.RAW	normal
-colon sample 2	2	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 25	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	not applicable	not applicable	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091103_nCO_5557_FP/W091103_nCO_5557_FP_rafkt_ft8_cc_01.RAW	W091103_nCO_5557_FP_rafkt_ft8_cc_01.RAW	normal
-lung sample 2	2	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 26	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	not applicable	not applicable	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091103_nLU_5557_FP/W091103_nLU_5557_FP_rafkt_ft8_cc_01.RAW	W091103_nLU_5557_FP_rafkt_ft8_cc_01.RAW	normal
-lung sample 2	2	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 27	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091218_nLU_5557_OGE/W091218_LU_5557_01_OGE_raflt_ft8_cc_01.RAW	W091218_LU_5557_01_OGE_raflt_ft8_cc_01.RAW	normal
-lung sample 2	2	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 28	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091218_nLU_5557_OGE/W091218_LU_5557_02_OGE_raflt_ft8_cc_01.RAW	W091218_LU_5557_02_OGE_raflt_ft8_cc_01.RAW	normal
-lung sample 2	2	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 29	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091218_nLU_5557_OGE/W091218_LU_5557_03_OGE_raflt_ft8_cc_01.RAW	W091218_LU_5557_03_OGE_raflt_ft8_cc_01.RAW	normal
-lung sample 2	2	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 30	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091218_nLU_5557_OGE/W091218_LU_5557_04_OGE_raflt_ft8_cc_01.RAW	W091218_LU_5557_04_OGE_raflt_ft8_cc_01.RAW	normal
-lung sample 2	2	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 31	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091218_nLU_5557_OGE/W091218_LU_5557_05_OGE_raflt_ft8_cc_01.RAW	W091218_LU_5557_05_OGE_raflt_ft8_cc_01.RAW	normal
-lung sample 2	2	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 32	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091218_nLU_5557_OGE/W091218_LU_5557_06_OGE_raflt_ft8_cc_01.RAW	W091218_LU_5557_06_OGE_raflt_ft8_cc_01.RAW	normal
-lung sample 2	2	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 33	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091218_nLU_5557_OGE/W091218_LU_5557_07_OGE_raflt_ft8_cc_01.RAW	W091218_LU_5557_07_OGE_raflt_ft8_cc_01.RAW	normal
-lung sample 2	2	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 34	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091218_nLU_5557_OGE/W091218_LU_5557_08_OGE_raflt_ft8_cc_01.RAW	W091218_LU_5557_08_OGE_raflt_ft8_cc_01.RAW	normal
-lung sample 2	2	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 35	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091218_nLU_5557_OGE/W091218_LU_5557_09_10_OGE_raflt_ft8_cc_01.RAW	W091218_LU_5557_09_10_OGE_raflt_ft8_cc_01.RAW	normal
-lung sample 2	2	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 36	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091218_nLU_5557_OGE/W091218_LU_5557_11_OGE_raflt_ft8_cc_01.RAW	W091218_LU_5557_11_OGE_raflt_ft8_cc_01.RAW	normal
-lung sample 2	2	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 37	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091218_nLU_5557_OGE/W091218_LU_5557_12_OGE_raflt_ft8_cc_01.RAW	W091218_LU_5557_12_OGE_raflt_ft8_cc_01.RAW	normal
-colon sample 2	2	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 38	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091219_nCO_5557_OGE/W091219_CO_5557_01_OGE_raflt_ft8_cc_01.RAW	W091219_CO_5557_01_OGE_raflt_ft8_cc_01.RAW	normal
-colon sample 2	2	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 39	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091219_nCO_5557_OGE/W091219_CO_5557_02_OGE_raflt_ft8_cc_01.RAW	W091219_CO_5557_02_OGE_raflt_ft8_cc_01.RAW	normal
-colon sample 2	2	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 40	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091219_nCO_5557_OGE/W091219_CO_5557_03_OGE_raflt_ft8_cc_01.RAW	W091219_CO_5557_03_OGE_raflt_ft8_cc_01.RAW	normal
-colon sample 2	2	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 41	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091219_nCO_5557_OGE/W091219_CO_5557_04_OGE_raflt_ft8_cc_01.RAW	W091219_CO_5557_04_OGE_raflt_ft8_cc_01.RAW	normal
-colon sample 2	2	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 42	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091219_nCO_5557_OGE/W091219_CO_5557_05_OGE_raflt_ft8_cc_01.RAW	W091219_CO_5557_05_OGE_raflt_ft8_cc_01.RAW	normal
-colon sample 2	2	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 43	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091219_nCO_5557_OGE/W091219_CO_5557_06_OGE_raflt_ft8_cc_01.RAW	W091219_CO_5557_06_OGE_raflt_ft8_cc_01.RAW	normal
-colon sample 2	2	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 44	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091219_nCO_5557_OGE/W091219_CO_5557_07_OGE_raflt_ft8_cc_01.RAW	W091219_CO_5557_07_OGE_raflt_ft8_cc_01.RAW	normal
-colon sample 2	2	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 45	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091219_nCO_5557_OGE/W091219_CO_5557_08_OGE_raflt_ft8_cc_01.RAW	W091219_CO_5557_08_OGE_raflt_ft8_cc_01.RAW	normal
-colon sample 2	2	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 46	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091219_nCO_5557_OGE/W091219_CO_5557_09_10_OGE_raflt_ft8_cc_01.RAW	W091219_CO_5557_09_10_OGE_raflt_ft8_cc_01.RAW	normal
-colon sample 2	2	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 47	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091219_nCO_5557_OGE/W091219_CO_5557_11_OGE_raflt_ft8_cc_01.RAW	W091219_CO_5557_11_OGE_raflt_ft8_cc_01.RAW	normal
-colon sample 2	2	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 48	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091219_nCO_5557_OGE/W091219_CO_5557_12_OGE_raflt_ft8_cc_01.RAW	W091219_CO_5557_12_OGE_raflt_ft8_cc_01.RAW	normal
-A375 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 49	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	not applicable	not applicable	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_1A/W091103_XG_A375_1A/W091103_XG_A375_1A_FP_rafkt_ft8_cc_01.RAW	W091103_XG_A375_1A_FP_rafkt_ft8_cc_01.RAW	melanoma
-A375 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 50	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_1A/W091211_XG_A375_1A_OGE/W091211_XG_A375_1A_01_OGE_raflt_ft8_cc_01.RAW	W091211_XG_A375_1A_01_OGE_raflt_ft8_cc_01.RAW	melanoma
-A375 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 51	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_1A/W091211_XG_A375_1A_OGE/W091211_XG_A375_1A_02_OGE_raflt_ft8_cc_01.RAW	W091211_XG_A375_1A_02_OGE_raflt_ft8_cc_01.RAW	melanoma
-A375 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 52	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_1A/W091211_XG_A375_1A_OGE/W091211_XG_A375_1A_03_OGE_raflt_ft8_cc_01.RAW	W091211_XG_A375_1A_03_OGE_raflt_ft8_cc_01.RAW	melanoma
-A375 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 53	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_1A/W091211_XG_A375_1A_OGE/W091211_XG_A375_1A_04_OGE_raflt_ft8_cc_01.RAW	W091211_XG_A375_1A_04_OGE_raflt_ft8_cc_01.RAW	melanoma
-A375 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 54	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_1A/W091211_XG_A375_1A_OGE/W091211_XG_A375_1A_05_OGE_raflt_ft8_cc_01.RAW	W091211_XG_A375_1A_05_OGE_raflt_ft8_cc_01.RAW	melanoma
-A375 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 55	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_1A/W091211_XG_A375_1A_OGE/W091211_XG_A375_1A_06_OGE_raflt_ft8_cc_01.RAW	W091211_XG_A375_1A_06_OGE_raflt_ft8_cc_01.RAW	melanoma
-A375 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 56	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_1A/W091211_XG_A375_1A_OGE/W091211_XG_A375_1A_07_OGE_raflt_ft8_cc_01.RAW	W091211_XG_A375_1A_07_OGE_raflt_ft8_cc_01.RAW	melanoma
-A375 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 57	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_1A/W091211_XG_A375_1A_OGE/W091211_XG_A375_1A_08_OGE_raflt_ft8_cc_01.RAW	W091211_XG_A375_1A_08_OGE_raflt_ft8_cc_01.RAW	melanoma
-A375 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 58	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_1A/W091211_XG_A375_1A_OGE/W091211_XG_A375_1A_09_10_OGE_raflt_ft8_cc_01.RAW	W091211_XG_A375_1A_09_10_OGE_raflt_ft8_cc_01.RAW	melanoma
-A375 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 59	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_1A/W091211_XG_A375_1A_OGE/W091211_XG_A375_1A_11_OGE_raflt_ft8_cc_01.RAW	W091211_XG_A375_1A_11_OGE_raflt_ft8_cc_01.RAW	melanoma
-A375 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 60	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_1A/W091211_XG_A375_1A_OGE/W091211_XG_A375_1A_12_OGE_raflt_ft8_cc_01.RAW	W091211_XG_A375_1A_12_OGE_raflt_ft8_cc_01.RAW	melanoma
-A375 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 61	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	not applicable	not applicable	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_3A/W091103_XG_A375_3A/W091103_XG_A375_3A_FP_rafkt_ft8_cc_01.RAW	W091103_XG_A375_3A_FP_rafkt_ft8_cc_01.RAW	melanoma
-A375 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 62	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_3A/W091212_XG_A375_3A_OGE/W091212_XG_A375_3A_01_OGE_raflt_ft8_cc_01.RAW	W091212_XG_A375_3A_01_OGE_raflt_ft8_cc_01.RAW	melanoma
-A375 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 63	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_3A/W091212_XG_A375_3A_OGE/W091212_XG_A375_3A_02_OGE_raflt_ft8_cc_01.RAW	W091212_XG_A375_3A_02_OGE_raflt_ft8_cc_01.RAW	melanoma
-A375 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 64	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_3A/W091212_XG_A375_3A_OGE/W091212_XG_A375_3A_03_OGE_raflt_ft8_cc_01.RAW	W091212_XG_A375_3A_03_OGE_raflt_ft8_cc_01.RAW	melanoma
-A375 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 65	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_3A/W091212_XG_A375_3A_OGE/W091212_XG_A375_3A_04_OGE_raflt_ft8_cc_01.RAW	W091212_XG_A375_3A_04_OGE_raflt_ft8_cc_01.RAW	melanoma
-A375 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 66	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_3A/W091212_XG_A375_3A_OGE/W091212_XG_A375_3A_05_OGE_raflt_ft8_cc_01.RAW	W091212_XG_A375_3A_05_OGE_raflt_ft8_cc_01.RAW	melanoma
-A375 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 67	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_3A/W091212_XG_A375_3A_OGE/W091212_XG_A375_3A_06_OGE_raflt_ft8_cc_01.RAW	W091212_XG_A375_3A_06_OGE_raflt_ft8_cc_01.RAW	melanoma
-A375 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 68	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_3A/W091212_XG_A375_3A_OGE/W091212_XG_A375_3A_07_OGE_raflt_ft8_cc_01.RAW	W091212_XG_A375_3A_07_OGE_raflt_ft8_cc_01.RAW	melanoma
-A375 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 69	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_3A/W091212_XG_A375_3A_OGE/W091212_XG_A375_3A_08_OGE_raflt_ft8_cc_01.RAW	W091212_XG_A375_3A_08_OGE_raflt_ft8_cc_01.RAW	melanoma
-A375 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 70	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_3A/W091212_XG_A375_3A_OGE/W091212_XG_A375_3A_09_10_OGE_raflt_ft8_cc_01.RAW	W091212_XG_A375_3A_09_10_OGE_raflt_ft8_cc_01.RAW	melanoma
-A375 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 71	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_3A/W091212_XG_A375_3A_OGE/W091212_XG_A375_3A_11_OGE_raflt_ft8_cc_01.RAW	W091212_XG_A375_3A_11_OGE_raflt_ft8_cc_01.RAW	melanoma
-A375 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 72	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_3A/W091212_XG_A375_3A_OGE/W091212_XG_A375_3A_12_OGE_raflt_ft8_cc_01.RAW	W091212_XG_A375_3A_12_OGE_raflt_ft8_cc_01.RAW	melanoma
-MA2 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 73	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	not applicable	not applicable	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_2B/W100120_XG_MA2_2B/W100120_XG_MA2_2B_FP_rafkt_ft8_cc_01.RAW	W100120_XG_MA2_2B_FP_rafkt_ft8_cc_01.RAW	melanoma
-MA2 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 74	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_2B/W100212_XG_MA2_2B_OGE/W100212_XG_MA2_2B_OGE_01_rafkt_ft8_cc_01.RAW	W100212_XG_MA2_2B_OGE_01_rafkt_ft8_cc_01.RAW	melanoma
-MA2 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 75	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_2B/W100212_XG_MA2_2B_OGE/W100212_XG_MA2_2B_OGE_02_rafkt_ft8_cc_01.RAW	W100212_XG_MA2_2B_OGE_02_rafkt_ft8_cc_01.RAW	melanoma
-MA2 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 76	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_2B/W100212_XG_MA2_2B_OGE/W100212_XG_MA2_2B_OGE_03_rafkt_ft8_cc_01.RAW	W100212_XG_MA2_2B_OGE_03_rafkt_ft8_cc_01.RAW	melanoma
-MA2 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 77	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_2B/W100212_XG_MA2_2B_OGE/W100212_XG_MA2_2B_OGE_04_rafkt_ft8_cc_01.RAW	W100212_XG_MA2_2B_OGE_04_rafkt_ft8_cc_01.RAW	melanoma
-MA2 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 78	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_2B/W100212_XG_MA2_2B_OGE/W100212_XG_MA2_2B_OGE_05_rafkt_ft8_cc_01.RAW	W100212_XG_MA2_2B_OGE_05_rafkt_ft8_cc_01.RAW	melanoma
-MA2 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 79	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_2B/W100212_XG_MA2_2B_OGE/W100212_XG_MA2_2B_OGE_06_rafkt_ft8_cc_01.RAW	W100212_XG_MA2_2B_OGE_06_rafkt_ft8_cc_01.RAW	melanoma
-MA2 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 80	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_2B/W100212_XG_MA2_2B_OGE/W100212_XG_MA2_2B_OGE_07_rafkt_ft8_cc_01.RAW	W100212_XG_MA2_2B_OGE_07_rafkt_ft8_cc_01.RAW	melanoma
-MA2 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 81	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_2B/W100212_XG_MA2_2B_OGE/W100212_XG_MA2_2B_OGE_08_rafkt_ft8_cc_01.RAW	W100212_XG_MA2_2B_OGE_08_rafkt_ft8_cc_01.RAW	melanoma
-MA2 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 82	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_2B/W100212_XG_MA2_2B_OGE/W100212_XG_MA2_2B_OGE_09_10_rafkt_ft8_cc_01.RAW	W100212_XG_MA2_2B_OGE_09_10_rafkt_ft8_cc_01.RAW	melanoma
-MA2 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 83	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_2B/W100212_XG_MA2_2B_OGE/W100212_XG_MA2_2B_OGE_11_rafkt_ft8_cc_01.RAW	W100212_XG_MA2_2B_OGE_11_rafkt_ft8_cc_01.RAW	melanoma
-MA2 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 84	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_2B/W100212_XG_MA2_2B_OGE/W100212_XG_MA2_2B_OGE_12_rafkt_ft8_cc_01.RAW	W100212_XG_MA2_2B_OGE_12_rafkt_ft8_cc_01.RAW	melanoma
-MA2 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 85	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	not applicable	not applicable	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_3A/W100120_XG_MA2_3A/W100120_XG_MA2_3A_FP_rafkt_ft8_cc_01.RAW	W100120_XG_MA2_3A_FP_rafkt_ft8_cc_01.RAW	melanoma
-MA2 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 86	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_3A/W100222_XG_MA2_3A_OGE/W100222_XG_MA2_3A_OGE_01_rafkt_ft8_cc_01.RAW	W100222_XG_MA2_3A_OGE_01_rafkt_ft8_cc_01.RAW	melanoma
-MA2 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 87	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_3A/W100222_XG_MA2_3A_OGE/W100222_XG_MA2_3A_OGE_02_rafkt_ft8_cc_01.RAW	W100222_XG_MA2_3A_OGE_02_rafkt_ft8_cc_01.RAW	melanoma
-MA2 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 88	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_3A/W100222_XG_MA2_3A_OGE/W100222_XG_MA2_3A_OGE_03_rafkt_ft8_cc_01.RAW	W100222_XG_MA2_3A_OGE_03_rafkt_ft8_cc_01.RAW	melanoma
-MA2 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 89	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_3A/W100222_XG_MA2_3A_OGE/W100222_XG_MA2_3A_OGE_04_rafkt_ft8_cc_01.RAW	W100222_XG_MA2_3A_OGE_04_rafkt_ft8_cc_01.RAW	melanoma
-MA2 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 90	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_3A/W100222_XG_MA2_3A_OGE/W100222_XG_MA2_3A_OGE_05_rafkt_ft8_cc_01.RAW	W100222_XG_MA2_3A_OGE_05_rafkt_ft8_cc_01.RAW	melanoma
-MA2 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 91	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_3A/W100222_XG_MA2_3A_OGE/W100222_XG_MA2_3A_OGE_06_rafkt_ft8_cc_01.RAW	W100222_XG_MA2_3A_OGE_06_rafkt_ft8_cc_01.RAW	melanoma
-MA2 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 92	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_3A/W100222_XG_MA2_3A_OGE/W100222_XG_MA2_3A_OGE_07_rafkt_ft8_cc_01.RAW	W100222_XG_MA2_3A_OGE_07_rafkt_ft8_cc_01.RAW	melanoma
-MA2 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 93	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_3A/W100222_XG_MA2_3A_OGE/W100222_XG_MA2_3A_OGE_08_rafkt_ft8_cc_01.RAW	W100222_XG_MA2_3A_OGE_08_rafkt_ft8_cc_01.RAW	melanoma
-MA2 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 94	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_3A/W100222_XG_MA2_3A_OGE/W100222_XG_MA2_3A_OGE_09_10_rafkt_ft8_cc_01.RAW	W100222_XG_MA2_3A_OGE_09_10_rafkt_ft8_cc_01.RAW	melanoma
-MA2 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 95	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_3A/W100222_XG_MA2_3A_OGE/W100222_XG_MA2_3A_OGE_11_rafkt_ft8_cc_01.RAW	W100222_XG_MA2_3A_OGE_11_rafkt_ft8_cc_01.RAW	melanoma
-MA2 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 96	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_3A/W100222_XG_MA2_3A_OGE/W100222_XG_MA2_3A_OGE_12_rafkt_ft8_cc_01.RAW	W100222_XG_MA2_3A_OGE_12_rafkt_ft8_cc_01.RAW	melanoma
\ No newline at end of file
+colon sample 1	1	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 1	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	not applicable	not applicable	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091103_CO_5555_FP/W091103_nCO_5555_FP_rafkt_ft8_cc_01.RAW	W091103_nCO_5555_FP_rafkt_ft8_cc_01.RAW	normal
+lung sample 1	1	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 2	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	not applicable	not applicable	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091103_LU_5555_FP/W091103_nLU_5555_FP_rafkt_ft8_cc_01.RAW	W091103_nLU_5555_FP_rafkt_ft8_cc_01.RAW	normal
+lung sample 1	1	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 3	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091119_LU_5555_OGE/W091119_LU_5555_01_OGE_raflt_ft8_cc_01.RAW	W091119_LU_5555_01_OGE_raflt_ft8_cc_01.RAW	normal
+lung sample 1	1	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 4	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091119_LU_5555_OGE/W091119_LU_5555_02_OGE_raflt_ft8_cc_01.RAW	W091119_LU_5555_02_OGE_raflt_ft8_cc_01.RAW	normal
+lung sample 1	1	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 5	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091119_LU_5555_OGE/W091119_LU_5555_03_OGE_raflt_ft8_cc_01.RAW	W091119_LU_5555_03_OGE_raflt_ft8_cc_01.RAW	normal
+lung sample 1	1	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 6	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091119_LU_5555_OGE/W091119_LU_5555_04_OGE_raflt_ft8_cc_01.RAW	W091119_LU_5555_04_OGE_raflt_ft8_cc_01.RAW	normal
+lung sample 1	1	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 7	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091119_LU_5555_OGE/W091119_LU_5555_05_OGE_raflt_ft8_cc_01.RAW	W091119_LU_5555_05_OGE_raflt_ft8_cc_01.RAW	normal
+lung sample 1	1	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 8	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091119_LU_5555_OGE/W091119_LU_5555_06_OGE_raflt_ft8_cc_01.RAW	W091119_LU_5555_06_OGE_raflt_ft8_cc_01.RAW	normal
+lung sample 1	1	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 9	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091119_LU_5555_OGE/W091119_LU_5555_07_OGE_raflt_ft8_cc_01.RAW	W091119_LU_5555_07_OGE_raflt_ft8_cc_01.RAW	normal
+lung sample 1	1	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 10	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091119_LU_5555_OGE/W091119_LU_5555_08_OGE_raflt_ft8_cc_01.RAW	W091119_LU_5555_08_OGE_raflt_ft8_cc_01.RAW	normal
+lung sample 1	1	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 11	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091119_LU_5555_OGE/W091119_LU_5555_09_10_OGE_raflt_ft8_cc_01.RAW	W091119_LU_5555_09_10_OGE_raflt_ft8_cc_01.RAW	normal
+lung sample 1	1	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 12	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091119_LU_5555_OGE/W091119_LU_5555_11_OGE_raflt_ft8_cc_02.RAW	W091119_LU_5555_11_OGE_raflt_ft8_cc_02.RAW	normal
+lung sample 1	1	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 13	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091119_LU_5555_OGE/W091119_LU_5555_12_OGE_raflt_ft8_cc_01.RAW	W091119_LU_5555_12_OGE_raflt_ft8_cc_01.RAW	normal
+colon sample 1	1	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 14	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091121_CO_5555_OGE/W091121_CO_5555_01_OGE_raflt_ft8_cc_01.RAW	W091121_CO_5555_01_OGE_raflt_ft8_cc_01.RAW	normal
+colon sample 1	1	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 15	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091121_CO_5555_OGE/W091121_CO_5555_02_OGE_raflt_ft8_cc_01.RAW	W091121_CO_5555_02_OGE_raflt_ft8_cc_01.RAW	normal
+colon sample 1	1	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 16	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091121_CO_5555_OGE/W091121_CO_5555_03_OGE_raflt_ft8_cc_01.RAW	W091121_CO_5555_03_OGE_raflt_ft8_cc_01.RAW	normal
+colon sample 1	1	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 18	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091121_CO_5555_OGE/W091121_CO_5555_05_OGE_raflt_ft8_cc_01.RAW	W091121_CO_5555_05_OGE_raflt_ft8_cc_01.RAW	normal
+colon sample 1	1	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 17	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091121_CO_5555_OGE/W091123_CO_5555_04_OGE_raflt_ft8_cc_01.RAW	W091123_CO_5555_04_OGE_raflt_ft8_cc_01.RAW	normal
+colon sample 1	1	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 19	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091121_CO_5555_OGE/W091123_CO_5555_06_OGE_raflt_ft8_cc_01.RAW	W091123_CO_5555_06_OGE_raflt_ft8_cc_01.RAW	normal
+colon sample 1	1	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 20	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091121_CO_5555_OGE/W091123_CO_5555_07_OGE_raflt_ft8_cc_01.RAW	W091123_CO_5555_07_OGE_raflt_ft8_cc_01.RAW	normal
+colon sample 1	1	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 21	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091121_CO_5555_OGE/W091123_CO_5555_08_OGE_raflt_ft8_cc_01.RAW	W091123_CO_5555_08_OGE_raflt_ft8_cc_01.RAW	normal
+colon sample 1	1	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 22	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091121_CO_5555_OGE/W091123_CO_5555_09_10_OGE_raflt_ft8_cc_01.RAW	W091123_CO_5555_09_10_OGE_raflt_ft8_cc_01.RAW	normal
+colon sample 1	1	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 23	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091121_CO_5555_OGE/W091123_CO_5555_11_OGE_raflt_ft8_cc_01.RAW	W091123_CO_5555_11_OGE_raflt_ft8_cc_01.RAW	normal
+colon sample 1	1	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 24	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5555/W091121_CO_5555_OGE/W091123_CO_5555_12_OGE_raflt_ft8_cc_01.RAW	W091123_CO_5555_12_OGE_raflt_ft8_cc_01.RAW	normal
+colon sample 2	2	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 25	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	not applicable	not applicable	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091103_nCO_5557_FP/W091103_nCO_5557_FP_rafkt_ft8_cc_01.RAW	W091103_nCO_5557_FP_rafkt_ft8_cc_01.RAW	normal
+lung sample 2	2	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 26	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	not applicable	not applicable	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091103_nLU_5557_FP/W091103_nLU_5557_FP_rafkt_ft8_cc_01.RAW	W091103_nLU_5557_FP_rafkt_ft8_cc_01.RAW	normal
+lung sample 2	2	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 27	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091218_nLU_5557_OGE/W091218_LU_5557_01_OGE_raflt_ft8_cc_01.RAW	W091218_LU_5557_01_OGE_raflt_ft8_cc_01.RAW	normal
+lung sample 2	2	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 28	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091218_nLU_5557_OGE/W091218_LU_5557_02_OGE_raflt_ft8_cc_01.RAW	W091218_LU_5557_02_OGE_raflt_ft8_cc_01.RAW	normal
+lung sample 2	2	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 29	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091218_nLU_5557_OGE/W091218_LU_5557_03_OGE_raflt_ft8_cc_01.RAW	W091218_LU_5557_03_OGE_raflt_ft8_cc_01.RAW	normal
+lung sample 2	2	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 30	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091218_nLU_5557_OGE/W091218_LU_5557_04_OGE_raflt_ft8_cc_01.RAW	W091218_LU_5557_04_OGE_raflt_ft8_cc_01.RAW	normal
+lung sample 2	2	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 31	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091218_nLU_5557_OGE/W091218_LU_5557_05_OGE_raflt_ft8_cc_01.RAW	W091218_LU_5557_05_OGE_raflt_ft8_cc_01.RAW	normal
+lung sample 2	2	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 32	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091218_nLU_5557_OGE/W091218_LU_5557_06_OGE_raflt_ft8_cc_01.RAW	W091218_LU_5557_06_OGE_raflt_ft8_cc_01.RAW	normal
+lung sample 2	2	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 33	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091218_nLU_5557_OGE/W091218_LU_5557_07_OGE_raflt_ft8_cc_01.RAW	W091218_LU_5557_07_OGE_raflt_ft8_cc_01.RAW	normal
+lung sample 2	2	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 34	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091218_nLU_5557_OGE/W091218_LU_5557_08_OGE_raflt_ft8_cc_01.RAW	W091218_LU_5557_08_OGE_raflt_ft8_cc_01.RAW	normal
+lung sample 2	2	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 35	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091218_nLU_5557_OGE/W091218_LU_5557_09_10_OGE_raflt_ft8_cc_01.RAW	W091218_LU_5557_09_10_OGE_raflt_ft8_cc_01.RAW	normal
+lung sample 2	2	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 36	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091218_nLU_5557_OGE/W091218_LU_5557_11_OGE_raflt_ft8_cc_01.RAW	W091218_LU_5557_11_OGE_raflt_ft8_cc_01.RAW	normal
+lung sample 2	2	mus musculus	lung	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 37	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091218_nLU_5557_OGE/W091218_LU_5557_12_OGE_raflt_ft8_cc_01.RAW	W091218_LU_5557_12_OGE_raflt_ft8_cc_01.RAW	normal
+colon sample 2	2	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 38	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091219_nCO_5557_OGE/W091219_CO_5557_01_OGE_raflt_ft8_cc_01.RAW	W091219_CO_5557_01_OGE_raflt_ft8_cc_01.RAW	normal
+colon sample 2	2	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 39	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091219_nCO_5557_OGE/W091219_CO_5557_02_OGE_raflt_ft8_cc_01.RAW	W091219_CO_5557_02_OGE_raflt_ft8_cc_01.RAW	normal
+colon sample 2	2	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 40	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091219_nCO_5557_OGE/W091219_CO_5557_03_OGE_raflt_ft8_cc_01.RAW	W091219_CO_5557_03_OGE_raflt_ft8_cc_01.RAW	normal
+colon sample 2	2	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 41	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091219_nCO_5557_OGE/W091219_CO_5557_04_OGE_raflt_ft8_cc_01.RAW	W091219_CO_5557_04_OGE_raflt_ft8_cc_01.RAW	normal
+colon sample 2	2	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 42	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091219_nCO_5557_OGE/W091219_CO_5557_05_OGE_raflt_ft8_cc_01.RAW	W091219_CO_5557_05_OGE_raflt_ft8_cc_01.RAW	normal
+colon sample 2	2	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 43	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091219_nCO_5557_OGE/W091219_CO_5557_06_OGE_raflt_ft8_cc_01.RAW	W091219_CO_5557_06_OGE_raflt_ft8_cc_01.RAW	normal
+colon sample 2	2	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 44	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091219_nCO_5557_OGE/W091219_CO_5557_07_OGE_raflt_ft8_cc_01.RAW	W091219_CO_5557_07_OGE_raflt_ft8_cc_01.RAW	normal
+colon sample 2	2	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 45	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091219_nCO_5557_OGE/W091219_CO_5557_08_OGE_raflt_ft8_cc_01.RAW	W091219_CO_5557_08_OGE_raflt_ft8_cc_01.RAW	normal
+colon sample 2	2	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 46	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091219_nCO_5557_OGE/W091219_CO_5557_09_10_OGE_raflt_ft8_cc_01.RAW	W091219_CO_5557_09_10_OGE_raflt_ft8_cc_01.RAW	normal
+colon sample 2	2	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 47	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091219_nCO_5557_OGE/W091219_CO_5557_11_OGE_raflt_ft8_cc_01.RAW	W091219_CO_5557_11_OGE_raflt_ft8_cc_01.RAW	normal
+colon sample 2	2	mus musculus	colon	not applicable	not available	not available	8w-12w	normal	NT=Extraction purification;AC=NCIT:C113061	run 48	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/NormalTissue/5557/W091219_nCO_5557_OGE/W091219_CO_5557_12_OGE_raflt_ft8_cc_01.RAW	W091219_CO_5557_12_OGE_raflt_ft8_cc_01.RAW	normal
+A375 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 49	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	not applicable	not applicable	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_1A/W091103_XG_A375_1A/W091103_XG_A375_1A_FP_rafkt_ft8_cc_01.RAW	W091103_XG_A375_1A_FP_rafkt_ft8_cc_01.RAW	melanoma
+A375 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 50	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_1A/W091211_XG_A375_1A_OGE/W091211_XG_A375_1A_01_OGE_raflt_ft8_cc_01.RAW	W091211_XG_A375_1A_01_OGE_raflt_ft8_cc_01.RAW	melanoma
+A375 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 51	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_1A/W091211_XG_A375_1A_OGE/W091211_XG_A375_1A_02_OGE_raflt_ft8_cc_01.RAW	W091211_XG_A375_1A_02_OGE_raflt_ft8_cc_01.RAW	melanoma
+A375 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 52	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_1A/W091211_XG_A375_1A_OGE/W091211_XG_A375_1A_03_OGE_raflt_ft8_cc_01.RAW	W091211_XG_A375_1A_03_OGE_raflt_ft8_cc_01.RAW	melanoma
+A375 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 53	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_1A/W091211_XG_A375_1A_OGE/W091211_XG_A375_1A_04_OGE_raflt_ft8_cc_01.RAW	W091211_XG_A375_1A_04_OGE_raflt_ft8_cc_01.RAW	melanoma
+A375 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 54	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_1A/W091211_XG_A375_1A_OGE/W091211_XG_A375_1A_05_OGE_raflt_ft8_cc_01.RAW	W091211_XG_A375_1A_05_OGE_raflt_ft8_cc_01.RAW	melanoma
+A375 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 55	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_1A/W091211_XG_A375_1A_OGE/W091211_XG_A375_1A_06_OGE_raflt_ft8_cc_01.RAW	W091211_XG_A375_1A_06_OGE_raflt_ft8_cc_01.RAW	melanoma
+A375 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 56	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_1A/W091211_XG_A375_1A_OGE/W091211_XG_A375_1A_07_OGE_raflt_ft8_cc_01.RAW	W091211_XG_A375_1A_07_OGE_raflt_ft8_cc_01.RAW	melanoma
+A375 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 57	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_1A/W091211_XG_A375_1A_OGE/W091211_XG_A375_1A_08_OGE_raflt_ft8_cc_01.RAW	W091211_XG_A375_1A_08_OGE_raflt_ft8_cc_01.RAW	melanoma
+A375 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 58	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_1A/W091211_XG_A375_1A_OGE/W091211_XG_A375_1A_09_10_OGE_raflt_ft8_cc_01.RAW	W091211_XG_A375_1A_09_10_OGE_raflt_ft8_cc_01.RAW	melanoma
+A375 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 59	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_1A/W091211_XG_A375_1A_OGE/W091211_XG_A375_1A_11_OGE_raflt_ft8_cc_01.RAW	W091211_XG_A375_1A_11_OGE_raflt_ft8_cc_01.RAW	melanoma
+A375 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 60	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_1A/W091211_XG_A375_1A_OGE/W091211_XG_A375_1A_12_OGE_raflt_ft8_cc_01.RAW	W091211_XG_A375_1A_12_OGE_raflt_ft8_cc_01.RAW	melanoma
+A375 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 61	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	not applicable	not applicable	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_3A/W091103_XG_A375_3A/W091103_XG_A375_3A_FP_rafkt_ft8_cc_01.RAW	W091103_XG_A375_3A_FP_rafkt_ft8_cc_01.RAW	melanoma
+A375 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 62	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_3A/W091212_XG_A375_3A_OGE/W091212_XG_A375_3A_01_OGE_raflt_ft8_cc_01.RAW	W091212_XG_A375_3A_01_OGE_raflt_ft8_cc_01.RAW	melanoma
+A375 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 63	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_3A/W091212_XG_A375_3A_OGE/W091212_XG_A375_3A_02_OGE_raflt_ft8_cc_01.RAW	W091212_XG_A375_3A_02_OGE_raflt_ft8_cc_01.RAW	melanoma
+A375 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 64	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_3A/W091212_XG_A375_3A_OGE/W091212_XG_A375_3A_03_OGE_raflt_ft8_cc_01.RAW	W091212_XG_A375_3A_03_OGE_raflt_ft8_cc_01.RAW	melanoma
+A375 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 65	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_3A/W091212_XG_A375_3A_OGE/W091212_XG_A375_3A_04_OGE_raflt_ft8_cc_01.RAW	W091212_XG_A375_3A_04_OGE_raflt_ft8_cc_01.RAW	melanoma
+A375 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 66	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_3A/W091212_XG_A375_3A_OGE/W091212_XG_A375_3A_05_OGE_raflt_ft8_cc_01.RAW	W091212_XG_A375_3A_05_OGE_raflt_ft8_cc_01.RAW	melanoma
+A375 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 67	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_3A/W091212_XG_A375_3A_OGE/W091212_XG_A375_3A_06_OGE_raflt_ft8_cc_01.RAW	W091212_XG_A375_3A_06_OGE_raflt_ft8_cc_01.RAW	melanoma
+A375 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 68	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_3A/W091212_XG_A375_3A_OGE/W091212_XG_A375_3A_07_OGE_raflt_ft8_cc_01.RAW	W091212_XG_A375_3A_07_OGE_raflt_ft8_cc_01.RAW	melanoma
+A375 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 69	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_3A/W091212_XG_A375_3A_OGE/W091212_XG_A375_3A_08_OGE_raflt_ft8_cc_01.RAW	W091212_XG_A375_3A_08_OGE_raflt_ft8_cc_01.RAW	melanoma
+A375 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 70	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_3A/W091212_XG_A375_3A_OGE/W091212_XG_A375_3A_09_10_OGE_raflt_ft8_cc_01.RAW	W091212_XG_A375_3A_09_10_OGE_raflt_ft8_cc_01.RAW	melanoma
+A375 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 71	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_3A/W091212_XG_A375_3A_OGE/W091212_XG_A375_3A_11_OGE_raflt_ft8_cc_01.RAW	W091212_XG_A375_3A_11_OGE_raflt_ft8_cc_01.RAW	melanoma
+A375 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	A375	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 72	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/A375_3A/W091212_XG_A375_3A_OGE/W091212_XG_A375_3A_12_OGE_raflt_ft8_cc_01.RAW	W091212_XG_A375_3A_12_OGE_raflt_ft8_cc_01.RAW	melanoma
+MA2 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 73	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	not applicable	not applicable	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_2B/W100120_XG_MA2_2B/W100120_XG_MA2_2B_FP_rafkt_ft8_cc_01.RAW	W100120_XG_MA2_2B_FP_rafkt_ft8_cc_01.RAW	melanoma
+MA2 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 74	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_2B/W100212_XG_MA2_2B_OGE/W100212_XG_MA2_2B_OGE_01_rafkt_ft8_cc_01.RAW	W100212_XG_MA2_2B_OGE_01_rafkt_ft8_cc_01.RAW	melanoma
+MA2 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 75	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_2B/W100212_XG_MA2_2B_OGE/W100212_XG_MA2_2B_OGE_02_rafkt_ft8_cc_01.RAW	W100212_XG_MA2_2B_OGE_02_rafkt_ft8_cc_01.RAW	melanoma
+MA2 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 76	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_2B/W100212_XG_MA2_2B_OGE/W100212_XG_MA2_2B_OGE_03_rafkt_ft8_cc_01.RAW	W100212_XG_MA2_2B_OGE_03_rafkt_ft8_cc_01.RAW	melanoma
+MA2 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 77	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_2B/W100212_XG_MA2_2B_OGE/W100212_XG_MA2_2B_OGE_04_rafkt_ft8_cc_01.RAW	W100212_XG_MA2_2B_OGE_04_rafkt_ft8_cc_01.RAW	melanoma
+MA2 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 78	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_2B/W100212_XG_MA2_2B_OGE/W100212_XG_MA2_2B_OGE_05_rafkt_ft8_cc_01.RAW	W100212_XG_MA2_2B_OGE_05_rafkt_ft8_cc_01.RAW	melanoma
+MA2 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 79	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_2B/W100212_XG_MA2_2B_OGE/W100212_XG_MA2_2B_OGE_06_rafkt_ft8_cc_01.RAW	W100212_XG_MA2_2B_OGE_06_rafkt_ft8_cc_01.RAW	melanoma
+MA2 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 80	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_2B/W100212_XG_MA2_2B_OGE/W100212_XG_MA2_2B_OGE_07_rafkt_ft8_cc_01.RAW	W100212_XG_MA2_2B_OGE_07_rafkt_ft8_cc_01.RAW	melanoma
+MA2 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 81	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_2B/W100212_XG_MA2_2B_OGE/W100212_XG_MA2_2B_OGE_08_rafkt_ft8_cc_01.RAW	W100212_XG_MA2_2B_OGE_08_rafkt_ft8_cc_01.RAW	melanoma
+MA2 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 82	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_2B/W100212_XG_MA2_2B_OGE/W100212_XG_MA2_2B_OGE_09_10_rafkt_ft8_cc_01.RAW	W100212_XG_MA2_2B_OGE_09_10_rafkt_ft8_cc_01.RAW	melanoma
+MA2 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 83	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_2B/W100212_XG_MA2_2B_OGE/W100212_XG_MA2_2B_OGE_11_rafkt_ft8_cc_01.RAW	W100212_XG_MA2_2B_OGE_11_rafkt_ft8_cc_01.RAW	melanoma
+MA2 sample 1	1	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 84	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_2B/W100212_XG_MA2_2B_OGE/W100212_XG_MA2_2B_OGE_12_rafkt_ft8_cc_01.RAW	W100212_XG_MA2_2B_OGE_12_rafkt_ft8_cc_01.RAW	melanoma
+MA2 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 85	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	not applicable	not applicable	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_3A/W100120_XG_MA2_3A/W100120_XG_MA2_3A_FP_rafkt_ft8_cc_01.RAW	W100120_XG_MA2_3A_FP_rafkt_ft8_cc_01.RAW	melanoma
+MA2 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 86	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_3A/W100222_XG_MA2_3A_OGE/W100222_XG_MA2_3A_OGE_01_rafkt_ft8_cc_01.RAW	W100222_XG_MA2_3A_OGE_01_rafkt_ft8_cc_01.RAW	melanoma
+MA2 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 87	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_3A/W100222_XG_MA2_3A_OGE/W100222_XG_MA2_3A_OGE_02_rafkt_ft8_cc_01.RAW	W100222_XG_MA2_3A_OGE_02_rafkt_ft8_cc_01.RAW	melanoma
+MA2 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 88	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_3A/W100222_XG_MA2_3A_OGE/W100222_XG_MA2_3A_OGE_03_rafkt_ft8_cc_01.RAW	W100222_XG_MA2_3A_OGE_03_rafkt_ft8_cc_01.RAW	melanoma
+MA2 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 89	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_3A/W100222_XG_MA2_3A_OGE/W100222_XG_MA2_3A_OGE_04_rafkt_ft8_cc_01.RAW	W100222_XG_MA2_3A_OGE_04_rafkt_ft8_cc_01.RAW	melanoma
+MA2 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 90	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_3A/W100222_XG_MA2_3A_OGE/W100222_XG_MA2_3A_OGE_05_rafkt_ft8_cc_01.RAW	W100222_XG_MA2_3A_OGE_05_rafkt_ft8_cc_01.RAW	melanoma
+MA2 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 91	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_3A/W100222_XG_MA2_3A_OGE/W100222_XG_MA2_3A_OGE_06_rafkt_ft8_cc_01.RAW	W100222_XG_MA2_3A_OGE_06_rafkt_ft8_cc_01.RAW	melanoma
+MA2 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 92	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_3A/W100222_XG_MA2_3A_OGE/W100222_XG_MA2_3A_OGE_07_rafkt_ft8_cc_01.RAW	W100222_XG_MA2_3A_OGE_07_rafkt_ft8_cc_01.RAW	melanoma
+MA2 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 93	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_3A/W100222_XG_MA2_3A_OGE/W100222_XG_MA2_3A_OGE_08_rafkt_ft8_cc_01.RAW	W100222_XG_MA2_3A_OGE_08_rafkt_ft8_cc_01.RAW	melanoma
+MA2 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 94	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_3A/W100222_XG_MA2_3A_OGE/W100222_XG_MA2_3A_OGE_09_10_rafkt_ft8_cc_01.RAW	W100222_XG_MA2_3A_OGE_09_10_rafkt_ft8_cc_01.RAW	melanoma
+MA2 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 95	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_3A/W100222_XG_MA2_3A_OGE/W100222_XG_MA2_3A_OGE_11_rafkt_ft8_cc_01.RAW	W100222_XG_MA2_3A_OGE_11_rafkt_ft8_cc_01.RAW	melanoma
+MA2 sample 2	2	homo sapiens	not available	cancer cell line grown in mice	tumor cell	MA2	54y	melanoma	NT=Extraction purification;AC=NCIT:C113061	run 96	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078494/spectrum/XG/MA2_3A/W100222_XG_MA2_3A_OGE/W100222_XG_MA2_3A_OGE_12_rafkt_ft8_cc_01.RAW	W100222_XG_MA2_3A_OGE_12_rafkt_ft8_cc_01.RAW	melanoma
\ No newline at end of file
diff --git a/annotated-projects/MSV000078535/MSV000078535.sdrf.tsv b/annotated-projects/MSV000078535/MSV000078535.sdrf.tsv
index d7c7fcb0..437f88ee 100644
--- a/annotated-projects/MSV000078535/MSV000078535.sdrf.tsv
+++ b/annotated-projects/MSV000078535/MSV000078535.sdrf.tsv
@@ -1,45 +1,45 @@
 source name	characteristics[biological replicate]	characteristics[organism]	characteristics[organism part]	characteristics[xenograft]	characteristics[cell type]	characteristics[cell line]	characteristics[age]	characteristics[sex]	characteristics[disease]	characteristics[enrichment process]	characteristics[phenotype]	assay name	technology type	comment[cleavage agent details]	comment[cleavage agent details]	comment[cleavage agent details]	comment[fractionation method]	comment[fraction identifier]	comment[fragment mass tolerance]	comment[precursor mass tolerance]	comment[technical replicate]	comment[instrument]	comment[label]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[tool metadata]	comment[file uri]	comment[data file]	factor value[phenotype]
-LM2_3	1	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=increased metastatic potential;AC=MP:0001272	run 1	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/LM2/W101005_LM2_3_OGE/W101005_LM2_3_OGE01_rafkt_ft8_cc_01.RAW	W101005_LM2_3_OGE01_rafkt_ft8_cc_01.RAW	NT=increased metastatic potential;AC=MP:0001272
-LM2_3	1	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=increased metastatic potential;AC=MP:0001272	run 2	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/LM2/W101005_LM2_3_OGE/W101005_LM2_3_OGE02_rafkt_ft8_cc_01.RAW	W101005_LM2_3_OGE02_rafkt_ft8_cc_01.RAW	NT=increased metastatic potential;AC=MP:0001272
-LM2_3	1	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=increased metastatic potential;AC=MP:0001272	run 3	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/LM2/W101005_LM2_3_OGE/W101005_LM2_3_OGE03_rafkt_ft8_cc_01.RAW	W101005_LM2_3_OGE03_rafkt_ft8_cc_01.RAW	NT=increased metastatic potential;AC=MP:0001272
-LM2_3	1	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=increased metastatic potential;AC=MP:0001272	run 4	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/LM2/W101005_LM2_3_OGE/W101005_LM2_3_OGE04_rafkt_ft8_cc_01.RAW	W101005_LM2_3_OGE04_rafkt_ft8_cc_01.RAW	NT=increased metastatic potential;AC=MP:0001272
-LM2_3	1	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=increased metastatic potential;AC=MP:0001272	run 5	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/LM2/W101005_LM2_3_OGE/W101005_LM2_3_OGE05_rafkt_ft8_cc_01.RAW	W101005_LM2_3_OGE05_rafkt_ft8_cc_01.RAW	NT=increased metastatic potential;AC=MP:0001272
-LM2_3	1	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=increased metastatic potential;AC=MP:0001272	run 6	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/LM2/W101005_LM2_3_OGE/W101005_LM2_3_OGE06_rafkt_ft8_cc_01.RAW	W101005_LM2_3_OGE06_rafkt_ft8_cc_01.RAW	NT=increased metastatic potential;AC=MP:0001272
-LM2_3	1	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=increased metastatic potential;AC=MP:0001272	run 7	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/LM2/W101005_LM2_3_OGE/W101005_LM2_3_OGE07_rafkt_ft8_cc_01.RAW	W101005_LM2_3_OGE07_rafkt_ft8_cc_01.RAW	NT=increased metastatic potential;AC=MP:0001272
-LM2_3	1	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=increased metastatic potential;AC=MP:0001272	run 8	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/LM2/W101005_LM2_3_OGE/W101005_LM2_3_OGE08_rafkt_ft8_cc_01.RAW	W101005_LM2_3_OGE08_rafkt_ft8_cc_01.RAW	NT=increased metastatic potential;AC=MP:0001272
-LM2_3	1	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=increased metastatic potential;AC=MP:0001272	run 9	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/LM2/W101005_LM2_3_OGE/W101005_LM2_3_OGE09_10_rafkt_ft8_cc_01.RAW	W101005_LM2_3_OGE09_10_rafkt_ft8_cc_01.RAW	NT=increased metastatic potential;AC=MP:0001272
-LM2_3	1	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=increased metastatic potential;AC=MP:0001272	run 10	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/LM2/W101005_LM2_3_OGE/W101005_LM2_3_OGE11_rafkt_ft8_cc_01.RAW	W101005_LM2_3_OGE11_rafkt_ft8_cc_01.RAW	NT=increased metastatic potential;AC=MP:0001272
-LM2_1	2	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=increased metastatic potential;AC=MP:0001272	run 11	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/LM2/W101005_LM2_3_OGE/W101005_LM2_3_OGE12_rafkt_ft8_cc_01.RAW	W101005_LM2_3_OGE12_rafkt_ft8_cc_01.RAW	NT=increased metastatic potential;AC=MP:0001272
-LM2_1	2	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=increased metastatic potential;AC=MP:0001272	run 12	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/LM2/W101023_LM2_1_OGE/W101023_LM2_1_OGE01_rafkt_ft8_cc_01.RAW	W101023_LM2_1_OGE01_rafkt_ft8_cc_01.RAW	NT=increased metastatic potential;AC=MP:0001272
-LM2_1	2	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=increased metastatic potential;AC=MP:0001272	run 13	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/LM2/W101023_LM2_1_OGE/W101023_LM2_1_OGE02_rafkt_ft8_cc_01.RAW	W101023_LM2_1_OGE02_rafkt_ft8_cc_01.RAW	NT=increased metastatic potential;AC=MP:0001272
-LM2_1	2	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=increased metastatic potential;AC=MP:0001272	run 14	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/LM2/W101023_LM2_1_OGE/W101023_LM2_1_OGE03_rafkt_ft8_cc_01.RAW	W101023_LM2_1_OGE03_rafkt_ft8_cc_01.RAW	NT=increased metastatic potential;AC=MP:0001272
-LM2_1	2	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=increased metastatic potential;AC=MP:0001272	run 15	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/LM2/W101023_LM2_1_OGE/W101023_LM2_1_OGE04_rafkt_ft8_cc_01.RAW	W101023_LM2_1_OGE04_rafkt_ft8_cc_01.RAW	NT=increased metastatic potential;AC=MP:0001272
-LM2_1	2	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=increased metastatic potential;AC=MP:0001272	run 16	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/LM2/W101023_LM2_1_OGE/W101023_LM2_1_OGE05_rafkt_ft8_cc_01.RAW	W101023_LM2_1_OGE05_rafkt_ft8_cc_01.RAW	NT=increased metastatic potential;AC=MP:0001272
-LM2_1	2	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=increased metastatic potential;AC=MP:0001272	run 17	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/LM2/W101023_LM2_1_OGE/W101023_LM2_1_OGE06_rafkt_ft8_cc_01.RAW	W101023_LM2_1_OGE06_rafkt_ft8_cc_01.RAW	NT=increased metastatic potential;AC=MP:0001272
-LM2_1	2	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=increased metastatic potential;AC=MP:0001272	run 18	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/LM2/W101023_LM2_1_OGE/W101023_LM2_1_OGE07_rafkt_ft8_cc_01.RAW	W101023_LM2_1_OGE07_rafkt_ft8_cc_01.RAW	NT=increased metastatic potential;AC=MP:0001272
-LM2_1	2	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=increased metastatic potential;AC=MP:0001272	run 19	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/LM2/W101023_LM2_1_OGE/W101023_LM2_1_OGE08_rafkt_ft8_cc_01.RAW	W101023_LM2_1_OGE08_rafkt_ft8_cc_01.RAW	NT=increased metastatic potential;AC=MP:0001272
-LM2_1	2	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=increased metastatic potential;AC=MP:0001272	run 20	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/LM2/W101023_LM2_1_OGE/W101023_LM2_1_OGE09_10_rafkt_ft8_cc_01.RAW	W101023_LM2_1_OGE09_10_rafkt_ft8_cc_01.RAW	NT=increased metastatic potential;AC=MP:0001272
-LM2_1	2	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=increased metastatic potential;AC=MP:0001272	run 21	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/LM2/W101023_LM2_1_OGE/W101023_LM2_1_OGE11_rafkt_ft8_cc_01.RAW	W101023_LM2_1_OGE11_rafkt_ft8_cc_01.RAW	NT=increased metastatic potential;AC=MP:0001272
-LM2_1	2	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=increased metastatic potential;AC=MP:0001272	run 22	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/LM2/W101023_LM2_1_OGE/W101023_LM2_1_OGE12_rafkt_ft8_cc_01.RAW	W101023_LM2_1_OGE12_rafkt_ft8_cc_01.RAW	NT=increased metastatic potential;AC=MP:0001272
-MDAMB231_1	1	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=decreased metastatic potential;AC=MP:0001273	run 23	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/MDAMB231/D101003_MDAMB231_1_OGE/D101001_MDAMB231_1_OGE01_rafkt_ft8_cc_01.RAW	D101001_MDAMB231_1_OGE01_rafkt_ft8_cc_01.RAW	NT=decreased metastatic potential;AC=MP:0001273
-MDAMB231_1	1	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=decreased metastatic potential;AC=MP:0001273	run 24	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/MDAMB231/D101003_MDAMB231_1_OGE/D101003_MDAMB231_1_OGE02_rafkt_ft8_cc_01.RAW	D101003_MDAMB231_1_OGE02_rafkt_ft8_cc_01.RAW	NT=decreased metastatic potential;AC=MP:0001273
-MDAMB231_1	1	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=decreased metastatic potential;AC=MP:0001273	run 25	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/MDAMB231/D101003_MDAMB231_1_OGE/D101003_MDAMB231_1_OGE03_rafkt_ft8_cc_01.RAW	D101003_MDAMB231_1_OGE03_rafkt_ft8_cc_01.RAW	NT=decreased metastatic potential;AC=MP:0001273
-MDAMB231_1	1	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=decreased metastatic potential;AC=MP:0001273	run 26	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/MDAMB231/D101003_MDAMB231_1_OGE/D101003_MDAMB231_1_OGE04_rafkt_ft8_cc_01.RAW	D101003_MDAMB231_1_OGE04_rafkt_ft8_cc_01.RAW	NT=decreased metastatic potential;AC=MP:0001273
-MDAMB231_1	1	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=decreased metastatic potential;AC=MP:0001273	run 27	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/MDAMB231/D101003_MDAMB231_1_OGE/D101003_MDAMB231_1_OGE05_rafkt_ft8_cc_01.RAW	D101003_MDAMB231_1_OGE05_rafkt_ft8_cc_01.RAW	NT=decreased metastatic potential;AC=MP:0001273
-MDAMB231_1	1	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=decreased metastatic potential;AC=MP:0001273	run 28	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/MDAMB231/D101003_MDAMB231_1_OGE/D101003_MDAMB231_1_OGE06_rafkt_ft8_cc_01.RAW	D101003_MDAMB231_1_OGE06_rafkt_ft8_cc_01.RAW	NT=decreased metastatic potential;AC=MP:0001273
-MDAMB231_1	1	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=decreased metastatic potential;AC=MP:0001273	run 29	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/MDAMB231/D101003_MDAMB231_1_OGE/D101003_MDAMB231_1_OGE07_rafkt_ft8_cc_01.RAW	D101003_MDAMB231_1_OGE07_rafkt_ft8_cc_01.RAW	NT=decreased metastatic potential;AC=MP:0001273
-MDAMB231_1	1	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=decreased metastatic potential;AC=MP:0001273	run 30	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/MDAMB231/D101003_MDAMB231_1_OGE/D101003_MDAMB231_1_OGE08_rafkt_ft8_cc_01.RAW	D101003_MDAMB231_1_OGE08_rafkt_ft8_cc_01.RAW	NT=decreased metastatic potential;AC=MP:0001273
-MDAMB231_1	1	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=decreased metastatic potential;AC=MP:0001273	run 31	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/MDAMB231/D101003_MDAMB231_1_OGE/D101003_MDAMB231_1_OGE09_10_rafkt_ft8_cc_01.RAW	D101003_MDAMB231_1_OGE09_10_rafkt_ft8_cc_01.RAW	NT=decreased metastatic potential;AC=MP:0001273
-MDAMB231_1	1	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=decreased metastatic potential;AC=MP:0001273	run 32	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/MDAMB231/D101003_MDAMB231_1_OGE/D101003_MDAMB231_1_OGE11_rafkt_ft8_cc_01.RAW	D101003_MDAMB231_1_OGE11_rafkt_ft8_cc_01.RAW	NT=decreased metastatic potential;AC=MP:0001273
-MDAMB231_1	1	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=decreased metastatic potential;AC=MP:0001273	run 33	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/MDAMB231/D101003_MDAMB231_1_OGE/D101003_MDAMB231_1_OGE12_rafkt_ft8_cc_01.RAW	D101003_MDAMB231_1_OGE12_rafkt_ft8_cc_01.RAW	NT=decreased metastatic potential;AC=MP:0001273
-MDAMB231_2	2	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=decreased metastatic potential;AC=MP:0001273	run 34	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/MDAMB231/W101022_MDAMB231_2_OGE/W101022_MDAMB231_2_OGE01_rafkt_ft8_cc_01.RAW	W101022_MDAMB231_2_OGE01_rafkt_ft8_cc_01.RAW	NT=decreased metastatic potential;AC=MP:0001273
-MDAMB231_2	2	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=decreased metastatic potential;AC=MP:0001273	run 35	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/MDAMB231/W101022_MDAMB231_2_OGE/W101022_MDAMB231_2_OGE02_rafkt_ft8_cc_01.RAW	W101022_MDAMB231_2_OGE02_rafkt_ft8_cc_01.RAW	NT=decreased metastatic potential;AC=MP:0001273
-MDAMB231_2	2	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=decreased metastatic potential;AC=MP:0001273	run 36	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/MDAMB231/W101022_MDAMB231_2_OGE/W101022_MDAMB231_2_OGE03_rafkt_ft8_cc_01.RAW	W101022_MDAMB231_2_OGE03_rafkt_ft8_cc_01.RAW	NT=decreased metastatic potential;AC=MP:0001273
-MDAMB231_2	2	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=decreased metastatic potential;AC=MP:0001273	run 37	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/MDAMB231/W101022_MDAMB231_2_OGE/W101022_MDAMB231_2_OGE04_rafkt_ft8_cc_01.RAW	W101022_MDAMB231_2_OGE04_rafkt_ft8_cc_01.RAW	NT=decreased metastatic potential;AC=MP:0001273
-MDAMB231_2	2	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=decreased metastatic potential;AC=MP:0001273	run 38	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/MDAMB231/W101022_MDAMB231_2_OGE/W101022_MDAMB231_2_OGE05_rafkt_ft8_cc_01.RAW	W101022_MDAMB231_2_OGE05_rafkt_ft8_cc_01.RAW	NT=decreased metastatic potential;AC=MP:0001273
-MDAMB231_2	2	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=decreased metastatic potential;AC=MP:0001273	run 39	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/MDAMB231/W101022_MDAMB231_2_OGE/W101022_MDAMB231_2_OGE06_rafkt_ft8_cc_01.RAW	W101022_MDAMB231_2_OGE06_rafkt_ft8_cc_01.RAW	NT=decreased metastatic potential;AC=MP:0001273
-MDAMB231_2	2	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=decreased metastatic potential;AC=MP:0001273	run 40	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/MDAMB231/W101022_MDAMB231_2_OGE/W101022_MDAMB231_2_OGE07_rafkt_ft8_cc_01.RAW	W101022_MDAMB231_2_OGE07_rafkt_ft8_cc_01.RAW	NT=decreased metastatic potential;AC=MP:0001273
-MDAMB231_2	2	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=decreased metastatic potential;AC=MP:0001273	run 41	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/MDAMB231/W101022_MDAMB231_2_OGE/W101022_MDAMB231_2_OGE08_rafkt_ft8_cc_01.RAW	W101022_MDAMB231_2_OGE08_rafkt_ft8_cc_01.RAW	NT=decreased metastatic potential;AC=MP:0001273
-MDAMB231_2	2	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=decreased metastatic potential;AC=MP:0001273	run 42	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/MDAMB231/W101022_MDAMB231_2_OGE/W101022_MDAMB231_2_OGE09_10_rafkt_ft8_cc_01.RAW	W101022_MDAMB231_2_OGE09_10_rafkt_ft8_cc_01.RAW	NT=decreased metastatic potential;AC=MP:0001273
-MDAMB231_2	2	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=decreased metastatic potential;AC=MP:0001273	run 43	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/MDAMB231/W101022_MDAMB231_2_OGE/W101022_MDAMB231_2_OGE11_rafkt_ft8_cc_01.RAW	W101022_MDAMB231_2_OGE11_rafkt_ft8_cc_01.RAW	NT=decreased metastatic potential;AC=MP:0001273
-MDAMB231_2	2	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=decreased metastatic potential;AC=MP:0001273	run 44	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/MDAMB231/W101022_MDAMB231_2_OGE/W101022_MDAMB231_2_OGE12_rafkt_ft8_cc_01.RAW	W101022_MDAMB231_2_OGE12_rafkt_ft8_cc_01.RAW	NT=decreased metastatic potential;AC=MP:0001273
\ No newline at end of file
+LM2_3	1	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=increased metastatic potential;AC=MP:0001272	run 1	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/LM2/W101005_LM2_3_OGE/W101005_LM2_3_OGE01_rafkt_ft8_cc_01.RAW	W101005_LM2_3_OGE01_rafkt_ft8_cc_01.RAW	NT=increased metastatic potential;AC=MP:0001272
+LM2_3	1	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=increased metastatic potential;AC=MP:0001272	run 2	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/LM2/W101005_LM2_3_OGE/W101005_LM2_3_OGE02_rafkt_ft8_cc_01.RAW	W101005_LM2_3_OGE02_rafkt_ft8_cc_01.RAW	NT=increased metastatic potential;AC=MP:0001272
+LM2_3	1	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=increased metastatic potential;AC=MP:0001272	run 3	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/LM2/W101005_LM2_3_OGE/W101005_LM2_3_OGE03_rafkt_ft8_cc_01.RAW	W101005_LM2_3_OGE03_rafkt_ft8_cc_01.RAW	NT=increased metastatic potential;AC=MP:0001272
+LM2_3	1	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=increased metastatic potential;AC=MP:0001272	run 4	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/LM2/W101005_LM2_3_OGE/W101005_LM2_3_OGE04_rafkt_ft8_cc_01.RAW	W101005_LM2_3_OGE04_rafkt_ft8_cc_01.RAW	NT=increased metastatic potential;AC=MP:0001272
+LM2_3	1	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=increased metastatic potential;AC=MP:0001272	run 5	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/LM2/W101005_LM2_3_OGE/W101005_LM2_3_OGE05_rafkt_ft8_cc_01.RAW	W101005_LM2_3_OGE05_rafkt_ft8_cc_01.RAW	NT=increased metastatic potential;AC=MP:0001272
+LM2_3	1	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=increased metastatic potential;AC=MP:0001272	run 6	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/LM2/W101005_LM2_3_OGE/W101005_LM2_3_OGE06_rafkt_ft8_cc_01.RAW	W101005_LM2_3_OGE06_rafkt_ft8_cc_01.RAW	NT=increased metastatic potential;AC=MP:0001272
+LM2_3	1	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=increased metastatic potential;AC=MP:0001272	run 7	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/LM2/W101005_LM2_3_OGE/W101005_LM2_3_OGE07_rafkt_ft8_cc_01.RAW	W101005_LM2_3_OGE07_rafkt_ft8_cc_01.RAW	NT=increased metastatic potential;AC=MP:0001272
+LM2_3	1	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=increased metastatic potential;AC=MP:0001272	run 8	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/LM2/W101005_LM2_3_OGE/W101005_LM2_3_OGE08_rafkt_ft8_cc_01.RAW	W101005_LM2_3_OGE08_rafkt_ft8_cc_01.RAW	NT=increased metastatic potential;AC=MP:0001272
+LM2_3	1	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=increased metastatic potential;AC=MP:0001272	run 9	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/LM2/W101005_LM2_3_OGE/W101005_LM2_3_OGE09_10_rafkt_ft8_cc_01.RAW	W101005_LM2_3_OGE09_10_rafkt_ft8_cc_01.RAW	NT=increased metastatic potential;AC=MP:0001272
+LM2_3	1	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=increased metastatic potential;AC=MP:0001272	run 10	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/LM2/W101005_LM2_3_OGE/W101005_LM2_3_OGE11_rafkt_ft8_cc_01.RAW	W101005_LM2_3_OGE11_rafkt_ft8_cc_01.RAW	NT=increased metastatic potential;AC=MP:0001272
+LM2_1	2	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=increased metastatic potential;AC=MP:0001272	run 11	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/LM2/W101005_LM2_3_OGE/W101005_LM2_3_OGE12_rafkt_ft8_cc_01.RAW	W101005_LM2_3_OGE12_rafkt_ft8_cc_01.RAW	NT=increased metastatic potential;AC=MP:0001272
+LM2_1	2	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=increased metastatic potential;AC=MP:0001272	run 12	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/LM2/W101023_LM2_1_OGE/W101023_LM2_1_OGE01_rafkt_ft8_cc_01.RAW	W101023_LM2_1_OGE01_rafkt_ft8_cc_01.RAW	NT=increased metastatic potential;AC=MP:0001272
+LM2_1	2	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=increased metastatic potential;AC=MP:0001272	run 13	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/LM2/W101023_LM2_1_OGE/W101023_LM2_1_OGE02_rafkt_ft8_cc_01.RAW	W101023_LM2_1_OGE02_rafkt_ft8_cc_01.RAW	NT=increased metastatic potential;AC=MP:0001272
+LM2_1	2	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=increased metastatic potential;AC=MP:0001272	run 14	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/LM2/W101023_LM2_1_OGE/W101023_LM2_1_OGE03_rafkt_ft8_cc_01.RAW	W101023_LM2_1_OGE03_rafkt_ft8_cc_01.RAW	NT=increased metastatic potential;AC=MP:0001272
+LM2_1	2	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=increased metastatic potential;AC=MP:0001272	run 15	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/LM2/W101023_LM2_1_OGE/W101023_LM2_1_OGE04_rafkt_ft8_cc_01.RAW	W101023_LM2_1_OGE04_rafkt_ft8_cc_01.RAW	NT=increased metastatic potential;AC=MP:0001272
+LM2_1	2	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=increased metastatic potential;AC=MP:0001272	run 16	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/LM2/W101023_LM2_1_OGE/W101023_LM2_1_OGE05_rafkt_ft8_cc_01.RAW	W101023_LM2_1_OGE05_rafkt_ft8_cc_01.RAW	NT=increased metastatic potential;AC=MP:0001272
+LM2_1	2	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=increased metastatic potential;AC=MP:0001272	run 17	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/LM2/W101023_LM2_1_OGE/W101023_LM2_1_OGE06_rafkt_ft8_cc_01.RAW	W101023_LM2_1_OGE06_rafkt_ft8_cc_01.RAW	NT=increased metastatic potential;AC=MP:0001272
+LM2_1	2	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=increased metastatic potential;AC=MP:0001272	run 18	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/LM2/W101023_LM2_1_OGE/W101023_LM2_1_OGE07_rafkt_ft8_cc_01.RAW	W101023_LM2_1_OGE07_rafkt_ft8_cc_01.RAW	NT=increased metastatic potential;AC=MP:0001272
+LM2_1	2	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=increased metastatic potential;AC=MP:0001272	run 19	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/LM2/W101023_LM2_1_OGE/W101023_LM2_1_OGE08_rafkt_ft8_cc_01.RAW	W101023_LM2_1_OGE08_rafkt_ft8_cc_01.RAW	NT=increased metastatic potential;AC=MP:0001272
+LM2_1	2	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=increased metastatic potential;AC=MP:0001272	run 20	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/LM2/W101023_LM2_1_OGE/W101023_LM2_1_OGE09_10_rafkt_ft8_cc_01.RAW	W101023_LM2_1_OGE09_10_rafkt_ft8_cc_01.RAW	NT=increased metastatic potential;AC=MP:0001272
+LM2_1	2	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=increased metastatic potential;AC=MP:0001272	run 21	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/LM2/W101023_LM2_1_OGE/W101023_LM2_1_OGE11_rafkt_ft8_cc_01.RAW	W101023_LM2_1_OGE11_rafkt_ft8_cc_01.RAW	NT=increased metastatic potential;AC=MP:0001272
+LM2_1	2	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=increased metastatic potential;AC=MP:0001272	run 22	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/LM2/W101023_LM2_1_OGE/W101023_LM2_1_OGE12_rafkt_ft8_cc_01.RAW	W101023_LM2_1_OGE12_rafkt_ft8_cc_01.RAW	NT=increased metastatic potential;AC=MP:0001272
+MDAMB231_1	1	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=decreased metastatic potential;AC=MP:0001273	run 23	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/MDAMB231/D101003_MDAMB231_1_OGE/D101001_MDAMB231_1_OGE01_rafkt_ft8_cc_01.RAW	D101001_MDAMB231_1_OGE01_rafkt_ft8_cc_01.RAW	NT=decreased metastatic potential;AC=MP:0001273
+MDAMB231_1	1	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=decreased metastatic potential;AC=MP:0001273	run 24	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/MDAMB231/D101003_MDAMB231_1_OGE/D101003_MDAMB231_1_OGE02_rafkt_ft8_cc_01.RAW	D101003_MDAMB231_1_OGE02_rafkt_ft8_cc_01.RAW	NT=decreased metastatic potential;AC=MP:0001273
+MDAMB231_1	1	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=decreased metastatic potential;AC=MP:0001273	run 25	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/MDAMB231/D101003_MDAMB231_1_OGE/D101003_MDAMB231_1_OGE03_rafkt_ft8_cc_01.RAW	D101003_MDAMB231_1_OGE03_rafkt_ft8_cc_01.RAW	NT=decreased metastatic potential;AC=MP:0001273
+MDAMB231_1	1	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=decreased metastatic potential;AC=MP:0001273	run 26	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/MDAMB231/D101003_MDAMB231_1_OGE/D101003_MDAMB231_1_OGE04_rafkt_ft8_cc_01.RAW	D101003_MDAMB231_1_OGE04_rafkt_ft8_cc_01.RAW	NT=decreased metastatic potential;AC=MP:0001273
+MDAMB231_1	1	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=decreased metastatic potential;AC=MP:0001273	run 27	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/MDAMB231/D101003_MDAMB231_1_OGE/D101003_MDAMB231_1_OGE05_rafkt_ft8_cc_01.RAW	D101003_MDAMB231_1_OGE05_rafkt_ft8_cc_01.RAW	NT=decreased metastatic potential;AC=MP:0001273
+MDAMB231_1	1	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=decreased metastatic potential;AC=MP:0001273	run 28	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/MDAMB231/D101003_MDAMB231_1_OGE/D101003_MDAMB231_1_OGE06_rafkt_ft8_cc_01.RAW	D101003_MDAMB231_1_OGE06_rafkt_ft8_cc_01.RAW	NT=decreased metastatic potential;AC=MP:0001273
+MDAMB231_1	1	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=decreased metastatic potential;AC=MP:0001273	run 29	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/MDAMB231/D101003_MDAMB231_1_OGE/D101003_MDAMB231_1_OGE07_rafkt_ft8_cc_01.RAW	D101003_MDAMB231_1_OGE07_rafkt_ft8_cc_01.RAW	NT=decreased metastatic potential;AC=MP:0001273
+MDAMB231_1	1	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=decreased metastatic potential;AC=MP:0001273	run 30	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/MDAMB231/D101003_MDAMB231_1_OGE/D101003_MDAMB231_1_OGE08_rafkt_ft8_cc_01.RAW	D101003_MDAMB231_1_OGE08_rafkt_ft8_cc_01.RAW	NT=decreased metastatic potential;AC=MP:0001273
+MDAMB231_1	1	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=decreased metastatic potential;AC=MP:0001273	run 31	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/MDAMB231/D101003_MDAMB231_1_OGE/D101003_MDAMB231_1_OGE09_10_rafkt_ft8_cc_01.RAW	D101003_MDAMB231_1_OGE09_10_rafkt_ft8_cc_01.RAW	NT=decreased metastatic potential;AC=MP:0001273
+MDAMB231_1	1	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=decreased metastatic potential;AC=MP:0001273	run 32	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/MDAMB231/D101003_MDAMB231_1_OGE/D101003_MDAMB231_1_OGE11_rafkt_ft8_cc_01.RAW	D101003_MDAMB231_1_OGE11_rafkt_ft8_cc_01.RAW	NT=decreased metastatic potential;AC=MP:0001273
+MDAMB231_1	1	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=decreased metastatic potential;AC=MP:0001273	run 33	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/MDAMB231/D101003_MDAMB231_1_OGE/D101003_MDAMB231_1_OGE12_rafkt_ft8_cc_01.RAW	D101003_MDAMB231_1_OGE12_rafkt_ft8_cc_01.RAW	NT=decreased metastatic potential;AC=MP:0001273
+MDAMB231_2	2	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=decreased metastatic potential;AC=MP:0001273	run 34	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/MDAMB231/W101022_MDAMB231_2_OGE/W101022_MDAMB231_2_OGE01_rafkt_ft8_cc_01.RAW	W101022_MDAMB231_2_OGE01_rafkt_ft8_cc_01.RAW	NT=decreased metastatic potential;AC=MP:0001273
+MDAMB231_2	2	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=decreased metastatic potential;AC=MP:0001273	run 35	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/MDAMB231/W101022_MDAMB231_2_OGE/W101022_MDAMB231_2_OGE02_rafkt_ft8_cc_01.RAW	W101022_MDAMB231_2_OGE02_rafkt_ft8_cc_01.RAW	NT=decreased metastatic potential;AC=MP:0001273
+MDAMB231_2	2	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=decreased metastatic potential;AC=MP:0001273	run 36	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/MDAMB231/W101022_MDAMB231_2_OGE/W101022_MDAMB231_2_OGE03_rafkt_ft8_cc_01.RAW	W101022_MDAMB231_2_OGE03_rafkt_ft8_cc_01.RAW	NT=decreased metastatic potential;AC=MP:0001273
+MDAMB231_2	2	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=decreased metastatic potential;AC=MP:0001273	run 37	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/MDAMB231/W101022_MDAMB231_2_OGE/W101022_MDAMB231_2_OGE04_rafkt_ft8_cc_01.RAW	W101022_MDAMB231_2_OGE04_rafkt_ft8_cc_01.RAW	NT=decreased metastatic potential;AC=MP:0001273
+MDAMB231_2	2	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=decreased metastatic potential;AC=MP:0001273	run 38	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/MDAMB231/W101022_MDAMB231_2_OGE/W101022_MDAMB231_2_OGE05_rafkt_ft8_cc_01.RAW	W101022_MDAMB231_2_OGE05_rafkt_ft8_cc_01.RAW	NT=decreased metastatic potential;AC=MP:0001273
+MDAMB231_2	2	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=decreased metastatic potential;AC=MP:0001273	run 39	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/MDAMB231/W101022_MDAMB231_2_OGE/W101022_MDAMB231_2_OGE06_rafkt_ft8_cc_01.RAW	W101022_MDAMB231_2_OGE06_rafkt_ft8_cc_01.RAW	NT=decreased metastatic potential;AC=MP:0001273
+MDAMB231_2	2	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=decreased metastatic potential;AC=MP:0001273	run 40	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/MDAMB231/W101022_MDAMB231_2_OGE/W101022_MDAMB231_2_OGE07_rafkt_ft8_cc_01.RAW	W101022_MDAMB231_2_OGE07_rafkt_ft8_cc_01.RAW	NT=decreased metastatic potential;AC=MP:0001273
+MDAMB231_2	2	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=decreased metastatic potential;AC=MP:0001273	run 41	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/MDAMB231/W101022_MDAMB231_2_OGE/W101022_MDAMB231_2_OGE08_rafkt_ft8_cc_01.RAW	W101022_MDAMB231_2_OGE08_rafkt_ft8_cc_01.RAW	NT=decreased metastatic potential;AC=MP:0001273
+MDAMB231_2	2	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=decreased metastatic potential;AC=MP:0001273	run 42	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/MDAMB231/W101022_MDAMB231_2_OGE/W101022_MDAMB231_2_OGE09_10_rafkt_ft8_cc_01.RAW	W101022_MDAMB231_2_OGE09_10_rafkt_ft8_cc_01.RAW	NT=decreased metastatic potential;AC=MP:0001273
+MDAMB231_2	2	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=decreased metastatic potential;AC=MP:0001273	run 43	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/MDAMB231/W101022_MDAMB231_2_OGE/W101022_MDAMB231_2_OGE11_rafkt_ft8_cc_01.RAW	W101022_MDAMB231_2_OGE11_rafkt_ft8_cc_01.RAW	NT=decreased metastatic potential;AC=MP:0001273
+MDAMB231_2	2	homo sapiens	mammary gland	cancer cell line grown in mice	mammary gland epithelial cell	MDAMB231	51y	F	adenocarcinoma	NT= Extraction purification;AC=NCIT:C113061	NT=decreased metastatic potential;AC=MP:0001273	run 44	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap;AC=MS:1000449	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078535/spectrum/MDAMB231/W101022_MDAMB231_2_OGE/W101022_MDAMB231_2_OGE12_rafkt_ft8_cc_01.RAW	W101022_MDAMB231_2_OGE12_rafkt_ft8_cc_01.RAW	NT=decreased metastatic potential;AC=MP:0001273
\ No newline at end of file
diff --git a/annotated-projects/MSV000078555/MSV000078555.sdrf.tsv b/annotated-projects/MSV000078555/MSV000078555.sdrf.tsv
index 0babe748..abc81c34 100644
--- a/annotated-projects/MSV000078555/MSV000078555.sdrf.tsv
+++ b/annotated-projects/MSV000078555/MSV000078555.sdrf.tsv
@@ -1,177 +1,177 @@
 source name	characteristics[biological replicate]	characteristics[organism]	characteristics[organism part]	characteristics[cell type]	characteristics[age]	characteristics[ancestry category]	characteristics[sex]	characteristics[disease]	characteristics[individual]	characteristics[pool]	characteristics[enrichment process]	assay name	technology type	comment[cleavage agent details]	comment[cleavage agent details]	comment[cleavage agent details]	comment[fractionation method]	comment[fraction identifier]	comment[fragment mass tolerance]	comment[precursor mass tolerance]	comment[technical replicate]	comment[instrument]	comment[label]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[tool metadata]	comment[file uri]	comment[data file]	factor value[disease]
-Liver Metastasis Pateint 1 	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 1	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110731_LiK_540/D110729_MGH_540_OGE08_rafkt_ft8dt_cc_01.RAW	D110729_MGH_540_OGE08_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 1	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 2	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9 _10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110731_LiK_540/D110729_MGH_540_OGE09_10_rafkt_ft8dt_cc_01.RAW	D110729_MGH_540_OGE09_10_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 1	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 3	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110731_LiK_540/D110729_MGH_540_OGE11_rafkt_ft8dt_cc_01.RAW	D110729_MGH_540_OGE11_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 1	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 4	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	12	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110731_LiK_540/D110729_MGH_540_OGE12_rafkt_ft8dt_cc_01.RAW	D110729_MGH_540_OGE12_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 1	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 5	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110731_LiK_540/D110731_MGH_540_OGE01_rafkt_ft8dt_cc_01.RAW	D110731_MGH_540_OGE01_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 1	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 6	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110731_LiK_540/D110731_MGH_540_OGE02_rafkt_ft8dt_cc_01.RAW	D110731_MGH_540_OGE02_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 1	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 7	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110731_LiK_540/D110731_MGH_540_OGE03_rafkt_ft8dt_cc_01.RAW	D110731_MGH_540_OGE03_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 1	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 8	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110731_LiK_540/D110731_MGH_540_OGE04_rafkt_ft8dt_cc_01.RAW	D110731_MGH_540_OGE04_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 1	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 9	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110731_LiK_540/D110731_MGH_540_OGE05_rafkt_ft8dt_cc_01.RAW	D110731_MGH_540_OGE05_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 1	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 10	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110731_LiK_540/D110731_MGH_540_OGE06_rafkt_ft8dt_cc_01.RAW	D110731_MGH_540_OGE06_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 1	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 11	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110731_LiK_540/D110731_MGH_540_OGE07_rafkt_ft8dt_cc_01.RAW	D110731_MGH_540_OGE07_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Normal Colon Patient 1	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 12	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110801_CoN_446/D110801_MGH_446_OGE01_rafkt_ft8_cc_01.RAW	D110801_MGH_446_OGE01_rafkt_ft8_cc_01.RAW	normal
-Normal Colon Patient 1	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 13	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110801_CoN_446/D110801_MGH_446_OGE02_rafkt_ft8_cc_01.RAW	D110801_MGH_446_OGE02_rafkt_ft8_cc_01.RAW	normal
-Normal Colon Patient 1	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 14	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110801_CoN_446/D110801_MGH_446_OGE03_rafkt_ft8_cc_01.RAW	D110801_MGH_446_OGE03_rafkt_ft8_cc_01.RAW	normal
-Normal Colon Patient 1	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 15	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110801_CoN_446/D110801_MGH_446_OGE04_rafkt_ft8_cc_01.RAW	D110801_MGH_446_OGE04_rafkt_ft8_cc_01.RAW	normal
-Normal Colon Patient 1	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 16	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110801_CoN_446/D110801_MGH_446_OGE05_rafkt_ft8_cc_01.RAW	D110801_MGH_446_OGE05_rafkt_ft8_cc_01.RAW	normal
-Normal Colon Patient 1	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 17	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110801_CoN_446/D110801_MGH_446_OGE06_rafkt_ft8_cc_01.RAW	D110801_MGH_446_OGE06_rafkt_ft8_cc_01.RAW	normal
-Normal Colon Patient 1	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 18	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110801_CoN_446/D110801_MGH_446_OGE07_rafkt_ft8_cc_01.RAW	D110801_MGH_446_OGE07_rafkt_ft8_cc_01.RAW	normal
-Normal Colon Patient 1	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 19	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110801_CoN_446/D110801_MGH_446_OGE08_rafkt_ft8_cc_01.RAW	D110801_MGH_446_OGE08_rafkt_ft8_cc_01.RAW	normal
-Normal Colon Patient 1	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 20	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9_10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110801_CoN_446/D110801_MGH_446_OGE09_10_rafkt_ft8_cc_01.RAW	D110801_MGH_446_OGE09_10_rafkt_ft8_cc_01.RAW	normal
-Normal Colon Patient 1	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 21	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110801_CoN_446/D110801_MGH_446_OGE11_rafkt_ft8_cc_01.RAW	D110801_MGH_446_OGE11_rafkt_ft8_cc_01.RAW	normal
-Normal Colon Patient 1	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 22	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	12	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110801_CoN_446/D110801_MGH_446_OGE12_rafkt_ft8_cc_01.RAW	D110801_MGH_446_OGE12_rafkt_ft8_cc_01.RAW	normal
-Normal Colon Patient 1	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 23	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110806_CoN_446A/D110728_MGH_446A_OGE01_rafkt_ft8dt_cc_01.RAW	D110728_MGH_446A_OGE01_rafkt_ft8dt_cc_01.RAW	normal
-Normal Colon Patient 1	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 24	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110806_CoN_446A/D110728_MGH_446A_OGE02_rafkt_ft8dt_cc_01.RAW	D110728_MGH_446A_OGE02_rafkt_ft8dt_cc_01.RAW	normal
-Normal Colon Patient 1	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 25	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110806_CoN_446A/D110806_MGH_446A_OGE03_rafkt_ft8dt_cc_01.RAW	D110806_MGH_446A_OGE03_rafkt_ft8dt_cc_01.RAW	normal
-Normal Colon Patient 1	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 26	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110806_CoN_446A/D110806_MGH_446A_OGE04_rafkt_ft8dt_cc_01.RAW	D110806_MGH_446A_OGE04_rafkt_ft8dt_cc_01.RAW	normal
-Normal Colon Patient 1	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 27	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110806_CoN_446A/D110806_MGH_446A_OGE05_rafkt_ft8dt_cc_01.RAW	D110806_MGH_446A_OGE05_rafkt_ft8dt_cc_01.RAW	normal
-Normal Colon Patient 1	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 28	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110806_CoN_446A/D110806_MGH_446A_OGE06_rafkt_ft8dt_cc_01.RAW	D110806_MGH_446A_OGE06_rafkt_ft8dt_cc_01.RAW	normal
-Normal Colon Patient 1	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 29	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110806_CoN_446A/D110806_MGH_446A_OGE07_rafkt_ft8dt_cc_01.RAW	D110806_MGH_446A_OGE07_rafkt_ft8dt_cc_01.RAW	normal
-Normal Colon Patient 1	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 30	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110806_CoN_446A/D110806_MGH_446A_OGE08_rafkt_ft8dt_cc_01.RAW	D110806_MGH_446A_OGE08_rafkt_ft8dt_cc_01.RAW	normal
-Normal Colon Patient 1	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 31	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9_10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110806_CoN_446A/D110806_MGH_446A_OGE09_10_rafkt_ft8dt_cc_01.RAW	D110806_MGH_446A_OGE09_10_rafkt_ft8dt_cc_01.RAW	normal
-Normal Colon Patient 1	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 32	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110806_CoN_446A/D110806_MGH_446A_OGE11_rafkt_ft8dt_cc_01.RAW	D110806_MGH_446A_OGE11_rafkt_ft8dt_cc_01.RAW	normal
-Normal Colon Patient 1	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 33	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	12	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110806_CoN_446A/D110806_MGH_446A_OGE12_rafkt_ft8dt_cc_01.RAW	D110806_MGH_446A_OGE12_rafkt_ft8dt_cc_01.RAW	normal
-Liver Metastasis Patient 1	2	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 34	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111019_LiK_540a/D111019_MGH_540a_OGE01_rafkt_ft8dt_cc_01.RAW	D111019_MGH_540a_OGE01_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 1	2	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 35	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111019_LiK_540a/D111019_MGH_540a_OGE02_rafkt_ft8dt_cc_01.RAW	D111019_MGH_540a_OGE02_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 1	2	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 36	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111019_LiK_540a/D111019_MGH_540a_OGE03_rafkt_ft8dt_cc_01.RAW	D111019_MGH_540a_OGE03_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 1	2	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 37	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111019_LiK_540a/D111019_MGH_540a_OGE04_rafkt_ft8dt_cc_01.RAW	D111019_MGH_540a_OGE04_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 1	2	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 38	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111019_LiK_540a/D111019_MGH_540a_OGE05_rafkt_ft8dt_cc_01.RAW	D111019_MGH_540a_OGE05_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 1	2	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 39	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111019_LiK_540a/D111019_MGH_540a_OGE06_rafkt_ft8dt_cc_01.RAW	D111019_MGH_540a_OGE06_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 1	2	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 40	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111019_LiK_540a/D111019_MGH_540a_OGE07_rafkt_ft8dt_cc_01.RAW	D111019_MGH_540a_OGE07_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 1	2	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 41	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111019_LiK_540a/D111019_MGH_540a_OGE08_rafkt_ft8dt_cc_01.RAW	D111019_MGH_540a_OGE08_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 1	2	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 42	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9_10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111019_LiK_540a/D111019_MGH_540a_OGE09_10_rafkt_ft8dt_cc_01.RAW	D111019_MGH_540a_OGE09_10_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 1	2	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 43	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111019_LiK_540a/D111019_MGH_540a_OGE11_rafkt_ft8dt_cc_01.RAW	D111019_MGH_540a_OGE11_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 1	2	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 44	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	12	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111019_LiK_540a/D111019_MGH_540a_OGE12_rafkt_ft8dt_cc_01.RAW	D111019_MGH_540a_OGE12_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Colon Tumor Patient 1	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 45	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9_10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111129_CoK_445a/D111129_MGH_445a_OGE09_10_rafkt_ft8dt_cc_01.RAW	D111129_MGH_445a_OGE09_10_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 1	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 46	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111129_CoK_445a/D111129_MGH_445a_OGE11_rafkt_ft8dt_cc_01.RAW	D111129_MGH_445a_OGE11_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 1	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 47	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	12	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111129_CoK_445a/D111129_MGH_445a_OGE12_rafkt_ft8dt_cc_01.RAW	D111129_MGH_445a_OGE12_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 1	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 48	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111129_CoK_445a/D111130_MGH_445a_OGE01_rafkt_ft8dt_cc_01.RAW	D111130_MGH_445a_OGE01_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 1	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 49	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111129_CoK_445a/D111130_MGH_445a_OGE02_rafkt_ft8dt_cc_01.RAW	D111130_MGH_445a_OGE02_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 1	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 50	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111129_CoK_445a/D111130_MGH_445a_OGE03_rafkt_ft8dt_cc_01.RAW	D111130_MGH_445a_OGE03_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 1	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 51	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111129_CoK_445a/D111201_MGH_445a_OGE04_rafkt_ft8dt_cc_01.RAW	D111201_MGH_445a_OGE04_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 1	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 52	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111129_CoK_445a/D111201_MGH_445a_OGE05_rafkt_ft8dt_cc_01.RAW	D111201_MGH_445a_OGE05_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 1	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 53	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111129_CoK_445a/D111202_MGH_445a_OGE06_rafkt_ft8dt_cc_01.RAW	D111202_MGH_445a_OGE06_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 1	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 54	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111129_CoK_445a/D111202_MGH_445a_OGE07_rafkt_ft8dt_cc_01.RAW	D111202_MGH_445a_OGE07_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 1	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 55	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111129_CoK_445a/D111202_MGH_445a_OGE08_rafkt_ft8dt_cc_01.RAW	D111202_MGH_445a_OGE08_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 1	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 56	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111202_CoK_445/D111202_MGH_445_OGE01_rafkt_ft8dt_cc_01.RAW	D111202_MGH_445_OGE01_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 1	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 57	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111202_CoK_445/D111202_MGH_445_OGE02_rafkt_ft8dt_cc_01.RAW	D111202_MGH_445_OGE02_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 1	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 58	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111202_CoK_445/D111202_MGH_445_OGE03_rafkt_ft8dt_cc_01.RAW	D111202_MGH_445_OGE03_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 1	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 59	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111202_CoK_445/D111202_MGH_445_OGE04_rafkt_ft8dt_cc_01.RAW	D111202_MGH_445_OGE04_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 1	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 60	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111202_CoK_445/D111202_MGH_445_OGE05_rafkt_ft8dt_cc_01.RAW	D111202_MGH_445_OGE05_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 1	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 61	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	10_11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111202_CoK_445/D111205_MGH_445_OGE010_11_rafkt_ft8dt_cc_01.RAW	D111205_MGH_445_OGE010_11_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 1	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 62	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111202_CoK_445/D111205_MGH_445_OGE06_rafkt_ft8dt_cc_01.RAW	D111205_MGH_445_OGE06_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 1	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 63	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111202_CoK_445/D111205_MGH_445_OGE07_rafkt_ft8dt_cc_01.RAW	D111205_MGH_445_OGE07_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 1	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 64	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111202_CoK_445/D111205_MGH_445_OGE08_rafkt_ft8dt_cc_01.RAW	D111205_MGH_445_OGE08_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 1	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 65	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111202_CoK_445/D111205_MGH_445_OGE09_rafkt_ft8dt_cc_01.RAW	D111205_MGH_445_OGE09_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 1	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 66	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	12	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111202_CoK_445/D111205_MGH_445_OGE12_rafkt_ft8dt_cc_01.RAW	D111205_MGH_445_OGE12_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Normal Colon Patient 2	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 67	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120204_CoN_2207/D120204_MGH_2207_OGE01_rafkt_ft8dt_cc_01.RAW	D120204_MGH_2207_OGE01_rafkt_ft8dt_cc_01.RAW	normal
-Normal Colon Patient 2	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 68	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120204_CoN_2207/D120204_MGH_2207_OGE02_rafkt_ft8dt_cc_01.RAW	D120204_MGH_2207_OGE02_rafkt_ft8dt_cc_01.RAW	normal
-Normal Colon Patient 2	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 69	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120204_CoN_2207/D120204_MGH_2207_OGE03_rafkt_ft8dt_cc_01.RAW	D120204_MGH_2207_OGE03_rafkt_ft8dt_cc_01.RAW	normal
-Normal Colon Patient 2	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 70	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120204_CoN_2207/D120204_MGH_2207_OGE04_rafkt_ft8dt_cc_01.RAW	D120204_MGH_2207_OGE04_rafkt_ft8dt_cc_01.RAW	normal
-Normal Colon Patient 2	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 71	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120204_CoN_2207/D120204_MGH_2207_OGE05_rafkt_ft8dt_cc_01.RAW	D120204_MGH_2207_OGE05_rafkt_ft8dt_cc_01.RAW	normal
-Normal Colon Patient 2	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 72	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120204_CoN_2207/D120204_MGH_2207_OGE06_rafkt_ft8dt_cc_01.RAW	D120204_MGH_2207_OGE06_rafkt_ft8dt_cc_01.RAW	normal
-Normal Colon Patient 2	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 73	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120204_CoN_2207/D120204_MGH_2207_OGE07_rafkt_ft8dt_cc_01.RAW	D120204_MGH_2207_OGE07_rafkt_ft8dt_cc_01.RAW	normal
-Normal Colon Patient 2	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 74	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120204_CoN_2207/D120204_MGH_2207_OGE08_rafkt_ft8dt_cc_01.RAW	D120204_MGH_2207_OGE08_rafkt_ft8dt_cc_01.RAW	normal
-Normal Colon Patient 2	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 75	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9_10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120204_CoN_2207/D120204_MGH_2207_OGE09_10_rafkt_ft8dt_cc_01.RAW	D120204_MGH_2207_OGE09_10_rafkt_ft8dt_cc_01.RAW	normal
-Normal Colon Patient 2	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 76	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120204_CoN_2207/D120204_MGH_2207_OGE11_rafkt_ft8dt_cc_01.RAW	D120204_MGH_2207_OGE11_rafkt_ft8dt_cc_01.RAW	normal
-Normal Colon Patient 2	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 77	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	12	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120204_CoN_2207/D120204_MGH_2207_OGE12_rafkt_ft8dt_cc_01.RAW	D120204_MGH_2207_OGE12_rafkt_ft8dt_cc_01.RAW	normal
-Colon Tumor Patient 2	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 78	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120205_CoK_2205/D120205_MGH_2205_OGE01_rafkt_ft8dt_cc_01.RAW	D120205_MGH_2205_OGE01_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 2	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 79	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120205_CoK_2205/D120205_MGH_2205_OGE02_rafkt_ft8dt_cc_01.RAW	D120205_MGH_2205_OGE02_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 2	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 80	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120205_CoK_2205/D120205_MGH_2205_OGE03_rafkt_ft8dt_cc_01.RAW	D120205_MGH_2205_OGE03_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 2	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 81	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120205_CoK_2205/D120205_MGH_2205_OGE04_rafkt_ft8dt_cc_01.RAW	D120205_MGH_2205_OGE04_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 2	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 82	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120205_CoK_2205/D120205_MGH_2205_OGE05_rafkt_ft8dt_cc_01.RAW	D120205_MGH_2205_OGE05_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 2	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 83	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120205_CoK_2205/D120205_MGH_2205_OGE06_rafkt_ft8dt_cc_01.RAW	D120205_MGH_2205_OGE06_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 2	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 84	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120205_CoK_2205/D120205_MGH_2205_OGE07_rafkt_ft8dt_cc_01.RAW	D120205_MGH_2205_OGE07_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 2	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 85	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120205_CoK_2205/D120205_MGH_2205_OGE08_rafkt_ft8dt_cc_01.RAW	D120205_MGH_2205_OGE08_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 2	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 86	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9_10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120205_CoK_2205/D120205_MGH_2205_OGE09_10_rafkt_ft8dt_cc_01.RAW	D120205_MGH_2205_OGE09_10_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 2	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 87	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120205_CoK_2205/D120205_MGH_2205_OGE11_rafkt_ft8dt_cc_01.RAW	D120205_MGH_2205_OGE11_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 2	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 88	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	12	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120205_CoK_2205/D120205_MGH_2205_OGE12_rafkt_ft8dt_cc_01.RAW	D120205_MGH_2205_OGE12_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 2	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 89	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120217_CoK_2205A/D120217_MGH_2205A_OGE08_rafkt_ft8dt_cc_01.RAW	D120217_MGH_2205A_OGE08_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 2	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 90	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120217_CoK_2205A/D120217_MGH_2205A_OGE09_10_rafkt_ft8dt_cc_01.RAW	D120217_MGH_2205A_OGE09_10_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 2	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 91	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120217_CoK_2205A/D120217_MGH_2205A_OGE11_rafkt_ft8dt_cc_01.RAW	D120217_MGH_2205A_OGE11_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 2	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 92	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	12	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120217_CoK_2205A/D120217_MGH_2205A_OGE12_rafkt_ft8dt_cc_01.RAW	D120217_MGH_2205A_OGE12_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 2	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 93	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120217_CoK_2205A/D120221_MGH_2205A_OGE01_rafkt_ft8dt_cc_01.RAW	D120221_MGH_2205A_OGE01_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 2	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 94	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120217_CoK_2205A/D120221_MGH_2205A_OGE02_rafkt_ft8dt_cc_01.RAW	D120221_MGH_2205A_OGE02_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 2	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 95	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120217_CoK_2205A/D120221_MGH_2205A_OGE03_rafkt_ft8dt_cc_01.RAW	D120221_MGH_2205A_OGE03_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 2	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 96	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120217_CoK_2205A/D120221_MGH_2205A_OGE04_rafkt_ft8dt_cc_01.RAW	D120221_MGH_2205A_OGE04_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 2	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 97	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120217_CoK_2205A/D120221_MGH_2205A_OGE05_rafkt_ft8dt_cc_01.RAW	D120221_MGH_2205A_OGE05_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 2	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 98	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120217_CoK_2205A/D120221_MGH_2205A_OGE06_rafkt_ft8dt_cc_01.RAW	D120221_MGH_2205A_OGE06_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 2	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 99	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120217_CoK_2205A/D120221_MGH_2205A_OGE07_rafkt_ft8dt_cc_01.RAW	D120221_MGH_2205A_OGE07_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Liver Metastasis Patient 2	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 100	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120222_LiK_2446/D120222_MGH_2446_OGE01_rafkt_ft8dt_cc_01.RAW	D120222_MGH_2446_OGE01_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 2	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 101	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120222_LiK_2446/D120222_MGH_2446_OGE02_rafkt_ft8dt_cc_01.RAW	D120222_MGH_2446_OGE02_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 2	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 102	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120222_LiK_2446/D120222_MGH_2446_OGE03_rafkt_ft8dt_cc_01.RAW	D120222_MGH_2446_OGE03_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 2	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 103	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120222_LiK_2446/D120222_MGH_2446_OGE04_rafkt_ft8dt_cc_01.RAW	D120222_MGH_2446_OGE04_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 2	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 104	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120222_LiK_2446/D120222_MGH_2446_OGE05_rafkt_ft8dt_cc_01.RAW	D120222_MGH_2446_OGE05_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 2	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 105	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120222_LiK_2446/D120222_MGH_2446_OGE06_rafkt_ft8dt_cc_01.RAW	D120222_MGH_2446_OGE06_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 2	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 106	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120222_LiK_2446/D120222_MGH_2446_OGE07_rafkt_ft8dt_cc_01.RAW	D120222_MGH_2446_OGE07_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 2	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 107	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120222_LiK_2446/D120222_MGH_2446_OGE08_rafkt_ft8dt_cc_01.RAW	D120222_MGH_2446_OGE08_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 2	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 108	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9_10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120222_LiK_2446/D120222_MGH_2446_OGE09_10_rafkt_ft8dt_cc_01.RAW	D120222_MGH_2446_OGE09_10_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 2	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 109	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120222_LiK_2446/D120222_MGH_2446_OGE11_rafkt_ft8dt_cc_01.RAW	D120222_MGH_2446_OGE11_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 2	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 110	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	12	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120222_LiK_2446/D120222_MGH_2446_OGE12_rafkt_ft8dt_cc_01.RAW	D120222_MGH_2446_OGE12_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 2	2	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 111	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120223_LiK_2446A/D120223_MGH_2446A_OGE01_rafkt_ft8dt_cc_01.RAW	D120223_MGH_2446A_OGE01_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 2	2	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 112	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120223_LiK_2446A/D120223_MGH_2446A_OGE02_rafkt_ft8dt_cc_01.RAW	D120223_MGH_2446A_OGE02_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 2	2	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 113	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120223_LiK_2446A/D120223_MGH_2446A_OGE03_rafkt_ft8dt_cc_01.RAW	D120223_MGH_2446A_OGE03_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 2	2	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 114	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120223_LiK_2446A/D120223_MGH_2446A_OGE04_rafkt_ft8dt_cc_01.RAW	D120223_MGH_2446A_OGE04_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 2	2	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 115	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120223_LiK_2446A/D120223_MGH_2446A_OGE05_rafkt_ft8dt_cc_01.RAW	D120223_MGH_2446A_OGE05_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 2	2	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 116	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120223_LiK_2446A/D120223_MGH_2446A_OGE06_rafkt_ft8dt_cc_01.RAW	D120223_MGH_2446A_OGE06_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 2	2	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 117	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120223_LiK_2446A/D120223_MGH_2446A_OGE07_rafkt_ft8dt_cc_01.RAW	D120223_MGH_2446A_OGE07_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 2	2	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 118	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120223_LiK_2446A/D120223_MGH_2446A_OGE08_rafkt_ft8dt_cc_01.RAW	D120223_MGH_2446A_OGE08_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 2	2	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 119	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9_10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120223_LiK_2446A/D120223_MGH_2446A_OGE09_10_rafkt_ft8dt_cc_01.RAW	D120223_MGH_2446A_OGE09_10_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 2	2	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 120	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120223_LiK_2446A/D120223_MGH_2446A_OGE11_rafkt_ft8dt_cc_01.RAW	D120223_MGH_2446A_OGE11_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 2	2	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 121	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	12	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120223_LiK_2446A/D120223_MGH_2446A_OGE12_rafkt_ft8dt_cc_01.RAW	D120223_MGH_2446A_OGE12_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Normal Liver [Pool 1]	1	homo sapiens	liver	hepatocyte	not available	not available	not available	normal	not applicable	pooled	NT= Extraction purification;AC=NCIT:C113061	run 122	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120417_LiN_HS1/D120417_MGH_HS1_NLi_OGE03_rafkt_ft8dt_cc_01.RAW	D120417_MGH_HS1_NLi_OGE03_rafkt_ft8dt_cc_01.RAW	normal
-Normal Liver [Pool 1]	1	homo sapiens	liver	hepatocyte	not available	not available	not available	normal	not applicable	pooled	NT= Extraction purification;AC=NCIT:C113061	run 123	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120417_LiN_HS1/D120417_MGH_HS1_NLi_OGE04_rafkt_ft8dt_cc_01.RAW	D120417_MGH_HS1_NLi_OGE04_rafkt_ft8dt_cc_01.RAW	normal
-Normal Liver [Pool 1]	1	homo sapiens	liver	hepatocyte	not available	not available	not available	normal	not applicable	pooled	NT= Extraction purification;AC=NCIT:C113061	run 124	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120417_LiN_HS1/D120417_MGH_HS1_NLi_OGE05_rafkt_ft8dt_cc_01.RAW	D120417_MGH_HS1_NLi_OGE05_rafkt_ft8dt_cc_01.RAW	normal
-Normal Liver [Pool 1]	1	homo sapiens	liver	hepatocyte	not available	not available	not available	normal	not applicable	pooled	NT= Extraction purification;AC=NCIT:C113061	run 125	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120417_LiN_HS1/D120417_MGH_HS1_NLi_OGE06_rafkt_ft8dt_cc_01.RAW	D120417_MGH_HS1_NLi_OGE06_rafkt_ft8dt_cc_01.RAW	normal
-Normal Liver [Pool 1]	1	homo sapiens	liver	hepatocyte	not available	not available	not available	normal	not applicable	pooled	NT= Extraction purification;AC=NCIT:C113061	run 126	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120417_LiN_HS1/D120417_MGH_HS1_NLi_OGE07_rafkt_ft8dt_cc_01.RAW	D120417_MGH_HS1_NLi_OGE07_rafkt_ft8dt_cc_01.RAW	normal
-Normal Liver [Pool 1]	1	homo sapiens	liver	hepatocyte	not available	not available	not available	normal	not applicable	pooled	NT= Extraction purification;AC=NCIT:C113061	run 127	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120417_LiN_HS1/D120417_MGH_HS1_NLi_OGE08_rafkt_ft8dt_cc_01.RAW	D120417_MGH_HS1_NLi_OGE08_rafkt_ft8dt_cc_01.RAW	normal
-Normal Liver [Pool 1]	1	homo sapiens	liver	hepatocyte	not available	not available	not available	normal	not applicable	pooled	NT= Extraction purification;AC=NCIT:C113061	run 128	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9_10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120417_LiN_HS1/D120417_MGH_HS1_NLi_OGE09_10_rafkt_ft8dt_cc_01.RAW	D120417_MGH_HS1_NLi_OGE09_10_rafkt_ft8dt_cc_01.RAW	normal
-Normal Liver [Pool 1]	1	homo sapiens	liver	hepatocyte	not available	not available	not available	normal	not applicable	pooled	NT= Extraction purification;AC=NCIT:C113061	run 129	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120417_LiN_HS1/D120417_MGH_HS1_NLi_OGE11_rafkt_ft8dt_cc_01.RAW	D120417_MGH_HS1_NLi_OGE11_rafkt_ft8dt_cc_01.RAW	normal
-Normal Liver [Pool 1]	1	homo sapiens	liver	hepatocyte	not available	not available	not available	normal	not applicable	pooled	NT= Extraction purification;AC=NCIT:C113061	run 130	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	12	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120417_LiN_HS1/D120417_MGH_HS1_NLi_OGE12_rafkt_ft8dt_cc_01.RAW	D120417_MGH_HS1_NLi_OGE12_rafkt_ft8dt_cc_01.RAW	normal
-Normal Liver [Pool 1]	1	homo sapiens	liver	hepatocyte	not available	not available	not available	normal	not applicable	pooled	NT= Extraction purification;AC=NCIT:C113061	run 131	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120417_LiN_HS1/D120419_MGH_HS1_NLi_OGE01_rafkt_ft8dt_cc_01.RAW	D120419_MGH_HS1_NLi_OGE01_rafkt_ft8dt_cc_01.RAW	normal
-Normal Liver [Pool 1]	1	homo sapiens	liver	hepatocyte	not available	not available	not available	normal	not applicable	pooled	NT= Extraction purification;AC=NCIT:C113061	run 132	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120417_LiN_HS1/D120419_MGH_HS1_NLi_OGE02_rafkt_ft8dt_cc_01.RAW	D120419_MGH_HS1_NLi_OGE02_rafkt_ft8dt_cc_01.RAW	normal
-Normal Liver [Pool 2]	1	homo sapiens	liver	hepatocyte	not available	not available	not available	normal	not applicable	pooled	NT= Extraction purification;AC=NCIT:C113061	run 133	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120504_LiN_HS2/D120504_MGH_HS2_NLi_OGE01_rafkt_ft8dt_cc_01.RAW	D120504_MGH_HS2_NLi_OGE01_rafkt_ft8dt_cc_01.RAW	normal
-Normal Liver [Pool 2]	1	homo sapiens	liver	hepatocyte	not available	not available	not available	normal	not applicable	pooled	NT= Extraction purification;AC=NCIT:C113061	run 134	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120504_LiN_HS2/D120504_MGH_HS2_NLi_OGE02_rafkt_ft8dt_cc_01.RAW	D120504_MGH_HS2_NLi_OGE02_rafkt_ft8dt_cc_01.RAW	normal
-Normal Liver [Pool 2]	1	homo sapiens	liver	hepatocyte	not available	not available	not available	normal	not applicable	pooled	NT= Extraction purification;AC=NCIT:C113061	run 135	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120504_LiN_HS2/D120504_MGH_HS2_NLi_OGE03_rafkt_ft8dt_cc_01.RAW	D120504_MGH_HS2_NLi_OGE03_rafkt_ft8dt_cc_01.RAW	normal
-Normal Liver [Pool 2]	1	homo sapiens	liver	hepatocyte	not available	not available	not available	normal	not applicable	pooled	NT= Extraction purification;AC=NCIT:C113061	run 136	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120504_LiN_HS2/D120504_MGH_HS2_NLi_OGE04_rafkt_ft8dt_cc_01.RAW	D120504_MGH_HS2_NLi_OGE04_rafkt_ft8dt_cc_01.RAW	normal
-Normal Liver [Pool 2]	1	homo sapiens	liver	hepatocyte	not available	not available	not available	normal	not applicable	pooled	NT= Extraction purification;AC=NCIT:C113061	run 137	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120504_LiN_HS2/D120504_MGH_HS2_NLi_OGE05_rafkt_ft8dt_cc_01.RAW	D120504_MGH_HS2_NLi_OGE05_rafkt_ft8dt_cc_01.RAW	normal
-Normal Liver [Pool 2]	1	homo sapiens	liver	hepatocyte	not available	not available	not available	normal	not applicable	pooled	NT= Extraction purification;AC=NCIT:C113061	run 138	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120504_LiN_HS2/D120504_MGH_HS2_NLi_OGE06_rafkt_ft8dt_cc_01.RAW	D120504_MGH_HS2_NLi_OGE06_rafkt_ft8dt_cc_01.RAW	normal
-Normal Liver [Pool 2]	1	homo sapiens	liver	hepatocyte	not available	not available	not available	normal	not applicable	pooled	NT= Extraction purification;AC=NCIT:C113061	run 139	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120504_LiN_HS2/D120504_MGH_HS2_NLi_OGE07_rafkt_ft8dt_cc_01.RAW	D120504_MGH_HS2_NLi_OGE07_rafkt_ft8dt_cc_01.RAW	normal
-Normal Liver [Pool 2]	1	homo sapiens	liver	hepatocyte	not available	not available	not available	normal	not applicable	pooled	NT= Extraction purification;AC=NCIT:C113061	run 140	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120504_LiN_HS2/D120504_MGH_HS2_NLi_OGE08_rafkt_ft8dt_cc_01.RAW	D120504_MGH_HS2_NLi_OGE08_rafkt_ft8dt_cc_01.RAW	normal
-Normal Liver [Pool 2]	1	homo sapiens	liver	hepatocyte	not available	not available	not available	normal	not applicable	pooled	NT= Extraction purification;AC=NCIT:C113061	run 141	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9_10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120504_LiN_HS2/D120504_MGH_HS2_NLi_OGE09_10_rafkt_ft8dt_cc_01.RAW	D120504_MGH_HS2_NLi_OGE09_10_rafkt_ft8dt_cc_01.RAW	normal
-Normal Liver [Pool 2]	1	homo sapiens	liver	hepatocyte	not available	not available	not available	normal	not applicable	pooled	NT= Extraction purification;AC=NCIT:C113061	run 142	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120504_LiN_HS2/D120504_MGH_HS2_NLi_OGE11_rafkt_ft8dt_cc_01.RAW	D120504_MGH_HS2_NLi_OGE11_rafkt_ft8dt_cc_01.RAW	normal
-Normal Liver [Pool 2]	1	homo sapiens	liver	hepatocyte	not available	not available	not available	normal	not applicable	pooled	NT= Extraction purification;AC=NCIT:C113061	run 143	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	12	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120504_LiN_HS2/D120504_MGH_HS2_NLi_OGE12_rafkt_ft8dt_cc_01.RAW	D120504_MGH_HS2_NLi_OGE12_rafkt_ft8dt_cc_01.RAW	normal
-Normal Colon Patient 3	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 144	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121010_CoN_1948A/D121010_MGH_NCo_1948A_OGE01_rafkt_ft8dt_cc_01.RAW	D121010_MGH_NCo_1948A_OGE01_rafkt_ft8dt_cc_01.RAW	normal
-Normal Colon Patient 3	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 145	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121010_CoN_1948A/D121010_MGH_NCo_1948A_OGE02_rafkt_ft8dt_cc_01.RAW	D121010_MGH_NCo_1948A_OGE02_rafkt_ft8dt_cc_01.RAW	normal
-Normal Colon Patient 3	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 146	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121010_CoN_1948A/D121010_MGH_NCo_1948A_OGE03_rafkt_ft8dt_cc_01.RAW	D121010_MGH_NCo_1948A_OGE03_rafkt_ft8dt_cc_01.RAW	normal
-Normal Colon Patient 3	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 147	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121010_CoN_1948A/D121010_MGH_NCo_1948A_OGE04_rafkt_ft8dt_cc_01.RAW	D121010_MGH_NCo_1948A_OGE04_rafkt_ft8dt_cc_01.RAW	normal
-Normal Colon Patient 3	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 148	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121010_CoN_1948A/D121010_MGH_NCo_1948A_OGE05_rafkt_ft8dt_cc_01.RAW	D121010_MGH_NCo_1948A_OGE05_rafkt_ft8dt_cc_01.RAW	normal
-Normal Colon Patient 3	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 149	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121010_CoN_1948A/D121010_MGH_NCo_1948A_OGE06_rafkt_ft8dt_cc_01.RAW	D121010_MGH_NCo_1948A_OGE06_rafkt_ft8dt_cc_01.RAW	normal
-Normal Colon Patient 3	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 150	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121010_CoN_1948A/D121010_MGH_NCo_1948A_OGE07_rafkt_ft8dt_cc_01.RAW	D121010_MGH_NCo_1948A_OGE07_rafkt_ft8dt_cc_01.RAW	normal
-Normal Colon Patient 3	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 151	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121010_CoN_1948A/D121010_MGH_NCo_1948A_OGE08_rafkt_ft8dt_cc_01.RAW	D121010_MGH_NCo_1948A_OGE08_rafkt_ft8dt_cc_01.RAW	normal
-Normal Colon Patient 3	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 152	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9_10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121010_CoN_1948A/D121010_MGH_NCo_1948A_OGE09_10_rafkt_ft8dt_cc_01.RAW	D121010_MGH_NCo_1948A_OGE09_10_rafkt_ft8dt_cc_01.RAW	normal
-Normal Colon Patient 3	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 153	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121010_CoN_1948A/D121010_MGH_NCo_1948A_OGE11_rafkt_ft8dt_cc_01.RAW	D121010_MGH_NCo_1948A_OGE11_rafkt_ft8dt_cc_01.RAW	normal
-Normal Colon Patient 3	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 154	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	12	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121010_CoN_1948A/D121010_MGH_NCo_1948A_OGE12_rafkt_ft8dt_cc_01.RAW	D121010_MGH_NCo_1948A_OGE12_rafkt_ft8dt_cc_01.RAW	normal
-Colon Tumor Patient 3	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 155	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121011_CoK_1947/D121011_MGH_CoK_1947_OGE01_rafkt_ft8dt_cc_01.RAW	D121011_MGH_CoK_1947_OGE01_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 3	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 156	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121011_CoK_1947/D121011_MGH_CoK_1947_OGE02_rafkt_ft8dt_cc_01.RAW	D121011_MGH_CoK_1947_OGE02_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 3	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 157	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121011_CoK_1947/D121011_MGH_CoK_1947_OGE03_rafkt_ft8dt_cc_01.RAW	D121011_MGH_CoK_1947_OGE03_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 3	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 158	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121011_CoK_1947/D121011_MGH_CoK_1947_OGE04_rafkt_ft8dt_cc_01.RAW	D121011_MGH_CoK_1947_OGE04_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 3	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 159	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121011_CoK_1947/D121011_MGH_CoK_1947_OGE05_rafkt_ft8dt_cc_01.RAW	D121011_MGH_CoK_1947_OGE05_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 3	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 160	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121011_CoK_1947/D121011_MGH_CoK_1947_OGE06_rafkt_ft8dt_cc_01.RAW	D121011_MGH_CoK_1947_OGE06_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 3	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 161	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121011_CoK_1947/D121011_MGH_CoK_1947_OGE07_rafkt_ft8dt_cc_01.RAW	D121011_MGH_CoK_1947_OGE07_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 3	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 162	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121011_CoK_1947/D121011_MGH_CoK_1947_OGE08_rafkt_ft8dt_cc_01.RAW	D121011_MGH_CoK_1947_OGE08_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 3	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 163	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9_10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121011_CoK_1947/D121011_MGH_CoK_1947_OGE09_10_rafkt_ft8dt_cc_01.RAW	D121011_MGH_CoK_1947_OGE09_10_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 3	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 164	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121011_CoK_1947/D121011_MGH_CoK_1947_OGE11_rafkt_ft8dt_cc_01.RAW	D121011_MGH_CoK_1947_OGE11_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Colon Tumor Patient 3	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 165	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	12	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121011_CoK_1947/D121011_MGH_CoK_1947_OGE12_rafkt_ft8dt_cc_01.RAW	D121011_MGH_CoK_1947_OGE12_rafkt_ft8dt_cc_01.RAW	colon carcinoma
-Liver Metastasis Patient 3	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 166	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121012_LiK_2333A/D121012_MGH_LiK_2333A_OGE01_rafkt_ft8dt_cc_01.RAW	D121012_MGH_LiK_2333A_OGE01_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 3	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 167	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121012_LiK_2333A/D121012_MGH_LiK_2333A_OGE02_rafkt_ft8dt_cc_01.RAW	D121012_MGH_LiK_2333A_OGE02_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 3	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 168	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121012_LiK_2333A/D121012_MGH_LiK_2333A_OGE03_rafkt_ft8dt_cc_01.RAW	D121012_MGH_LiK_2333A_OGE03_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 3	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 169	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121012_LiK_2333A/D121012_MGH_LiK_2333A_OGE04_rafkt_ft8dt_cc_01.RAW	D121012_MGH_LiK_2333A_OGE04_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 3	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 170	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121012_LiK_2333A/D121012_MGH_LiK_2333A_OGE05_rafkt_ft8dt_cc_01.RAW	D121012_MGH_LiK_2333A_OGE05_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 3	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 171	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121012_LiK_2333A/D121012_MGH_LiK_2333A_OGE06_rafkt_ft8dt_cc_01.RAW	D121012_MGH_LiK_2333A_OGE06_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 3	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 172	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121012_LiK_2333A/D121012_MGH_LiK_2333A_OGE07_rafkt_ft8dt_cc_01.RAW	D121012_MGH_LiK_2333A_OGE07_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 3	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 173	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121012_LiK_2333A/D121012_MGH_LiK_2333A_OGE08_rafkt_ft8dt_cc_01.RAW	D121012_MGH_LiK_2333A_OGE08_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 3	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 174	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9_10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121012_LiK_2333A/D121012_MGH_LiK_2333A_OGE09_10_rafkt_ft8dt_cc_01.RAW	D121012_MGH_LiK_2333A_OGE09_10_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 3	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 175	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121012_LiK_2333A/D121012_MGH_LiK_2333A_OGE11_rafkt_ft8dt_cc_01.RAW	D121012_MGH_LiK_2333A_OGE11_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
-Liver Metastasis Patient 3	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 176	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	12	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121012_LiK_2333A/D121012_MGH_LiK_2333A_OGE12_rafkt_ft8dt_cc_01.RAW	D121012_MGH_LiK_2333A_OGE12_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
\ No newline at end of file
+Liver Metastasis Pateint 1 	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 1	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110731_LiK_540/D110729_MGH_540_OGE08_rafkt_ft8dt_cc_01.RAW	D110729_MGH_540_OGE08_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 1	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 2	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9 _10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110731_LiK_540/D110729_MGH_540_OGE09_10_rafkt_ft8dt_cc_01.RAW	D110729_MGH_540_OGE09_10_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 1	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 3	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110731_LiK_540/D110729_MGH_540_OGE11_rafkt_ft8dt_cc_01.RAW	D110729_MGH_540_OGE11_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 1	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 4	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	12	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110731_LiK_540/D110729_MGH_540_OGE12_rafkt_ft8dt_cc_01.RAW	D110729_MGH_540_OGE12_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 1	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 5	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110731_LiK_540/D110731_MGH_540_OGE01_rafkt_ft8dt_cc_01.RAW	D110731_MGH_540_OGE01_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 1	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 6	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110731_LiK_540/D110731_MGH_540_OGE02_rafkt_ft8dt_cc_01.RAW	D110731_MGH_540_OGE02_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 1	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 7	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110731_LiK_540/D110731_MGH_540_OGE03_rafkt_ft8dt_cc_01.RAW	D110731_MGH_540_OGE03_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 1	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 8	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110731_LiK_540/D110731_MGH_540_OGE04_rafkt_ft8dt_cc_01.RAW	D110731_MGH_540_OGE04_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 1	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 9	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110731_LiK_540/D110731_MGH_540_OGE05_rafkt_ft8dt_cc_01.RAW	D110731_MGH_540_OGE05_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 1	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 10	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110731_LiK_540/D110731_MGH_540_OGE06_rafkt_ft8dt_cc_01.RAW	D110731_MGH_540_OGE06_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 1	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 11	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110731_LiK_540/D110731_MGH_540_OGE07_rafkt_ft8dt_cc_01.RAW	D110731_MGH_540_OGE07_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Normal Colon Patient 1	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 12	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110801_CoN_446/D110801_MGH_446_OGE01_rafkt_ft8_cc_01.RAW	D110801_MGH_446_OGE01_rafkt_ft8_cc_01.RAW	normal
+Normal Colon Patient 1	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 13	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110801_CoN_446/D110801_MGH_446_OGE02_rafkt_ft8_cc_01.RAW	D110801_MGH_446_OGE02_rafkt_ft8_cc_01.RAW	normal
+Normal Colon Patient 1	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 14	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110801_CoN_446/D110801_MGH_446_OGE03_rafkt_ft8_cc_01.RAW	D110801_MGH_446_OGE03_rafkt_ft8_cc_01.RAW	normal
+Normal Colon Patient 1	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 15	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110801_CoN_446/D110801_MGH_446_OGE04_rafkt_ft8_cc_01.RAW	D110801_MGH_446_OGE04_rafkt_ft8_cc_01.RAW	normal
+Normal Colon Patient 1	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 16	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110801_CoN_446/D110801_MGH_446_OGE05_rafkt_ft8_cc_01.RAW	D110801_MGH_446_OGE05_rafkt_ft8_cc_01.RAW	normal
+Normal Colon Patient 1	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 17	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110801_CoN_446/D110801_MGH_446_OGE06_rafkt_ft8_cc_01.RAW	D110801_MGH_446_OGE06_rafkt_ft8_cc_01.RAW	normal
+Normal Colon Patient 1	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 18	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110801_CoN_446/D110801_MGH_446_OGE07_rafkt_ft8_cc_01.RAW	D110801_MGH_446_OGE07_rafkt_ft8_cc_01.RAW	normal
+Normal Colon Patient 1	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 19	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110801_CoN_446/D110801_MGH_446_OGE08_rafkt_ft8_cc_01.RAW	D110801_MGH_446_OGE08_rafkt_ft8_cc_01.RAW	normal
+Normal Colon Patient 1	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 20	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9_10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110801_CoN_446/D110801_MGH_446_OGE09_10_rafkt_ft8_cc_01.RAW	D110801_MGH_446_OGE09_10_rafkt_ft8_cc_01.RAW	normal
+Normal Colon Patient 1	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 21	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110801_CoN_446/D110801_MGH_446_OGE11_rafkt_ft8_cc_01.RAW	D110801_MGH_446_OGE11_rafkt_ft8_cc_01.RAW	normal
+Normal Colon Patient 1	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 22	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	12	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110801_CoN_446/D110801_MGH_446_OGE12_rafkt_ft8_cc_01.RAW	D110801_MGH_446_OGE12_rafkt_ft8_cc_01.RAW	normal
+Normal Colon Patient 1	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 23	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110806_CoN_446A/D110728_MGH_446A_OGE01_rafkt_ft8dt_cc_01.RAW	D110728_MGH_446A_OGE01_rafkt_ft8dt_cc_01.RAW	normal
+Normal Colon Patient 1	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 24	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110806_CoN_446A/D110728_MGH_446A_OGE02_rafkt_ft8dt_cc_01.RAW	D110728_MGH_446A_OGE02_rafkt_ft8dt_cc_01.RAW	normal
+Normal Colon Patient 1	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 25	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110806_CoN_446A/D110806_MGH_446A_OGE03_rafkt_ft8dt_cc_01.RAW	D110806_MGH_446A_OGE03_rafkt_ft8dt_cc_01.RAW	normal
+Normal Colon Patient 1	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 26	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110806_CoN_446A/D110806_MGH_446A_OGE04_rafkt_ft8dt_cc_01.RAW	D110806_MGH_446A_OGE04_rafkt_ft8dt_cc_01.RAW	normal
+Normal Colon Patient 1	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 27	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110806_CoN_446A/D110806_MGH_446A_OGE05_rafkt_ft8dt_cc_01.RAW	D110806_MGH_446A_OGE05_rafkt_ft8dt_cc_01.RAW	normal
+Normal Colon Patient 1	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 28	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110806_CoN_446A/D110806_MGH_446A_OGE06_rafkt_ft8dt_cc_01.RAW	D110806_MGH_446A_OGE06_rafkt_ft8dt_cc_01.RAW	normal
+Normal Colon Patient 1	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 29	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110806_CoN_446A/D110806_MGH_446A_OGE07_rafkt_ft8dt_cc_01.RAW	D110806_MGH_446A_OGE07_rafkt_ft8dt_cc_01.RAW	normal
+Normal Colon Patient 1	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 30	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110806_CoN_446A/D110806_MGH_446A_OGE08_rafkt_ft8dt_cc_01.RAW	D110806_MGH_446A_OGE08_rafkt_ft8dt_cc_01.RAW	normal
+Normal Colon Patient 1	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 31	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9_10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110806_CoN_446A/D110806_MGH_446A_OGE09_10_rafkt_ft8dt_cc_01.RAW	D110806_MGH_446A_OGE09_10_rafkt_ft8dt_cc_01.RAW	normal
+Normal Colon Patient 1	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 32	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110806_CoN_446A/D110806_MGH_446A_OGE11_rafkt_ft8dt_cc_01.RAW	D110806_MGH_446A_OGE11_rafkt_ft8dt_cc_01.RAW	normal
+Normal Colon Patient 1	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 33	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	12	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D110806_CoN_446A/D110806_MGH_446A_OGE12_rafkt_ft8dt_cc_01.RAW	D110806_MGH_446A_OGE12_rafkt_ft8dt_cc_01.RAW	normal
+Liver Metastasis Patient 1	2	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 34	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111019_LiK_540a/D111019_MGH_540a_OGE01_rafkt_ft8dt_cc_01.RAW	D111019_MGH_540a_OGE01_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 1	2	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 35	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111019_LiK_540a/D111019_MGH_540a_OGE02_rafkt_ft8dt_cc_01.RAW	D111019_MGH_540a_OGE02_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 1	2	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 36	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111019_LiK_540a/D111019_MGH_540a_OGE03_rafkt_ft8dt_cc_01.RAW	D111019_MGH_540a_OGE03_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 1	2	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 37	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111019_LiK_540a/D111019_MGH_540a_OGE04_rafkt_ft8dt_cc_01.RAW	D111019_MGH_540a_OGE04_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 1	2	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 38	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111019_LiK_540a/D111019_MGH_540a_OGE05_rafkt_ft8dt_cc_01.RAW	D111019_MGH_540a_OGE05_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 1	2	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 39	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111019_LiK_540a/D111019_MGH_540a_OGE06_rafkt_ft8dt_cc_01.RAW	D111019_MGH_540a_OGE06_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 1	2	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 40	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111019_LiK_540a/D111019_MGH_540a_OGE07_rafkt_ft8dt_cc_01.RAW	D111019_MGH_540a_OGE07_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 1	2	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 41	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111019_LiK_540a/D111019_MGH_540a_OGE08_rafkt_ft8dt_cc_01.RAW	D111019_MGH_540a_OGE08_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 1	2	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 42	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9_10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111019_LiK_540a/D111019_MGH_540a_OGE09_10_rafkt_ft8dt_cc_01.RAW	D111019_MGH_540a_OGE09_10_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 1	2	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 43	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111019_LiK_540a/D111019_MGH_540a_OGE11_rafkt_ft8dt_cc_01.RAW	D111019_MGH_540a_OGE11_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 1	2	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 44	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	12	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111019_LiK_540a/D111019_MGH_540a_OGE12_rafkt_ft8dt_cc_01.RAW	D111019_MGH_540a_OGE12_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Colon Tumor Patient 1	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 45	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9_10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111129_CoK_445a/D111129_MGH_445a_OGE09_10_rafkt_ft8dt_cc_01.RAW	D111129_MGH_445a_OGE09_10_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 1	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 46	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111129_CoK_445a/D111129_MGH_445a_OGE11_rafkt_ft8dt_cc_01.RAW	D111129_MGH_445a_OGE11_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 1	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 47	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	12	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111129_CoK_445a/D111129_MGH_445a_OGE12_rafkt_ft8dt_cc_01.RAW	D111129_MGH_445a_OGE12_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 1	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 48	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111129_CoK_445a/D111130_MGH_445a_OGE01_rafkt_ft8dt_cc_01.RAW	D111130_MGH_445a_OGE01_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 1	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 49	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111129_CoK_445a/D111130_MGH_445a_OGE02_rafkt_ft8dt_cc_01.RAW	D111130_MGH_445a_OGE02_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 1	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 50	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111129_CoK_445a/D111130_MGH_445a_OGE03_rafkt_ft8dt_cc_01.RAW	D111130_MGH_445a_OGE03_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 1	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 51	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111129_CoK_445a/D111201_MGH_445a_OGE04_rafkt_ft8dt_cc_01.RAW	D111201_MGH_445a_OGE04_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 1	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 52	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111129_CoK_445a/D111201_MGH_445a_OGE05_rafkt_ft8dt_cc_01.RAW	D111201_MGH_445a_OGE05_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 1	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 53	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111129_CoK_445a/D111202_MGH_445a_OGE06_rafkt_ft8dt_cc_01.RAW	D111202_MGH_445a_OGE06_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 1	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 54	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111129_CoK_445a/D111202_MGH_445a_OGE07_rafkt_ft8dt_cc_01.RAW	D111202_MGH_445a_OGE07_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 1	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 55	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111129_CoK_445a/D111202_MGH_445a_OGE08_rafkt_ft8dt_cc_01.RAW	D111202_MGH_445a_OGE08_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 1	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 56	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111202_CoK_445/D111202_MGH_445_OGE01_rafkt_ft8dt_cc_01.RAW	D111202_MGH_445_OGE01_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 1	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 57	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111202_CoK_445/D111202_MGH_445_OGE02_rafkt_ft8dt_cc_01.RAW	D111202_MGH_445_OGE02_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 1	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 58	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111202_CoK_445/D111202_MGH_445_OGE03_rafkt_ft8dt_cc_01.RAW	D111202_MGH_445_OGE03_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 1	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 59	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111202_CoK_445/D111202_MGH_445_OGE04_rafkt_ft8dt_cc_01.RAW	D111202_MGH_445_OGE04_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 1	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 60	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111202_CoK_445/D111202_MGH_445_OGE05_rafkt_ft8dt_cc_01.RAW	D111202_MGH_445_OGE05_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 1	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 61	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	10_11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111202_CoK_445/D111205_MGH_445_OGE010_11_rafkt_ft8dt_cc_01.RAW	D111205_MGH_445_OGE010_11_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 1	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 62	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111202_CoK_445/D111205_MGH_445_OGE06_rafkt_ft8dt_cc_01.RAW	D111205_MGH_445_OGE06_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 1	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 63	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111202_CoK_445/D111205_MGH_445_OGE07_rafkt_ft8dt_cc_01.RAW	D111205_MGH_445_OGE07_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 1	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 64	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111202_CoK_445/D111205_MGH_445_OGE08_rafkt_ft8dt_cc_01.RAW	D111205_MGH_445_OGE08_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 1	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 65	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111202_CoK_445/D111205_MGH_445_OGE09_rafkt_ft8dt_cc_01.RAW	D111205_MGH_445_OGE09_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 1	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	1	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 66	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	12	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D111202_CoK_445/D111205_MGH_445_OGE12_rafkt_ft8dt_cc_01.RAW	D111205_MGH_445_OGE12_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Normal Colon Patient 2	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 67	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120204_CoN_2207/D120204_MGH_2207_OGE01_rafkt_ft8dt_cc_01.RAW	D120204_MGH_2207_OGE01_rafkt_ft8dt_cc_01.RAW	normal
+Normal Colon Patient 2	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 68	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120204_CoN_2207/D120204_MGH_2207_OGE02_rafkt_ft8dt_cc_01.RAW	D120204_MGH_2207_OGE02_rafkt_ft8dt_cc_01.RAW	normal
+Normal Colon Patient 2	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 69	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120204_CoN_2207/D120204_MGH_2207_OGE03_rafkt_ft8dt_cc_01.RAW	D120204_MGH_2207_OGE03_rafkt_ft8dt_cc_01.RAW	normal
+Normal Colon Patient 2	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 70	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120204_CoN_2207/D120204_MGH_2207_OGE04_rafkt_ft8dt_cc_01.RAW	D120204_MGH_2207_OGE04_rafkt_ft8dt_cc_01.RAW	normal
+Normal Colon Patient 2	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 71	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120204_CoN_2207/D120204_MGH_2207_OGE05_rafkt_ft8dt_cc_01.RAW	D120204_MGH_2207_OGE05_rafkt_ft8dt_cc_01.RAW	normal
+Normal Colon Patient 2	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 72	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120204_CoN_2207/D120204_MGH_2207_OGE06_rafkt_ft8dt_cc_01.RAW	D120204_MGH_2207_OGE06_rafkt_ft8dt_cc_01.RAW	normal
+Normal Colon Patient 2	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 73	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120204_CoN_2207/D120204_MGH_2207_OGE07_rafkt_ft8dt_cc_01.RAW	D120204_MGH_2207_OGE07_rafkt_ft8dt_cc_01.RAW	normal
+Normal Colon Patient 2	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 74	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120204_CoN_2207/D120204_MGH_2207_OGE08_rafkt_ft8dt_cc_01.RAW	D120204_MGH_2207_OGE08_rafkt_ft8dt_cc_01.RAW	normal
+Normal Colon Patient 2	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 75	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9_10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120204_CoN_2207/D120204_MGH_2207_OGE09_10_rafkt_ft8dt_cc_01.RAW	D120204_MGH_2207_OGE09_10_rafkt_ft8dt_cc_01.RAW	normal
+Normal Colon Patient 2	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 76	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120204_CoN_2207/D120204_MGH_2207_OGE11_rafkt_ft8dt_cc_01.RAW	D120204_MGH_2207_OGE11_rafkt_ft8dt_cc_01.RAW	normal
+Normal Colon Patient 2	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 77	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	12	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120204_CoN_2207/D120204_MGH_2207_OGE12_rafkt_ft8dt_cc_01.RAW	D120204_MGH_2207_OGE12_rafkt_ft8dt_cc_01.RAW	normal
+Colon Tumor Patient 2	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 78	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120205_CoK_2205/D120205_MGH_2205_OGE01_rafkt_ft8dt_cc_01.RAW	D120205_MGH_2205_OGE01_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 2	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 79	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120205_CoK_2205/D120205_MGH_2205_OGE02_rafkt_ft8dt_cc_01.RAW	D120205_MGH_2205_OGE02_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 2	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 80	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120205_CoK_2205/D120205_MGH_2205_OGE03_rafkt_ft8dt_cc_01.RAW	D120205_MGH_2205_OGE03_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 2	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 81	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120205_CoK_2205/D120205_MGH_2205_OGE04_rafkt_ft8dt_cc_01.RAW	D120205_MGH_2205_OGE04_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 2	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 82	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120205_CoK_2205/D120205_MGH_2205_OGE05_rafkt_ft8dt_cc_01.RAW	D120205_MGH_2205_OGE05_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 2	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 83	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120205_CoK_2205/D120205_MGH_2205_OGE06_rafkt_ft8dt_cc_01.RAW	D120205_MGH_2205_OGE06_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 2	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 84	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120205_CoK_2205/D120205_MGH_2205_OGE07_rafkt_ft8dt_cc_01.RAW	D120205_MGH_2205_OGE07_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 2	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 85	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120205_CoK_2205/D120205_MGH_2205_OGE08_rafkt_ft8dt_cc_01.RAW	D120205_MGH_2205_OGE08_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 2	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 86	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9_10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120205_CoK_2205/D120205_MGH_2205_OGE09_10_rafkt_ft8dt_cc_01.RAW	D120205_MGH_2205_OGE09_10_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 2	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 87	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120205_CoK_2205/D120205_MGH_2205_OGE11_rafkt_ft8dt_cc_01.RAW	D120205_MGH_2205_OGE11_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 2	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 88	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	12	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120205_CoK_2205/D120205_MGH_2205_OGE12_rafkt_ft8dt_cc_01.RAW	D120205_MGH_2205_OGE12_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 2	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 89	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120217_CoK_2205A/D120217_MGH_2205A_OGE08_rafkt_ft8dt_cc_01.RAW	D120217_MGH_2205A_OGE08_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 2	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 90	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120217_CoK_2205A/D120217_MGH_2205A_OGE09_10_rafkt_ft8dt_cc_01.RAW	D120217_MGH_2205A_OGE09_10_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 2	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 91	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120217_CoK_2205A/D120217_MGH_2205A_OGE11_rafkt_ft8dt_cc_01.RAW	D120217_MGH_2205A_OGE11_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 2	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 92	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	12	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120217_CoK_2205A/D120217_MGH_2205A_OGE12_rafkt_ft8dt_cc_01.RAW	D120217_MGH_2205A_OGE12_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 2	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 93	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120217_CoK_2205A/D120221_MGH_2205A_OGE01_rafkt_ft8dt_cc_01.RAW	D120221_MGH_2205A_OGE01_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 2	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 94	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120217_CoK_2205A/D120221_MGH_2205A_OGE02_rafkt_ft8dt_cc_01.RAW	D120221_MGH_2205A_OGE02_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 2	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 95	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120217_CoK_2205A/D120221_MGH_2205A_OGE03_rafkt_ft8dt_cc_01.RAW	D120221_MGH_2205A_OGE03_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 2	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 96	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120217_CoK_2205A/D120221_MGH_2205A_OGE04_rafkt_ft8dt_cc_01.RAW	D120221_MGH_2205A_OGE04_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 2	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 97	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120217_CoK_2205A/D120221_MGH_2205A_OGE05_rafkt_ft8dt_cc_01.RAW	D120221_MGH_2205A_OGE05_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 2	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 98	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120217_CoK_2205A/D120221_MGH_2205A_OGE06_rafkt_ft8dt_cc_01.RAW	D120221_MGH_2205A_OGE06_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 2	2	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 99	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120217_CoK_2205A/D120221_MGH_2205A_OGE07_rafkt_ft8dt_cc_01.RAW	D120221_MGH_2205A_OGE07_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Liver Metastasis Patient 2	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 100	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120222_LiK_2446/D120222_MGH_2446_OGE01_rafkt_ft8dt_cc_01.RAW	D120222_MGH_2446_OGE01_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 2	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 101	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120222_LiK_2446/D120222_MGH_2446_OGE02_rafkt_ft8dt_cc_01.RAW	D120222_MGH_2446_OGE02_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 2	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 102	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120222_LiK_2446/D120222_MGH_2446_OGE03_rafkt_ft8dt_cc_01.RAW	D120222_MGH_2446_OGE03_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 2	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 103	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120222_LiK_2446/D120222_MGH_2446_OGE04_rafkt_ft8dt_cc_01.RAW	D120222_MGH_2446_OGE04_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 2	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 104	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120222_LiK_2446/D120222_MGH_2446_OGE05_rafkt_ft8dt_cc_01.RAW	D120222_MGH_2446_OGE05_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 2	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 105	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120222_LiK_2446/D120222_MGH_2446_OGE06_rafkt_ft8dt_cc_01.RAW	D120222_MGH_2446_OGE06_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 2	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 106	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120222_LiK_2446/D120222_MGH_2446_OGE07_rafkt_ft8dt_cc_01.RAW	D120222_MGH_2446_OGE07_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 2	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 107	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120222_LiK_2446/D120222_MGH_2446_OGE08_rafkt_ft8dt_cc_01.RAW	D120222_MGH_2446_OGE08_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 2	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 108	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9_10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120222_LiK_2446/D120222_MGH_2446_OGE09_10_rafkt_ft8dt_cc_01.RAW	D120222_MGH_2446_OGE09_10_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 2	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 109	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120222_LiK_2446/D120222_MGH_2446_OGE11_rafkt_ft8dt_cc_01.RAW	D120222_MGH_2446_OGE11_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 2	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 110	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	12	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120222_LiK_2446/D120222_MGH_2446_OGE12_rafkt_ft8dt_cc_01.RAW	D120222_MGH_2446_OGE12_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 2	2	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 111	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120223_LiK_2446A/D120223_MGH_2446A_OGE01_rafkt_ft8dt_cc_01.RAW	D120223_MGH_2446A_OGE01_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 2	2	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 112	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120223_LiK_2446A/D120223_MGH_2446A_OGE02_rafkt_ft8dt_cc_01.RAW	D120223_MGH_2446A_OGE02_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 2	2	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 113	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120223_LiK_2446A/D120223_MGH_2446A_OGE03_rafkt_ft8dt_cc_01.RAW	D120223_MGH_2446A_OGE03_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 2	2	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 114	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120223_LiK_2446A/D120223_MGH_2446A_OGE04_rafkt_ft8dt_cc_01.RAW	D120223_MGH_2446A_OGE04_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 2	2	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 115	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120223_LiK_2446A/D120223_MGH_2446A_OGE05_rafkt_ft8dt_cc_01.RAW	D120223_MGH_2446A_OGE05_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 2	2	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 116	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120223_LiK_2446A/D120223_MGH_2446A_OGE06_rafkt_ft8dt_cc_01.RAW	D120223_MGH_2446A_OGE06_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 2	2	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 117	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120223_LiK_2446A/D120223_MGH_2446A_OGE07_rafkt_ft8dt_cc_01.RAW	D120223_MGH_2446A_OGE07_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 2	2	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 118	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120223_LiK_2446A/D120223_MGH_2446A_OGE08_rafkt_ft8dt_cc_01.RAW	D120223_MGH_2446A_OGE08_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 2	2	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 119	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9_10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120223_LiK_2446A/D120223_MGH_2446A_OGE09_10_rafkt_ft8dt_cc_01.RAW	D120223_MGH_2446A_OGE09_10_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 2	2	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 120	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120223_LiK_2446A/D120223_MGH_2446A_OGE11_rafkt_ft8dt_cc_01.RAW	D120223_MGH_2446A_OGE11_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 2	2	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	2	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 121	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	12	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120223_LiK_2446A/D120223_MGH_2446A_OGE12_rafkt_ft8dt_cc_01.RAW	D120223_MGH_2446A_OGE12_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Normal Liver [Pool 1]	1	homo sapiens	liver	hepatocyte	not available	not available	not available	normal	not applicable	pooled	NT= Extraction purification;AC=NCIT:C113061	run 122	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120417_LiN_HS1/D120417_MGH_HS1_NLi_OGE03_rafkt_ft8dt_cc_01.RAW	D120417_MGH_HS1_NLi_OGE03_rafkt_ft8dt_cc_01.RAW	normal
+Normal Liver [Pool 1]	1	homo sapiens	liver	hepatocyte	not available	not available	not available	normal	not applicable	pooled	NT= Extraction purification;AC=NCIT:C113061	run 123	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120417_LiN_HS1/D120417_MGH_HS1_NLi_OGE04_rafkt_ft8dt_cc_01.RAW	D120417_MGH_HS1_NLi_OGE04_rafkt_ft8dt_cc_01.RAW	normal
+Normal Liver [Pool 1]	1	homo sapiens	liver	hepatocyte	not available	not available	not available	normal	not applicable	pooled	NT= Extraction purification;AC=NCIT:C113061	run 124	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120417_LiN_HS1/D120417_MGH_HS1_NLi_OGE05_rafkt_ft8dt_cc_01.RAW	D120417_MGH_HS1_NLi_OGE05_rafkt_ft8dt_cc_01.RAW	normal
+Normal Liver [Pool 1]	1	homo sapiens	liver	hepatocyte	not available	not available	not available	normal	not applicable	pooled	NT= Extraction purification;AC=NCIT:C113061	run 125	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120417_LiN_HS1/D120417_MGH_HS1_NLi_OGE06_rafkt_ft8dt_cc_01.RAW	D120417_MGH_HS1_NLi_OGE06_rafkt_ft8dt_cc_01.RAW	normal
+Normal Liver [Pool 1]	1	homo sapiens	liver	hepatocyte	not available	not available	not available	normal	not applicable	pooled	NT= Extraction purification;AC=NCIT:C113061	run 126	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120417_LiN_HS1/D120417_MGH_HS1_NLi_OGE07_rafkt_ft8dt_cc_01.RAW	D120417_MGH_HS1_NLi_OGE07_rafkt_ft8dt_cc_01.RAW	normal
+Normal Liver [Pool 1]	1	homo sapiens	liver	hepatocyte	not available	not available	not available	normal	not applicable	pooled	NT= Extraction purification;AC=NCIT:C113061	run 127	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120417_LiN_HS1/D120417_MGH_HS1_NLi_OGE08_rafkt_ft8dt_cc_01.RAW	D120417_MGH_HS1_NLi_OGE08_rafkt_ft8dt_cc_01.RAW	normal
+Normal Liver [Pool 1]	1	homo sapiens	liver	hepatocyte	not available	not available	not available	normal	not applicable	pooled	NT= Extraction purification;AC=NCIT:C113061	run 128	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9_10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120417_LiN_HS1/D120417_MGH_HS1_NLi_OGE09_10_rafkt_ft8dt_cc_01.RAW	D120417_MGH_HS1_NLi_OGE09_10_rafkt_ft8dt_cc_01.RAW	normal
+Normal Liver [Pool 1]	1	homo sapiens	liver	hepatocyte	not available	not available	not available	normal	not applicable	pooled	NT= Extraction purification;AC=NCIT:C113061	run 129	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120417_LiN_HS1/D120417_MGH_HS1_NLi_OGE11_rafkt_ft8dt_cc_01.RAW	D120417_MGH_HS1_NLi_OGE11_rafkt_ft8dt_cc_01.RAW	normal
+Normal Liver [Pool 1]	1	homo sapiens	liver	hepatocyte	not available	not available	not available	normal	not applicable	pooled	NT= Extraction purification;AC=NCIT:C113061	run 130	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	12	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120417_LiN_HS1/D120417_MGH_HS1_NLi_OGE12_rafkt_ft8dt_cc_01.RAW	D120417_MGH_HS1_NLi_OGE12_rafkt_ft8dt_cc_01.RAW	normal
+Normal Liver [Pool 1]	1	homo sapiens	liver	hepatocyte	not available	not available	not available	normal	not applicable	pooled	NT= Extraction purification;AC=NCIT:C113061	run 131	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120417_LiN_HS1/D120419_MGH_HS1_NLi_OGE01_rafkt_ft8dt_cc_01.RAW	D120419_MGH_HS1_NLi_OGE01_rafkt_ft8dt_cc_01.RAW	normal
+Normal Liver [Pool 1]	1	homo sapiens	liver	hepatocyte	not available	not available	not available	normal	not applicable	pooled	NT= Extraction purification;AC=NCIT:C113061	run 132	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120417_LiN_HS1/D120419_MGH_HS1_NLi_OGE02_rafkt_ft8dt_cc_01.RAW	D120419_MGH_HS1_NLi_OGE02_rafkt_ft8dt_cc_01.RAW	normal
+Normal Liver [Pool 2]	1	homo sapiens	liver	hepatocyte	not available	not available	not available	normal	not applicable	pooled	NT= Extraction purification;AC=NCIT:C113061	run 133	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120504_LiN_HS2/D120504_MGH_HS2_NLi_OGE01_rafkt_ft8dt_cc_01.RAW	D120504_MGH_HS2_NLi_OGE01_rafkt_ft8dt_cc_01.RAW	normal
+Normal Liver [Pool 2]	1	homo sapiens	liver	hepatocyte	not available	not available	not available	normal	not applicable	pooled	NT= Extraction purification;AC=NCIT:C113061	run 134	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120504_LiN_HS2/D120504_MGH_HS2_NLi_OGE02_rafkt_ft8dt_cc_01.RAW	D120504_MGH_HS2_NLi_OGE02_rafkt_ft8dt_cc_01.RAW	normal
+Normal Liver [Pool 2]	1	homo sapiens	liver	hepatocyte	not available	not available	not available	normal	not applicable	pooled	NT= Extraction purification;AC=NCIT:C113061	run 135	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120504_LiN_HS2/D120504_MGH_HS2_NLi_OGE03_rafkt_ft8dt_cc_01.RAW	D120504_MGH_HS2_NLi_OGE03_rafkt_ft8dt_cc_01.RAW	normal
+Normal Liver [Pool 2]	1	homo sapiens	liver	hepatocyte	not available	not available	not available	normal	not applicable	pooled	NT= Extraction purification;AC=NCIT:C113061	run 136	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120504_LiN_HS2/D120504_MGH_HS2_NLi_OGE04_rafkt_ft8dt_cc_01.RAW	D120504_MGH_HS2_NLi_OGE04_rafkt_ft8dt_cc_01.RAW	normal
+Normal Liver [Pool 2]	1	homo sapiens	liver	hepatocyte	not available	not available	not available	normal	not applicable	pooled	NT= Extraction purification;AC=NCIT:C113061	run 137	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120504_LiN_HS2/D120504_MGH_HS2_NLi_OGE05_rafkt_ft8dt_cc_01.RAW	D120504_MGH_HS2_NLi_OGE05_rafkt_ft8dt_cc_01.RAW	normal
+Normal Liver [Pool 2]	1	homo sapiens	liver	hepatocyte	not available	not available	not available	normal	not applicable	pooled	NT= Extraction purification;AC=NCIT:C113061	run 138	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120504_LiN_HS2/D120504_MGH_HS2_NLi_OGE06_rafkt_ft8dt_cc_01.RAW	D120504_MGH_HS2_NLi_OGE06_rafkt_ft8dt_cc_01.RAW	normal
+Normal Liver [Pool 2]	1	homo sapiens	liver	hepatocyte	not available	not available	not available	normal	not applicable	pooled	NT= Extraction purification;AC=NCIT:C113061	run 139	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120504_LiN_HS2/D120504_MGH_HS2_NLi_OGE07_rafkt_ft8dt_cc_01.RAW	D120504_MGH_HS2_NLi_OGE07_rafkt_ft8dt_cc_01.RAW	normal
+Normal Liver [Pool 2]	1	homo sapiens	liver	hepatocyte	not available	not available	not available	normal	not applicable	pooled	NT= Extraction purification;AC=NCIT:C113061	run 140	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120504_LiN_HS2/D120504_MGH_HS2_NLi_OGE08_rafkt_ft8dt_cc_01.RAW	D120504_MGH_HS2_NLi_OGE08_rafkt_ft8dt_cc_01.RAW	normal
+Normal Liver [Pool 2]	1	homo sapiens	liver	hepatocyte	not available	not available	not available	normal	not applicable	pooled	NT= Extraction purification;AC=NCIT:C113061	run 141	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9_10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120504_LiN_HS2/D120504_MGH_HS2_NLi_OGE09_10_rafkt_ft8dt_cc_01.RAW	D120504_MGH_HS2_NLi_OGE09_10_rafkt_ft8dt_cc_01.RAW	normal
+Normal Liver [Pool 2]	1	homo sapiens	liver	hepatocyte	not available	not available	not available	normal	not applicable	pooled	NT= Extraction purification;AC=NCIT:C113061	run 142	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120504_LiN_HS2/D120504_MGH_HS2_NLi_OGE11_rafkt_ft8dt_cc_01.RAW	D120504_MGH_HS2_NLi_OGE11_rafkt_ft8dt_cc_01.RAW	normal
+Normal Liver [Pool 2]	1	homo sapiens	liver	hepatocyte	not available	not available	not available	normal	not applicable	pooled	NT= Extraction purification;AC=NCIT:C113061	run 143	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	12	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D120504_LiN_HS2/D120504_MGH_HS2_NLi_OGE12_rafkt_ft8dt_cc_01.RAW	D120504_MGH_HS2_NLi_OGE12_rafkt_ft8dt_cc_01.RAW	normal
+Normal Colon Patient 3	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 144	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121010_CoN_1948A/D121010_MGH_NCo_1948A_OGE01_rafkt_ft8dt_cc_01.RAW	D121010_MGH_NCo_1948A_OGE01_rafkt_ft8dt_cc_01.RAW	normal
+Normal Colon Patient 3	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 145	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121010_CoN_1948A/D121010_MGH_NCo_1948A_OGE02_rafkt_ft8dt_cc_01.RAW	D121010_MGH_NCo_1948A_OGE02_rafkt_ft8dt_cc_01.RAW	normal
+Normal Colon Patient 3	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 146	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121010_CoN_1948A/D121010_MGH_NCo_1948A_OGE03_rafkt_ft8dt_cc_01.RAW	D121010_MGH_NCo_1948A_OGE03_rafkt_ft8dt_cc_01.RAW	normal
+Normal Colon Patient 3	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 147	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121010_CoN_1948A/D121010_MGH_NCo_1948A_OGE04_rafkt_ft8dt_cc_01.RAW	D121010_MGH_NCo_1948A_OGE04_rafkt_ft8dt_cc_01.RAW	normal
+Normal Colon Patient 3	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 148	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121010_CoN_1948A/D121010_MGH_NCo_1948A_OGE05_rafkt_ft8dt_cc_01.RAW	D121010_MGH_NCo_1948A_OGE05_rafkt_ft8dt_cc_01.RAW	normal
+Normal Colon Patient 3	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 149	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121010_CoN_1948A/D121010_MGH_NCo_1948A_OGE06_rafkt_ft8dt_cc_01.RAW	D121010_MGH_NCo_1948A_OGE06_rafkt_ft8dt_cc_01.RAW	normal
+Normal Colon Patient 3	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 150	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121010_CoN_1948A/D121010_MGH_NCo_1948A_OGE07_rafkt_ft8dt_cc_01.RAW	D121010_MGH_NCo_1948A_OGE07_rafkt_ft8dt_cc_01.RAW	normal
+Normal Colon Patient 3	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 151	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121010_CoN_1948A/D121010_MGH_NCo_1948A_OGE08_rafkt_ft8dt_cc_01.RAW	D121010_MGH_NCo_1948A_OGE08_rafkt_ft8dt_cc_01.RAW	normal
+Normal Colon Patient 3	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 152	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9_10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121010_CoN_1948A/D121010_MGH_NCo_1948A_OGE09_10_rafkt_ft8dt_cc_01.RAW	D121010_MGH_NCo_1948A_OGE09_10_rafkt_ft8dt_cc_01.RAW	normal
+Normal Colon Patient 3	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 153	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121010_CoN_1948A/D121010_MGH_NCo_1948A_OGE11_rafkt_ft8dt_cc_01.RAW	D121010_MGH_NCo_1948A_OGE11_rafkt_ft8dt_cc_01.RAW	normal
+Normal Colon Patient 3	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	normal	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 154	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	12	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121010_CoN_1948A/D121010_MGH_NCo_1948A_OGE12_rafkt_ft8dt_cc_01.RAW	D121010_MGH_NCo_1948A_OGE12_rafkt_ft8dt_cc_01.RAW	normal
+Colon Tumor Patient 3	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 155	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121011_CoK_1947/D121011_MGH_CoK_1947_OGE01_rafkt_ft8dt_cc_01.RAW	D121011_MGH_CoK_1947_OGE01_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 3	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 156	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121011_CoK_1947/D121011_MGH_CoK_1947_OGE02_rafkt_ft8dt_cc_01.RAW	D121011_MGH_CoK_1947_OGE02_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 3	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 157	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121011_CoK_1947/D121011_MGH_CoK_1947_OGE03_rafkt_ft8dt_cc_01.RAW	D121011_MGH_CoK_1947_OGE03_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 3	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 158	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121011_CoK_1947/D121011_MGH_CoK_1947_OGE04_rafkt_ft8dt_cc_01.RAW	D121011_MGH_CoK_1947_OGE04_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 3	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 159	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121011_CoK_1947/D121011_MGH_CoK_1947_OGE05_rafkt_ft8dt_cc_01.RAW	D121011_MGH_CoK_1947_OGE05_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 3	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 160	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121011_CoK_1947/D121011_MGH_CoK_1947_OGE06_rafkt_ft8dt_cc_01.RAW	D121011_MGH_CoK_1947_OGE06_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 3	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 161	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121011_CoK_1947/D121011_MGH_CoK_1947_OGE07_rafkt_ft8dt_cc_01.RAW	D121011_MGH_CoK_1947_OGE07_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 3	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 162	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121011_CoK_1947/D121011_MGH_CoK_1947_OGE08_rafkt_ft8dt_cc_01.RAW	D121011_MGH_CoK_1947_OGE08_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 3	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 163	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9_10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121011_CoK_1947/D121011_MGH_CoK_1947_OGE09_10_rafkt_ft8dt_cc_01.RAW	D121011_MGH_CoK_1947_OGE09_10_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 3	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 164	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121011_CoK_1947/D121011_MGH_CoK_1947_OGE11_rafkt_ft8dt_cc_01.RAW	D121011_MGH_CoK_1947_OGE11_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Colon Tumor Patient 3	1	homo sapiens	colon	colon epithelial cell	not available	not available	not available	colon carcinoma	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 165	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	12	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121011_CoK_1947/D121011_MGH_CoK_1947_OGE12_rafkt_ft8dt_cc_01.RAW	D121011_MGH_CoK_1947_OGE12_rafkt_ft8dt_cc_01.RAW	colon carcinoma
+Liver Metastasis Patient 3	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 166	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121012_LiK_2333A/D121012_MGH_LiK_2333A_OGE01_rafkt_ft8dt_cc_01.RAW	D121012_MGH_LiK_2333A_OGE01_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 3	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 167	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121012_LiK_2333A/D121012_MGH_LiK_2333A_OGE02_rafkt_ft8dt_cc_01.RAW	D121012_MGH_LiK_2333A_OGE02_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 3	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 168	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121012_LiK_2333A/D121012_MGH_LiK_2333A_OGE03_rafkt_ft8dt_cc_01.RAW	D121012_MGH_LiK_2333A_OGE03_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 3	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 169	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121012_LiK_2333A/D121012_MGH_LiK_2333A_OGE04_rafkt_ft8dt_cc_01.RAW	D121012_MGH_LiK_2333A_OGE04_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 3	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 170	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	5	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121012_LiK_2333A/D121012_MGH_LiK_2333A_OGE05_rafkt_ft8dt_cc_01.RAW	D121012_MGH_LiK_2333A_OGE05_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 3	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 171	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	6	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121012_LiK_2333A/D121012_MGH_LiK_2333A_OGE06_rafkt_ft8dt_cc_01.RAW	D121012_MGH_LiK_2333A_OGE06_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 3	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 172	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	7	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121012_LiK_2333A/D121012_MGH_LiK_2333A_OGE07_rafkt_ft8dt_cc_01.RAW	D121012_MGH_LiK_2333A_OGE07_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 3	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 173	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	8	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121012_LiK_2333A/D121012_MGH_LiK_2333A_OGE08_rafkt_ft8dt_cc_01.RAW	D121012_MGH_LiK_2333A_OGE08_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 3	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 174	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	9_10	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121012_LiK_2333A/D121012_MGH_LiK_2333A_OGE09_10_rafkt_ft8dt_cc_01.RAW	D121012_MGH_LiK_2333A_OGE09_10_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 3	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 175	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	11	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121012_LiK_2333A/D121012_MGH_LiK_2333A_OGE11_rafkt_ft8dt_cc_01.RAW	D121012_MGH_LiK_2333A_OGE11_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
+Liver Metastasis Patient 3	1	homo sapiens	liver	hepatocyte	not available	not available	not available	metastatic malignant neoplasm in the liver	3	not pooled	NT= Extraction purification;AC=NCIT:C113061	run 176	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	off-gel electrophoresis	12	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Fixed;PP=Any N-term;TA=X	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000078555/spectrum/D121012_LiK_2333A/D121012_MGH_LiK_2333A_OGE12_rafkt_ft8dt_cc_01.RAW	D121012_MGH_LiK_2333A_OGE12_rafkt_ft8dt_cc_01.RAW	metastatic malignant neoplasm in the liver
\ No newline at end of file
diff --git a/annotated-projects/MSV000080451/MSV000080451.sdrf.tsv b/annotated-projects/MSV000080451/MSV000080451.sdrf.tsv
index f53ba450..8c178343 100644
--- a/annotated-projects/MSV000080451/MSV000080451.sdrf.tsv
+++ b/annotated-projects/MSV000080451/MSV000080451.sdrf.tsv
@@ -1,72 +1,72 @@
 source name	characteristics[biological replicate]	characteristics[organism]	characteristics[organism part]	characteristics[cell type]	characteristics[age]	characteristics[ancestry category]	characteristics[sex]	characteristics[disease]	characteristics[individual]	characteristics[enrichment process]	assay name	technology type	comment[cleavage agent details]	comment[fractionation method]	comment[fraction identifier]	comment[fragment mass tolerance]	comment[precursor mass tolerance]	comment[technical replicate]	comment[instrument]	comment[label]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[tool metadata]	comment[file uri]	comment[data file]	factor value[disease]
-Donor_1	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	1	NT= Extraction purification;AC=NCIT:C113061	run 1	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_1/020313ESGNBM1A.raw	020313ESGNBM1A.raw	normal
-Donor_1	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	1	NT= Extraction purification;AC=NCIT:C113061	run 2	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_1/020313ESGNBM1B.raw	020313ESGNBM1B.raw	normal
-Donor_1	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	1	NT= Extraction purification;AC=NCIT:C113061	run 3	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	3	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_1/020313ESGNBM1C.raw	020313ESGNBM1C.raw	normal
-Donor_10	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	10	NT= Extraction purification;AC=NCIT:C113061	run 4	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_10/101713ESGNBM4A.raw	101713ESGNBM4A.raw	normal
-Donor_10	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	10	NT= Extraction purification;AC=NCIT:C113061	run 5	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_10/101713ESGNBM4B.raw	101713ESGNBM4B.raw	normal
-Donor_10	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	10	NT= Extraction purification;AC=NCIT:C113061	run 6	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	3	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_10/101713ESGNBM4C.raw	101713ESGNBM4C.raw	normal
-Donor_10	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	10	NT= Extraction purification;AC=NCIT:C113061	run 7	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	4	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_10/101713ESGNBM4D.raw	101713ESGNBM4D.raw	normal
-Donor_2	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	2	NT= Extraction purification;AC=NCIT:C113061	run 8	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_2/020313ESGNBM2A.raw	020313ESGNBM2A.raw	normal
-Donor_2	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	2	NT= Extraction purification;AC=NCIT:C113061	run 9	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_2/020313ESGNBM2B.raw	020313ESGNBM2B.raw	normal
-Donor_2	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	2	NT= Extraction purification;AC=NCIT:C113061	run 10	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	3	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_2/020313ESGNBM2C.raw	020313ESGNBM2C.raw	normal
-Donor_3	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	3	NT= Extraction purification;AC=NCIT:C113061	run 11	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_3/020313ESGNBM3A.raw	020313ESGNBM3A.raw	normal
-Donor_3	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	3	NT= Extraction purification;AC=NCIT:C113061	run 12	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_3/020313ESGNBM3B.raw	020313ESGNBM3B.raw	normal
-Donor_3	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	3	NT= Extraction purification;AC=NCIT:C113061	run 13	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	3	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_3/020313ESGNBM3C.raw	020313ESGNBM3C.raw	normal
-Donor_4	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	4	NT= Extraction purification;AC=NCIT:C113061	run 14	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_4/042213RSGNBM3A.raw	042213RSGNBM3A.raw	normal
-Donor_4	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	4	NT= Extraction purification;AC=NCIT:C113061	run 15	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_4/042213RSGNBM3B.raw	042213RSGNBM3B.raw	normal
-Donor_5	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	5	NT= Extraction purification;AC=NCIT:C113061	run 16	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_5/042213RSGNBM4ARe.raw	042213RSGNBM4ARe.raw	normal
-Donor_5	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	5	NT= Extraction purification;AC=NCIT:C113061	run 17	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_5/042213RSGNBM4B.raw	042213RSGNBM4B.raw	normal
-Donor_6	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	6	NT= Extraction purification;AC=NCIT:C113061	run 18	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_6/042213RSGNBM5A.raw	042213RSGNBM5A.raw	normal
-Donor_6	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	6	NT= Extraction purification;AC=NCIT:C113061	run 19	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_6/042213RSGNBM5B.raw	042213RSGNBM5B.raw	normal
-Donor_7	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	7	NT= Extraction purification;AC=NCIT:C113061	run 20	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_7/101713ESGNBM1A.raw	101713ESGNBM1A.raw	normal
-Donor_7	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	7	NT= Extraction purification;AC=NCIT:C113061	run 21	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_7/101713ESGNBM1B.raw	101713ESGNBM1B.raw	normal
-Donor_7	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	7	NT= Extraction purification;AC=NCIT:C113061	run 22	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	3	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_7/101713ESGNBM1C.raw	101713ESGNBM1C.raw	normal
-Donor_8	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	8	NT= Extraction purification;AC=NCIT:C113061	run 23	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_8/101713ESGNBM2A.raw	101713ESGNBM2A.raw	normal
-Donor_8	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	8	NT= Extraction purification;AC=NCIT:C113061	run 24	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_8/101713ESGNBM2B.raw	101713ESGNBM2B.raw	normal
-Donor_8	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	8	NT= Extraction purification;AC=NCIT:C113061	run 25	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	3	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_8/101713ESGNBM2C.raw	101713ESGNBM2C.raw	normal
-Donor_8	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	8	NT= Extraction purification;AC=NCIT:C113061	run 26	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	4	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_8/101713ESGNBM2D.raw	101713ESGNBM2D.raw	normal
-Donor_9	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	9	NT= Extraction purification;AC=NCIT:C113061	run 27	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_9/101713ESGNBM3A.raw	101713ESGNBM3A.raw	normal
-Donor_9	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	9	NT= Extraction purification;AC=NCIT:C113061	run 28	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_9/101713ESGNBM3B.raw	101713ESGNBM3B.raw	normal
-Donor_9	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	9	NT= Extraction purification;AC=NCIT:C113061	run 29	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	3	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_9/101713ESGNBM3C.raw	101713ESGNBM3C.raw	normal
-MGUS_Patient_1	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	monoclonal gammopathy 	11	NT= Extraction purification;AC=NCIT:C113061	run 30	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/MGUS_Patient_1/102913ESGTO12A.raw	102913ESGTO12A.raw	monoclonal gammopathy
-MGUS_Patient_1	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	monoclonal gammopathy 	11	NT= Extraction purification;AC=NCIT:C113061	run 31	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/MGUS_Patient_1/102913ESGTO12B.raw	102913ESGTO12B.raw	monoclonal gammopathy
-MGUS_Patient_1	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	monoclonal gammopathy 	11	NT= Extraction purification;AC=NCIT:C113061	run 32	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	3	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/MGUS_Patient_1/102913ESGTO12C.raw	102913ESGTO12C.raw	monoclonal gammopathy
-MGUS_Patient_2	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	monoclonal gammopathy 	12	NT= Extraction purification;AC=NCIT:C113061	run 33	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/MGUS_Patient_2/102913ESGTO17A.raw	102913ESGTO17A.raw	monoclonal gammopathy
-MGUS_Patient_2	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	monoclonal gammopathy 	12	NT= Extraction purification;AC=NCIT:C113061	run 34	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/MGUS_Patient_2/102913ESGTO17B.raw	102913ESGTO17B.raw	monoclonal gammopathy
-MGUS_Patient_2	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	monoclonal gammopathy 	12	NT= Extraction purification;AC=NCIT:C113061	run 35	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	3	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/MGUS_Patient_2/102913ESGTO17C.raw	102913ESGTO17C.raw	monoclonal gammopathy
-MGUS_Patient_3	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	monoclonal gammopathy 	13	NT= Extraction purification;AC=NCIT:C113061	run 36	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/MGUS_Patient_3/102913ESGTO20A.raw	102913ESGTO20A.raw	monoclonal gammopathy
-MGUS_Patient_3	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	monoclonal gammopathy 	13	NT= Extraction purification;AC=NCIT:C113061	run 37	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/MGUS_Patient_3/102913ESGTO20B.raw	102913ESGTO20B.raw	monoclonal gammopathy
-MGUS_Patient_3	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	monoclonal gammopathy 	13	NT= Extraction purification;AC=NCIT:C113061	run 38	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	3	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/MGUS_Patient_3/102913ESGTO20B_1.raw	102913ESGTO20B_1.raw	monoclonal gammopathy
-New_Patient_1	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	14	NT= Extraction purification;AC=NCIT:C113061	run 39	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/New_Patient_1/102913ESGTO13A.raw	102913ESGTO13A.raw	multiple myeloma
-New_Patient_1	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	14	NT= Extraction purification;AC=NCIT:C113061	run 40	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/New_Patient_1/102913ESGTO13B.raw	102913ESGTO13B.raw	multiple myeloma
-New_Patient_1	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	14	NT= Extraction purification;AC=NCIT:C113061	run 41	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	3	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/New_Patient_1/102913ESGTO13C.raw	102913ESGTO13C.raw	multiple myeloma
-New_Patient_2	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	15	NT= Extraction purification;AC=NCIT:C113061	run 42	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/New_Patient_2/102913ESGTO15A.raw	102913ESGTO15A.raw	multiple myeloma
-New_Patient_2	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	15	NT= Extraction purification;AC=NCIT:C113061	run 43	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/New_Patient_2/102913ESGTO15B.raw	102913ESGTO15B.raw	multiple myeloma
-New_Patient_3	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	16	NT= Extraction purification;AC=NCIT:C113061	run 44	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/New_Patient_3/102913ESGTO16A.raw	102913ESGTO16A.raw	multiple myeloma
-New_Patient_3	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	16	NT= Extraction purification;AC=NCIT:C113061	run 45	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/New_Patient_3/102913ESGTO16B.raw	102913ESGTO16B.raw	multiple myeloma
-New_Patient_3	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	16	NT= Extraction purification;AC=NCIT:C113061	run 46	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	3	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/New_Patient_3/102913ESGTO16C.raw	102913ESGTO16C.raw	multiple myeloma
-New_Patient_4	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	17	NT= Extraction purification;AC=NCIT:C113061	run 47	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/New_Patient_4/020313ESGMM1A.raw	020313ESGMM1A.raw	multiple myeloma
-New_Patient_4	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	17	NT= Extraction purification;AC=NCIT:C113061	run 48	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/New_Patient_4/020313ESGMM1B.raw	020313ESGMM1B.raw	multiple myeloma
-New_Patient_4	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	17	NT= Extraction purification;AC=NCIT:C113061	run 49	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	3	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/New_Patient_4/020313ESGMM1C.raw	020313ESGMM1C.raw	multiple myeloma
-New_Patient_5	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	18	NT= Extraction purification;AC=NCIT:C113061	run 50	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/New_Patient_5/020313ESGMM2A.raw	020313ESGMM2A.raw	multiple myeloma
-New_Patient_5	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	18	NT= Extraction purification;AC=NCIT:C113061	run 51	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/New_Patient_5/020313ESGMM2B.raw	020313ESGMM2B.raw	multiple myeloma
-New_Patient_5	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	18	NT= Extraction purification;AC=NCIT:C113061	run 52	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	3	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/New_Patient_5/020313ESGMM2C.raw	020313ESGMM2C.raw	multiple myeloma
-New_Patient_6	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	19	NT= Extraction purification;AC=NCIT:C113061	run 53	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/New_Patient_6/042213RSGMM6A.raw	042213RSGMM6A.raw	multiple myeloma
-New_Patient_6	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	19	NT= Extraction purification;AC=NCIT:C113061	run 54	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/New_Patient_6/042213RSGMM6B.raw	042213RSGMM6B.raw	multiple myeloma
-New_Patient_7	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	20	NT= Extraction purification;AC=NCIT:C113061	run 55	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/New_Patient_7/042213RSGMM9A.raw	042213RSGMM9A.raw	multiple myeloma
-New_Patient_7	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	20	NT= Extraction purification;AC=NCIT:C113061	run 56	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/New_Patient_7/042213RSGMM9B.raw	042213RSGMM9B.raw	multiple myeloma
-Relapsed_Patient_1	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	21	NT= Extraction purification;AC=NCIT:C113061	run 57	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Relapsed_Patient_1/102913ESGTO11A.raw	102913ESGTO11A.raw 	multiple myeloma
-Relapsed_Patient_1	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	21	NT= Extraction purification;AC=NCIT:C113061	run 58	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Relapsed_Patient_1/102913ESGTO11B.raw	102913ESGTO11B.raw	multiple myeloma
-Relapsed_Patient_1	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	21	NT= Extraction purification;AC=NCIT:C113061	run 59	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	3	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Relapsed_Patient_1/102913ESGTO11C.raw	102913ESGTO11C.raw	multiple myeloma
-Relapsed_Patient_1	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	21	NT= Extraction purification;AC=NCIT:C113061	run 60	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	4	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Relapsed_Patient_1/102913ESGTO11D.raw	102913ESGTO11D.raw	multiple myeloma
-Relapsed_Patient_2	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	22	NT= Extraction purification;AC=NCIT:C113061	run 61	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Relapsed_Patient_2/102913ESGTO14A.raw	102913ESGTO14A.raw	multiple myeloma
-Relapsed_Patient_2	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	22	NT= Extraction purification;AC=NCIT:C113061	run 62	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Relapsed_Patient_2/102913ESGTO14B.raw	102913ESGTO14B.raw	multiple myeloma
-Relapsed_Patient_2	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	22	NT= Extraction purification;AC=NCIT:C113061	run 63	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	3	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Relapsed_Patient_2/102913ESGTO14C.raw	102913ESGTO14C.raw	multiple myeloma
-Relapsed_Patient_3	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	23	NT= Extraction purification;AC=NCIT:C113061	run 64	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Relapsed_Patient_3/102913ESGTO19A.raw	102913ESGTO19A.raw	multiple myeloma
-Relapsed_Patient_3	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	23	NT= Extraction purification;AC=NCIT:C113061	run 65	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Relapsed_Patient_3/102913ESGTO19B.raw	102913ESGTO19B.raw	multiple myeloma
-Relapsed_Patient_4	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	24	NT= Extraction purification;AC=NCIT:C113061	run 66	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Relapsed_Patient_4/020313ESGMM3A.raw	020313ESGMM3A.raw	multiple myeloma
-Relapsed_Patient_4	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	24	NT= Extraction purification;AC=NCIT:C113061	run 67	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Relapsed_Patient_4/020313ESGMM3B.raw	020313ESGMM3B.raw	multiple myeloma
-Relapsed_Patient_4	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	24	NT= Extraction purification;AC=NCIT:C113061	run 68	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	3	0.7 Da	20 ppm	1	NT=Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Relapsed_Patient_4/020313ESGMM3C.raw	020313ESGMM3C.raw	multiple myeloma
-Relapsed_Patient_5	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	25	NT= Extraction purification;AC=NCIT:C113061	run 69	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Relapsed_Patient_5/042213RSGMM7A.raw	042213RSGMM7A.raw	multiple myeloma
-Relapsed_Patient_5	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	25	NT= Extraction purification;AC=NCIT:C113061	run 70	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Relapsed_Patient_5/042213RSGMM7B.raw	042213RSGMM7B.raw	multiple myeloma
-Relapsed_Patient_6	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	26	NT= Extraction purification;AC=NCIT:C113061	run 71	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3)C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Relapsed_Patient_6/042213RSGMM8A.raw	042213RSGMM8A.raw	multiple myeloma
\ No newline at end of file
+Donor_1	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	1	NT= Extraction purification;AC=NCIT:C113061	run 1	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_1/020313ESGNBM1A.raw	020313ESGNBM1A.raw	normal
+Donor_1	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	1	NT= Extraction purification;AC=NCIT:C113061	run 2	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_1/020313ESGNBM1B.raw	020313ESGNBM1B.raw	normal
+Donor_1	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	1	NT= Extraction purification;AC=NCIT:C113061	run 3	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_1/020313ESGNBM1C.raw	020313ESGNBM1C.raw	normal
+Donor_10	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	10	NT= Extraction purification;AC=NCIT:C113061	run 4	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_10/101713ESGNBM4A.raw	101713ESGNBM4A.raw	normal
+Donor_10	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	10	NT= Extraction purification;AC=NCIT:C113061	run 5	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_10/101713ESGNBM4B.raw	101713ESGNBM4B.raw	normal
+Donor_10	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	10	NT= Extraction purification;AC=NCIT:C113061	run 6	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_10/101713ESGNBM4C.raw	101713ESGNBM4C.raw	normal
+Donor_10	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	10	NT= Extraction purification;AC=NCIT:C113061	run 7	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_10/101713ESGNBM4D.raw	101713ESGNBM4D.raw	normal
+Donor_2	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	2	NT= Extraction purification;AC=NCIT:C113061	run 8	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_2/020313ESGNBM2A.raw	020313ESGNBM2A.raw	normal
+Donor_2	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	2	NT= Extraction purification;AC=NCIT:C113061	run 9	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_2/020313ESGNBM2B.raw	020313ESGNBM2B.raw	normal
+Donor_2	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	2	NT= Extraction purification;AC=NCIT:C113061	run 10	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_2/020313ESGNBM2C.raw	020313ESGNBM2C.raw	normal
+Donor_3	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	3	NT= Extraction purification;AC=NCIT:C113061	run 11	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_3/020313ESGNBM3A.raw	020313ESGNBM3A.raw	normal
+Donor_3	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	3	NT= Extraction purification;AC=NCIT:C113061	run 12	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_3/020313ESGNBM3B.raw	020313ESGNBM3B.raw	normal
+Donor_3	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	3	NT= Extraction purification;AC=NCIT:C113061	run 13	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_3/020313ESGNBM3C.raw	020313ESGNBM3C.raw	normal
+Donor_4	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	4	NT= Extraction purification;AC=NCIT:C113061	run 14	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_4/042213RSGNBM3A.raw	042213RSGNBM3A.raw	normal
+Donor_4	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	4	NT= Extraction purification;AC=NCIT:C113061	run 15	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_4/042213RSGNBM3B.raw	042213RSGNBM3B.raw	normal
+Donor_5	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	5	NT= Extraction purification;AC=NCIT:C113061	run 16	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_5/042213RSGNBM4ARe.raw	042213RSGNBM4ARe.raw	normal
+Donor_5	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	5	NT= Extraction purification;AC=NCIT:C113061	run 17	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_5/042213RSGNBM4B.raw	042213RSGNBM4B.raw	normal
+Donor_6	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	6	NT= Extraction purification;AC=NCIT:C113061	run 18	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_6/042213RSGNBM5A.raw	042213RSGNBM5A.raw	normal
+Donor_6	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	6	NT= Extraction purification;AC=NCIT:C113061	run 19	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_6/042213RSGNBM5B.raw	042213RSGNBM5B.raw	normal
+Donor_7	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	7	NT= Extraction purification;AC=NCIT:C113061	run 20	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_7/101713ESGNBM1A.raw	101713ESGNBM1A.raw	normal
+Donor_7	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	7	NT= Extraction purification;AC=NCIT:C113061	run 21	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_7/101713ESGNBM1B.raw	101713ESGNBM1B.raw	normal
+Donor_7	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	7	NT= Extraction purification;AC=NCIT:C113061	run 22	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_7/101713ESGNBM1C.raw	101713ESGNBM1C.raw	normal
+Donor_8	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	8	NT= Extraction purification;AC=NCIT:C113061	run 23	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_8/101713ESGNBM2A.raw	101713ESGNBM2A.raw	normal
+Donor_8	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	8	NT= Extraction purification;AC=NCIT:C113061	run 24	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_8/101713ESGNBM2B.raw	101713ESGNBM2B.raw	normal
+Donor_8	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	8	NT= Extraction purification;AC=NCIT:C113061	run 25	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_8/101713ESGNBM2C.raw	101713ESGNBM2C.raw	normal
+Donor_8	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	8	NT= Extraction purification;AC=NCIT:C113061	run 26	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_8/101713ESGNBM2D.raw	101713ESGNBM2D.raw	normal
+Donor_9	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	9	NT= Extraction purification;AC=NCIT:C113061	run 27	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_9/101713ESGNBM3A.raw	101713ESGNBM3A.raw	normal
+Donor_9	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	9	NT= Extraction purification;AC=NCIT:C113061	run 28	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_9/101713ESGNBM3B.raw	101713ESGNBM3B.raw	normal
+Donor_9	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	normal	9	NT= Extraction purification;AC=NCIT:C113061	run 29	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Donor_9/101713ESGNBM3C.raw	101713ESGNBM3C.raw	normal
+MGUS_Patient_1	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	monoclonal gammopathy 	11	NT= Extraction purification;AC=NCIT:C113061	run 30	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/MGUS_Patient_1/102913ESGTO12A.raw	102913ESGTO12A.raw	monoclonal gammopathy
+MGUS_Patient_1	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	monoclonal gammopathy 	11	NT= Extraction purification;AC=NCIT:C113061	run 31	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/MGUS_Patient_1/102913ESGTO12B.raw	102913ESGTO12B.raw	monoclonal gammopathy
+MGUS_Patient_1	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	monoclonal gammopathy 	11	NT= Extraction purification;AC=NCIT:C113061	run 32	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/MGUS_Patient_1/102913ESGTO12C.raw	102913ESGTO12C.raw	monoclonal gammopathy
+MGUS_Patient_2	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	monoclonal gammopathy 	12	NT= Extraction purification;AC=NCIT:C113061	run 33	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/MGUS_Patient_2/102913ESGTO17A.raw	102913ESGTO17A.raw	monoclonal gammopathy
+MGUS_Patient_2	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	monoclonal gammopathy 	12	NT= Extraction purification;AC=NCIT:C113061	run 34	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/MGUS_Patient_2/102913ESGTO17B.raw	102913ESGTO17B.raw	monoclonal gammopathy
+MGUS_Patient_2	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	monoclonal gammopathy 	12	NT= Extraction purification;AC=NCIT:C113061	run 35	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/MGUS_Patient_2/102913ESGTO17C.raw	102913ESGTO17C.raw	monoclonal gammopathy
+MGUS_Patient_3	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	monoclonal gammopathy 	13	NT= Extraction purification;AC=NCIT:C113061	run 36	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/MGUS_Patient_3/102913ESGTO20A.raw	102913ESGTO20A.raw	monoclonal gammopathy
+MGUS_Patient_3	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	monoclonal gammopathy 	13	NT= Extraction purification;AC=NCIT:C113061	run 37	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/MGUS_Patient_3/102913ESGTO20B.raw	102913ESGTO20B.raw	monoclonal gammopathy
+MGUS_Patient_3	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	monoclonal gammopathy 	13	NT= Extraction purification;AC=NCIT:C113061	run 38	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/MGUS_Patient_3/102913ESGTO20B_1.raw	102913ESGTO20B_1.raw	monoclonal gammopathy
+New_Patient_1	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	14	NT= Extraction purification;AC=NCIT:C113061	run 39	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/New_Patient_1/102913ESGTO13A.raw	102913ESGTO13A.raw	multiple myeloma
+New_Patient_1	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	14	NT= Extraction purification;AC=NCIT:C113061	run 40	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/New_Patient_1/102913ESGTO13B.raw	102913ESGTO13B.raw	multiple myeloma
+New_Patient_1	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	14	NT= Extraction purification;AC=NCIT:C113061	run 41	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/New_Patient_1/102913ESGTO13C.raw	102913ESGTO13C.raw	multiple myeloma
+New_Patient_2	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	15	NT= Extraction purification;AC=NCIT:C113061	run 42	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/New_Patient_2/102913ESGTO15A.raw	102913ESGTO15A.raw	multiple myeloma
+New_Patient_2	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	15	NT= Extraction purification;AC=NCIT:C113061	run 43	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/New_Patient_2/102913ESGTO15B.raw	102913ESGTO15B.raw	multiple myeloma
+New_Patient_3	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	16	NT= Extraction purification;AC=NCIT:C113061	run 44	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/New_Patient_3/102913ESGTO16A.raw	102913ESGTO16A.raw	multiple myeloma
+New_Patient_3	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	16	NT= Extraction purification;AC=NCIT:C113061	run 45	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/New_Patient_3/102913ESGTO16B.raw	102913ESGTO16B.raw	multiple myeloma
+New_Patient_3	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	16	NT= Extraction purification;AC=NCIT:C113061	run 46	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/New_Patient_3/102913ESGTO16C.raw	102913ESGTO16C.raw	multiple myeloma
+New_Patient_4	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	17	NT= Extraction purification;AC=NCIT:C113061	run 47	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/New_Patient_4/020313ESGMM1A.raw	020313ESGMM1A.raw	multiple myeloma
+New_Patient_4	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	17	NT= Extraction purification;AC=NCIT:C113061	run 48	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/New_Patient_4/020313ESGMM1B.raw	020313ESGMM1B.raw	multiple myeloma
+New_Patient_4	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	17	NT= Extraction purification;AC=NCIT:C113061	run 49	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/New_Patient_4/020313ESGMM1C.raw	020313ESGMM1C.raw	multiple myeloma
+New_Patient_5	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	18	NT= Extraction purification;AC=NCIT:C113061	run 50	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/New_Patient_5/020313ESGMM2A.raw	020313ESGMM2A.raw	multiple myeloma
+New_Patient_5	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	18	NT= Extraction purification;AC=NCIT:C113061	run 51	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/New_Patient_5/020313ESGMM2B.raw	020313ESGMM2B.raw	multiple myeloma
+New_Patient_5	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	18	NT= Extraction purification;AC=NCIT:C113061	run 52	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/New_Patient_5/020313ESGMM2C.raw	020313ESGMM2C.raw	multiple myeloma
+New_Patient_6	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	19	NT= Extraction purification;AC=NCIT:C113061	run 53	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/New_Patient_6/042213RSGMM6A.raw	042213RSGMM6A.raw	multiple myeloma
+New_Patient_6	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	19	NT= Extraction purification;AC=NCIT:C113061	run 54	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/New_Patient_6/042213RSGMM6B.raw	042213RSGMM6B.raw	multiple myeloma
+New_Patient_7	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	20	NT= Extraction purification;AC=NCIT:C113061	run 55	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/New_Patient_7/042213RSGMM9A.raw	042213RSGMM9A.raw	multiple myeloma
+New_Patient_7	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	20	NT= Extraction purification;AC=NCIT:C113061	run 56	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/New_Patient_7/042213RSGMM9B.raw	042213RSGMM9B.raw	multiple myeloma
+Relapsed_Patient_1	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	21	NT= Extraction purification;AC=NCIT:C113061	run 57	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Relapsed_Patient_1/102913ESGTO11A.raw	102913ESGTO11A.raw 	multiple myeloma
+Relapsed_Patient_1	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	21	NT= Extraction purification;AC=NCIT:C113061	run 58	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Relapsed_Patient_1/102913ESGTO11B.raw	102913ESGTO11B.raw	multiple myeloma
+Relapsed_Patient_1	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	21	NT= Extraction purification;AC=NCIT:C113061	run 59	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Relapsed_Patient_1/102913ESGTO11C.raw	102913ESGTO11C.raw	multiple myeloma
+Relapsed_Patient_1	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	21	NT= Extraction purification;AC=NCIT:C113061	run 60	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	4	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Relapsed_Patient_1/102913ESGTO11D.raw	102913ESGTO11D.raw	multiple myeloma
+Relapsed_Patient_2	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	22	NT= Extraction purification;AC=NCIT:C113061	run 61	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Relapsed_Patient_2/102913ESGTO14A.raw	102913ESGTO14A.raw	multiple myeloma
+Relapsed_Patient_2	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	22	NT= Extraction purification;AC=NCIT:C113061	run 62	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Relapsed_Patient_2/102913ESGTO14B.raw	102913ESGTO14B.raw	multiple myeloma
+Relapsed_Patient_2	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	22	NT= Extraction purification;AC=NCIT:C113061	run 63	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Relapsed_Patient_2/102913ESGTO14C.raw	102913ESGTO14C.raw	multiple myeloma
+Relapsed_Patient_3	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	23	NT= Extraction purification;AC=NCIT:C113061	run 64	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Relapsed_Patient_3/102913ESGTO19A.raw	102913ESGTO19A.raw	multiple myeloma
+Relapsed_Patient_3	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	23	NT= Extraction purification;AC=NCIT:C113061	run 65	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Relapsed_Patient_3/102913ESGTO19B.raw	102913ESGTO19B.raw	multiple myeloma
+Relapsed_Patient_4	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	24	NT= Extraction purification;AC=NCIT:C113061	run 66	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Relapsed_Patient_4/020313ESGMM3A.raw	020313ESGMM3A.raw	multiple myeloma
+Relapsed_Patient_4	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	24	NT= Extraction purification;AC=NCIT:C113061	run 67	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Relapsed_Patient_4/020313ESGMM3B.raw	020313ESGMM3B.raw	multiple myeloma
+Relapsed_Patient_4	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	24	NT= Extraction purification;AC=NCIT:C113061	run 68	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	3	0.7 Da	20 ppm	1	NT=LTQ Orbitrap Elite;AC=MS:1001910	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Relapsed_Patient_4/020313ESGMM3C.raw	020313ESGMM3C.raw	multiple myeloma
+Relapsed_Patient_5	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	25	NT= Extraction purification;AC=NCIT:C113061	run 69	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Relapsed_Patient_5/042213RSGMM7A.raw	042213RSGMM7A.raw	multiple myeloma
+Relapsed_Patient_5	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	25	NT= Extraction purification;AC=NCIT:C113061	run 70	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	2	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Relapsed_Patient_5/042213RSGMM7B.raw	042213RSGMM7B.raw	multiple myeloma
+Relapsed_Patient_6	1	homo sapiens	bone marrow	bone marrow cell	not available	not available	not available	multiple myeloma	26	NT= Extraction purification;AC=NCIT:C113061	run 71	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251	Sodium dodecyl sulfate polyacrylamide gel electrophoresis	1	0.7 Da	20 ppm	1	NT=LTQ Orbitrap XL;AC=MS:1000556	label free sample	NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=P	lesSDRF v0.1.0	f.MSV000080451/raw/RawData/Relapsed_Patient_6/042213RSGMM8A.raw	042213RSGMM8A.raw	multiple myeloma
\ No newline at end of file
diff --git a/annotated-projects/PXD003469/PXD003469.sdrf.tsv b/annotated-projects/PXD003469/PXD003469.sdrf.tsv
index d1ea2e19..12fe6cd8 100644
--- a/annotated-projects/PXD003469/PXD003469.sdrf.tsv
+++ b/annotated-projects/PXD003469/PXD003469.sdrf.tsv
@@ -242,15 +242,15 @@ Sample 80	Homo sapiens	lymph node	not available	not available	Anaplastic large c
 Sample 81	Homo sapiens	lymphoblastic	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	Mac-1	no compound	glycosylation	2	cell	run 241	proteomic profiling by mass spectrometry	UM_A_2012_0818_a1-MAC1.mzXML	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0818_a1-MAC1.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Mac-1	no compound
 Sample 81	Homo sapiens	lymphoblastic	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	Mac-1	no compound	glycosylation	2	cell	run 242	proteomic profiling by mass spectrometry	UM_A_2012_0818_a2-MAC1.mzXML	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0818_a2-MAC1.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Mac-1	no compound
 Sample 81	Homo sapiens	lymphoblastic	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	Mac-1	no compound	glycosylation	2	cell	run 243	proteomic profiling by mass spectrometry	UM_A_2012_0818_a3-MAC1.mzXML	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0818_a3-MAC1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Mac-1	no compound
-Sample 82	Homo sapiens	lymphoblastic	not available	male	acute T cell leukemia		T lymphocyte	Jurkat	no compound	glycosylation	1	cell	run 244	proteomic profiling by mass spectrometry	UM_A_2012_0863_a1-JURKAT.mzXML	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0863_a1-JURKAT.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Jurkat	no compound
-Sample 82	Homo sapiens	lymphoblastic	not available	male	acute T cell leukemia		T lymphocyte	Jurkat	no compound	glycosylation	1	cell	run 245	proteomic profiling by mass spectrometry	UM_A_2012_0863_a2-JURKAT.mzXML	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0863_a2-JURKAT.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Jurkat	no compound
-Sample 82	Homo sapiens	lymphoblastic	not available	male	acute T cell leukemia		T lymphocyte	Jurkat	no compound	glycosylation	1	cell	run 246	proteomic profiling by mass spectrometry	UM_A_2012_0863_a3-JURKAT.mzXML	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0863_a3-JURKAT.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Jurkat	no compound
-Sample 83	Homo sapiens	lymphoblastic	not available	male	acute T cell leukemia		T lymphocyte	Jurkat	no compound	glycosylation	2	cell	run 247	proteomic profiling by mass spectrometry	UM_A_2012_0864_a1-JURKAT.mzXML	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0864_a1-JURKAT.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Jurkat	no compound
-Sample 83	Homo sapiens	lymphoblastic	not available	male	acute T cell leukemia		T lymphocyte	Jurkat	no compound	glycosylation	2	cell	run 248	proteomic profiling by mass spectrometry	UM_A_2012_0864_a2-JURKAT.mzXML	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0864_a2-JURKAT.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Jurkat	no compound
-Sample 83	Homo sapiens	lymphoblastic	not available	male	acute T cell leukemia		T lymphocyte	Jurkat	no compound	glycosylation	2	cell	run 249	proteomic profiling by mass spectrometry	UM_A_2012_0864_a3-JURKAT.mzXML	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0864_a3-JURKAT.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Jurkat	no compound
-Sample 84	Homo sapiens	lymphoblastic	not available	male	acute T cell leukemia		T lymphocyte	Jurkat	no compound	glycosylation	3	cell	run 250	proteomic profiling by mass spectrometry	UM_A_2012_0866_a1-JURKAT.mzXML	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0866_a1-JURKAT.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Jurkat	no compound
-Sample 84	Homo sapiens	lymphoblastic	not available	male	acute T cell leukemia		T lymphocyte	Jurkat	no compound	glycosylation	3	cell	run 251	proteomic profiling by mass spectrometry	UM_A_2012_0866_a2-JURKAT.mzXML	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0866_a2-JURKAT.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Jurkat	no compound
-Sample 84	Homo sapiens	lymphoblastic	not available	male	acute T cell leukemia		T lymphocyte	Jurkat	no compound	glycosylation	3	cell	run 252	proteomic profiling by mass spectrometry	UM_A_2012_0866_a3-JURKAT.mzXML	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0866_a3-JURKAT.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Jurkat	no compound
+Sample 82	Homo sapiens	lymphoblastic	not available	male	acute T cell leukemia	not available	T lymphocyte	Jurkat	no compound	glycosylation	1	cell	run 244	proteomic profiling by mass spectrometry	UM_A_2012_0863_a1-JURKAT.mzXML	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0863_a1-JURKAT.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Jurkat	no compound
+Sample 82	Homo sapiens	lymphoblastic	not available	male	acute T cell leukemia	not available	T lymphocyte	Jurkat	no compound	glycosylation	1	cell	run 245	proteomic profiling by mass spectrometry	UM_A_2012_0863_a2-JURKAT.mzXML	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0863_a2-JURKAT.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Jurkat	no compound
+Sample 82	Homo sapiens	lymphoblastic	not available	male	acute T cell leukemia	not available	T lymphocyte	Jurkat	no compound	glycosylation	1	cell	run 246	proteomic profiling by mass spectrometry	UM_A_2012_0863_a3-JURKAT.mzXML	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0863_a3-JURKAT.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Jurkat	no compound
+Sample 83	Homo sapiens	lymphoblastic	not available	male	acute T cell leukemia	not available	T lymphocyte	Jurkat	no compound	glycosylation	2	cell	run 247	proteomic profiling by mass spectrometry	UM_A_2012_0864_a1-JURKAT.mzXML	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0864_a1-JURKAT.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Jurkat	no compound
+Sample 83	Homo sapiens	lymphoblastic	not available	male	acute T cell leukemia	not available	T lymphocyte	Jurkat	no compound	glycosylation	2	cell	run 248	proteomic profiling by mass spectrometry	UM_A_2012_0864_a2-JURKAT.mzXML	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0864_a2-JURKAT.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Jurkat	no compound
+Sample 83	Homo sapiens	lymphoblastic	not available	male	acute T cell leukemia	not available	T lymphocyte	Jurkat	no compound	glycosylation	2	cell	run 249	proteomic profiling by mass spectrometry	UM_A_2012_0864_a3-JURKAT.mzXML	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0864_a3-JURKAT.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Jurkat	no compound
+Sample 84	Homo sapiens	lymphoblastic	not available	male	acute T cell leukemia	not available	T lymphocyte	Jurkat	no compound	glycosylation	3	cell	run 250	proteomic profiling by mass spectrometry	UM_A_2012_0866_a1-JURKAT.mzXML	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0866_a1-JURKAT.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Jurkat	no compound
+Sample 84	Homo sapiens	lymphoblastic	not available	male	acute T cell leukemia	not available	T lymphocyte	Jurkat	no compound	glycosylation	3	cell	run 251	proteomic profiling by mass spectrometry	UM_A_2012_0866_a2-JURKAT.mzXML	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0866_a2-JURKAT.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Jurkat	no compound
+Sample 84	Homo sapiens	lymphoblastic	not available	male	acute T cell leukemia	not available	T lymphocyte	Jurkat	no compound	glycosylation	3	cell	run 252	proteomic profiling by mass spectrometry	UM_A_2012_0866_a3-JURKAT.mzXML	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0866_a3-JURKAT.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Jurkat	no compound
 Sample 85	Homo sapiens	peripheral blood	75Y	female	Mantle cell lymphoma	not applicable	not applicable	not applicable	no compound	glycosylation	1	cell	run 253	proteomic profiling by mass spectrometry	UM_A_2012_0916_a1-PATEINT_3.mzXML	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0916_a1-PATEINT_3.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	no compound
 Sample 85	Homo sapiens	peripheral blood	75Y	female	Mantle cell lymphoma	not applicable	not applicable	not applicable	no compound	glycosylation	1	cell	run 254	proteomic profiling by mass spectrometry	UM_A_2012_0916_a2-PATEINT_3.mzXML	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0916_a2-PATEINT_3.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	no compound
 Sample 85	Homo sapiens	peripheral blood	75Y	female	Mantle cell lymphoma	not applicable	not applicable	not applicable	no compound	glycosylation	1	cell	run 255	proteomic profiling by mass spectrometry	UM_A_2012_0916_a3-PATEINT_3.mzXML	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0916_a3-PATEINT_3.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	no compound
diff --git a/annotated-projects/PXD012307/PXD012307.sdrf.tsv b/annotated-projects/PXD012307/PXD012307.sdrf.tsv
index 88439c91..b99d8814 100644
--- a/annotated-projects/PXD012307/PXD012307.sdrf.tsv
+++ b/annotated-projects/PXD012307/PXD012307.sdrf.tsv
@@ -1,4 +1,4 @@
-source name	characteristics[organism]	characteristics[organism part]	characteristics[cell type]	comment[age]	characteristics[ancestry category]	characteristics[sex]	characteristics[disease]	characteristics[biological replicate]	assay name	comment[proteomexchange accession number]	comment[data file]	comment[file uri]	comment[fraction identifier]	characteristics[technical replicate]	comment[instrument]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[cleavage agent details]	comment[cleavage agent details]	comment[label]	comment[precursor mass tolerance]	comment[fragment mass tolerance]
+source name	characteristics[organism]	characteristics[organism part]	characteristics[cell type]	characteristics[age]	characteristics[ancestry category]	characteristics[sex]	characteristics[disease]	characteristics[biological replicate]	assay name	comment[proteomexchange accession number]	comment[data file]	comment[file uri]	comment[fraction identifier]	comment[technical replicate]	comment[instrument]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[cleavage agent details]	comment[cleavage agent details]	comment[label]	comment[precursor mass tolerance]	comment[fragment mass tolerance]
 Sample 1	mus musculus	Lungs	not applicable	24 months	not applicable	not available	not available	1	run 1	PXD012307	20131023_EXQ8_HeSc_SA_ECM_old_14_1.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/01/PXD012307/20131023_EXQ8_HeSc_SA_ECM_old_14_1.raw	1	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Oxidation;MT=Variable;TA=P;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	label free	4.5 ppm	20 ppm
 Sample 1	mus musculus	Lungs	not applicable	24 months	not applicable	not available	not available	1	run 2	PXD012307	20131023_EXQ8_HeSc_SA_ECM_old_14_2.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/01/PXD012307/20131023_EXQ8_HeSc_SA_ECM_old_14_2.raw	2	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Oxidation;MT=Variable;TA=P;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	label free	4.5 ppm	20 ppm
 Sample 1	mus musculus	Lungs	not applicable	24 months	not applicable	not available	not available	1	run 3	PXD012307	20131023_EXQ8_HeSc_SA_ECM_old_14_3.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/01/PXD012307/20131023_EXQ8_HeSc_SA_ECM_old_14_3.raw	3	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Oxidation;MT=Variable;TA=P;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	label free	4.5 ppm	20 ppm
diff --git a/annotated-projects/PXD014557/PXD014557.sdrf.tsv b/annotated-projects/PXD014557/PXD014557.sdrf.tsv
index 55f812cd..61029832 100644
--- a/annotated-projects/PXD014557/PXD014557.sdrf.tsv
+++ b/annotated-projects/PXD014557/PXD014557.sdrf.tsv
@@ -1,401 +1,401 @@
-source name	characteristics[organism]	characteristics[organism part]	characteristics[organism part]	characteristics[cell type]	characteristics[age]	characteristics[ancestry category]	characteristics[sex]	characteristics[disease]	characteristics[developmental stage]	characteristics[biological replicate]	comment[Amyloid stage]	characteristics[individual]	assay name	technology type	comment[proteomexchange accession number]	comment[data file]	comment[file uri]	comment[fraction identifier]	comment[instrument]	comment[modification parameters]	comment[modification parameters]	comment[cleavage agent details]	comment[label]	comment[PTM]	comment[fragment mass tolerance]	comment[precursor mass tolerance]	comment[technical replicate]	comment[BRAAK]	comment[Age at Death]	factor value[sex]	factor value[disease]
-Sample 1	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	1	run 1	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 1	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	1	run 2	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 1	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	0	1	run 3	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 1	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	1	run 4	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 1	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	1	run 5	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N		0.02 Da	10 ppm	1	4	95	female	Alzheimer's Disease
-Sample 1	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	1	run 6	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C		0.02 Da	10 ppm	1	4	84	female	Alzheimer's Disease
-Sample 1	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	1	run 7	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N		0.02 Da	10 ppm	1	2	85	female	Normal
-Sample 1	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	B	1	run 8	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C		0.02 Da	10 ppm	1	2	92	female	Normal
-Sample 1	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	not avilable	1	run 9	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N		0.02 Da	10 ppm	1	1	88	male	Normal
-Sample 1	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	1	C	1	run 10	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131		0.02 Da	10 ppm	1	4	94	male	Alzheimer's Disease
-Sample 2	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	2	run 11	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 2	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	2	run 12	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 2	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	0	2	run 13	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 2	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	2	run 14	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 2	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	2	run 15	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N		0.02 Da	10 ppm	1	4	95	female	Alzheimer's Disease
-Sample 2	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	2	run 16	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C		0.02 Da	10 ppm	1	4	84	female	Alzheimer's Disease
-Sample 2	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	2	run 17	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N		0.02 Da	10 ppm	1	2	85	female	Normal
-Sample 2	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	B	2	run 18	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C		0.02 Da	10 ppm	1	2	92	female	Normal
-Sample 2	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	not avilable	2	run 19	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N		0.02 Da	10 ppm	1	1	88	male	Normal
-Sample 2	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	1	C	2	run 20	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131		0.02 Da	10 ppm	1	4	94	male	Alzheimer's Disease
-Sample 3	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	3	run 21	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 3	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	3	run 22	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 3	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	0	3	run 23	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 3	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	3	run 24	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 3	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	3	run 25	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N		0.02 Da	10 ppm	1	4	95	female	Alzheimer's Disease
-Sample 3	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	3	run 26	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C		0.02 Da	10 ppm	1	4	84	female	Alzheimer's Disease
-Sample 3	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	3	run 27	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N		0.02 Da	10 ppm	1	2	85	female	Normal
-Sample 3	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	B	3	run 28	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C		0.02 Da	10 ppm	1	2	92	female	Normal
-Sample 3	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	not avilable	3	run 29	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N		0.02 Da	10 ppm	1	1	88	male	Normal
-Sample 3	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	1	C	3	run 30	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131		0.02 Da	10 ppm	1	4	94	male	Alzheimer's Disease
-Sample 4	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	4	run 31	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 4	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	4	run 32	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 4	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	0	4	run 33	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 4	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	4	run 34	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 4	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	4	run 35	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N		0.02 Da	10 ppm	1	4	95	female	Alzheimer's Disease
-Sample 4	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	4	run 36	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C		0.02 Da	10 ppm	1	4	84	female	Alzheimer's Disease
-Sample 4	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	4	run 37	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N		0.02 Da	10 ppm	1	2	85	female	Normal
-Sample 4	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	B	4	run 38	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C		0.02 Da	10 ppm	1	2	92	female	Normal
-Sample 4	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	not avilable	4	run 39	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N		0.02 Da	10 ppm	1	1	88	male	Normal
-Sample 4	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	1	C	4	run 40	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131		0.02 Da	10 ppm	1	4	94	male	Alzheimer's Disease
-Sample 5	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	5	run 41	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 5	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	5	run 42	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 5	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	0	5	run 43	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 5	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	5	run 44	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 5	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	5	run 45	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N		0.02 Da	10 ppm	1	4	95	female	Alzheimer's Disease
-Sample 5	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	5	run 46	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C		0.02 Da	10 ppm	1	4	84	female	Alzheimer's Disease
-Sample 5	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	5	run 47	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N		0.02 Da	10 ppm	1	2	85	female	Normal
-Sample 5	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	B	5	run 48	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C		0.02 Da	10 ppm	1	2	92	female	Normal
-Sample 5	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	not avilable	5	run 49	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N		0.02 Da	10 ppm	1	1	88	male	Normal
-Sample 5	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	1	C	5	run 50	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131		0.02 Da	10 ppm	1	4	94	male	Alzheimer's Disease
-Sample 6	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	6	run 51	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 6	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	6	run 52	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 6	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	0	6	run 53	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 6	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	6	run 54	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 6	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	6	run 55	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N		0.02 Da	10 ppm	1	4	95	female	Alzheimer's Disease
-Sample 6	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	6	run 56	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C		0.02 Da	10 ppm	1	4	84	female	Alzheimer's Disease
-Sample 6	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	6	run 57	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N		0.02 Da	10 ppm	1	2	85	female	Normal
-Sample 6	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	B	6	run 58	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C		0.02 Da	10 ppm	1	2	92	female	Normal
-Sample 6	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1		6	run 59	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N		0.02 Da	10 ppm	1	1	88	male	Normal
-Sample 6	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	1	C	6	run 60	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131		0.02 Da	10 ppm	1	4	94	male	Alzheimer's Disease
-Sample 7	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	7	run 61	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 7	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	7	run 62	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 7	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	0	7	run 63	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 7	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	7	run 64	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 7	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	7	run 65	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N		0.02 Da	10 ppm	1	4	95	female	Alzheimer's Disease
-Sample 7	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	7	run 66	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C		0.02 Da	10 ppm	1	4	84	female	Alzheimer's Disease
-Sample 7	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1		7	run 67	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N		0.02 Da	10 ppm	1	2	85	female	Normal
-Sample 7	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	B	7	run 68	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C		0.02 Da	10 ppm	1	2	92	female	Normal
-Sample 7	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	not avilable	7	run 69	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N		0.02 Da	10 ppm	1	1	88	male	Normal
-Sample 7	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	1	C	7	run 70	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131		0.02 Da	10 ppm	1	4	94	male	Alzheimer's Disease
-Sample 8	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	8	run 71	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 8	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	8	run 72	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 8	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	0	8	run 73	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 8	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	8	run 74	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 8	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	8	run 75	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N		0.02 Da	10 ppm	1	4	95	female	Alzheimer's Disease
-Sample 8	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	8	run 76	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C		0.02 Da	10 ppm	1	4	84	female	Alzheimer's Disease
-Sample 8	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	8	run 77	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N		0.02 Da	10 ppm	1	2	85	female	Normal
-Sample 8	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	B	8	run 78	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C		0.02 Da	10 ppm	1	2	92	female	Normal
-Sample 8	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	not avilable	8	run 79	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N		0.02 Da	10 ppm	1	1	88	male	Normal
-Sample 8	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	1	C	8	run 80	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131		0.02 Da	10 ppm	1	4	94	male	Alzheimer's Disease
-Sample 9	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	9	run 81	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 9	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	9	run 82	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 9	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	0	9	run 83	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 9	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	9	run 84	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 9	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	9	run 85	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N		0.02 Da	10 ppm	1	4	95	female	Alzheimer's Disease
-Sample 9	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	9	run 86	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C		0.02 Da	10 ppm	1	4	84	female	Alzheimer's Disease
-Sample 9	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	9	run 87	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N		0.02 Da	10 ppm	1	2	85	female	Normal
-Sample 9	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	B	9	run 88	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C		0.02 Da	10 ppm	1	2	92	female	Normal
-Sample 9	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	not avilable	9	run 89	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N		0.02 Da	10 ppm	1	1	88	male	Normal
-Sample 9	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	1	C	9	run 90	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131		0.02 Da	10 ppm	1	4	94	male	Alzheimer's Disease
-Sample 10	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	10	run 91	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 10	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	10	run 92	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 10	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	0	10	run 93	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 10	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	10	run 94	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 10	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	10	run 95	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N		0.02 Da	10 ppm	1	4	95	female	Alzheimer's Disease
-Sample 10	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	10	run 96	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C		0.02 Da	10 ppm	1	4	84	female	Alzheimer's Disease
-Sample 10	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	10	run 97	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N		0.02 Da	10 ppm	1	2	85	female	Normal
-Sample 10	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	B	10	run 98	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C		0.02 Da	10 ppm	1	2	92	female	Normal
-Sample 10	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	not avilable	10	run 99	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N		0.02 Da	10 ppm	1	1	88	male	Normal
-Sample 10	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	1	C	10	run 100	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131		0.02 Da	10 ppm	1	4	94	male	Alzheimer's Disease
-Sample 11	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	11	run 101	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 11	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	11	run 102	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 11	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	0	11	run 103	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 11	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	11	run 104	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 11	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	11	run 105	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N		0.02 Da	10 ppm	1	4	95	female	Alzheimer's Disease
-Sample 11	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	11	run 106	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C		0.02 Da	10 ppm	1	4	84	female	Alzheimer's Disease
-Sample 11	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	11	run 107	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N		0.02 Da	10 ppm	1	2	85	female	Normal
-Sample 11	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	B	11	run 108	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C		0.02 Da	10 ppm	1	2	92	female	Normal
-Sample 11	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	not avilable	11	run 109	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N		0.02 Da	10 ppm	1	1	88	male	Normal
-Sample 11	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	1	C	11	run 110	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131		0.02 Da	10 ppm	1	4	94	male	Alzheimer's Disease
-Sample 12	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	12	run 111	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 12	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	12	run 112	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 12	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	0	12	run 113	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 12	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	12	run 114	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 12	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	12	run 115	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N		0.02 Da	10 ppm	1	4	95	female	Alzheimer's Disease
-Sample 12	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	12	run 116	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C		0.02 Da	10 ppm	1	4	84	female	Alzheimer's Disease
-Sample 12	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	12	run 117	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N		0.02 Da	10 ppm	1	2	85	female	Normal
-Sample 12	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	B	12	run 118	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C		0.02 Da	10 ppm	1	2	92	female	Normal
-Sample 12	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	not avilable	12	run 119	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N		0.02 Da	10 ppm	1	1	88	male	Normal
-Sample 12	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	1	C	12	run 120	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131		0.02 Da	10 ppm	1	4	94	male	Alzheimer's Disease
-Sample 13	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	13	run 121	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 13	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	13	run 122	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 13	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	0	13	run 123	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 13	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	13	run 124	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 13	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	13	run 125	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N		0.02 Da	10 ppm	1	4	95	female	Alzheimer's Disease
-Sample 13	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	13	run 126	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C		0.02 Da	10 ppm	1	4	84	female	Alzheimer's Disease
-Sample 13	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	13	run 127	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N		0.02 Da	10 ppm	1	2	85	female	Normal
-Sample 13	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	B	13	run 128	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C		0.02 Da	10 ppm	1	2	92	female	Normal
-Sample 13	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	not avilable	13	run 129	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N		0.02 Da	10 ppm	1	1	88	male	Normal
-Sample 13	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	1	C	13	run 130	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131		0.02 Da	10 ppm	1	4	94	male	Alzheimer's Disease
-Sample 14	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	14	run 131	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 14	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	14	run 132	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 14	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	0	14	run 133	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 14	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	14	run 134	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 14	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	14	run 135	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N		0.02 Da	10 ppm	1	4	95	female	Alzheimer's Disease
-Sample 14	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	14	run 136	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C		0.02 Da	10 ppm	1	4	84	female	Alzheimer's Disease
-Sample 14	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	14	run 137	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N		0.02 Da	10 ppm	1	2	85	female	Normal
-Sample 14	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	B	14	run 138	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C		0.02 Da	10 ppm	1	2	92	female	Normal
-Sample 14	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	not avilable	14	run 139	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N		0.02 Da	10 ppm	1	1	88	male	Normal
-Sample 14	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	1	C	14	run 140	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131		0.02 Da	10 ppm	1	4	94	male	Alzheimer's Disease
-Sample 15	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	15	run 141	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 15	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	15	run 142	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 15	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	0	15	run 143	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 15	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	15	run 144	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 15	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	15	run 145	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N		0.02 Da	10 ppm	1	4	95	female	Alzheimer's Disease
-Sample 15	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	15	run 146	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C		0.02 Da	10 ppm	1	4	84	female	Alzheimer's Disease
-Sample 15	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	15	run 147	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N		0.02 Da	10 ppm	1	2	85	female	Normal
-Sample 15	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	B	15	run 148	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C		0.02 Da	10 ppm	1	2	92	female	Normal
-Sample 15	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	not avilable	15	run 149	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N		0.02 Da	10 ppm	1	1	88	male	Normal
-Sample 15	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	1	C	15	run 150	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131		0.02 Da	10 ppm	1	4	94	male	Alzheimer's Disease
-Sample 16	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	16	run 151	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 16	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	16	run 152	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 16	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	0	16	run 153	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 16	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	16	run 154	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 16	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	16	run 155	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N		0.02 Da	10 ppm	1	4	95	female	Alzheimer's Disease
-Sample 16	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	16	run 156	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C		0.02 Da	10 ppm	1	4	84	female	Alzheimer's Disease
-Sample 16	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	16	run 157	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N		0.02 Da	10 ppm	1	2	85	female	Normal
-Sample 16	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	B	16	run 158	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C		0.02 Da	10 ppm	1	2	92	female	Normal
-Sample 16	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	not avilable	16	run 159	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N		0.02 Da	10 ppm	1	1	88	male	Normal
-Sample 16	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	1	C	16	run 160	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131		0.02 Da	10 ppm	1	4	94	male	Alzheimer's Disease
-Sample 17	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	17	run 161	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 17	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	17	run 162	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 17	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	0	17	run 163	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 17	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	17	run 164	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 17	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	17	run 165	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N		0.02 Da	10 ppm	1	4	95	female	Alzheimer's Disease
-Sample 17	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	17	run 166	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C		0.02 Da	10 ppm	1	4	84	female	Alzheimer's Disease
-Sample 17	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	17	run 167	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N		0.02 Da	10 ppm	1	2	85	female	Normal
-Sample 17	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	B	17	run 168	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C		0.02 Da	10 ppm	1	2	92	female	Normal
-Sample 17	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	not avilable	17	run 169	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N		0.02 Da	10 ppm	1	1	88	male	Normal
-Sample 17	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	1	C	17	run 170	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131		0.02 Da	10 ppm	1	4	94	male	Alzheimer's Disease
-Sample 18	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	18	run 171	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 18	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	18	run 172	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 18	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	0	18	run 173	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 18	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	18	run 174	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 18	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	18	run 175	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N		0.02 Da	10 ppm	1	4	95	female	Alzheimer's Disease
-Sample 18	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	18	run 176	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C		0.02 Da	10 ppm	1	4	84	female	Alzheimer's Disease
-Sample 18	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	18	run 177	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N		0.02 Da	10 ppm	1	2	85	female	Normal
-Sample 18	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	B	18	run 178	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C		0.02 Da	10 ppm	1	2	92	female	Normal
-Sample 18	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	not avilable	18	run 179	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N		0.02 Da	10 ppm	1	1	88	male	Normal
-Sample 18	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	1	C	18	run 180	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131		0.02 Da	10 ppm	1	4	94	male	Alzheimer's Disease
-Sample 19	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	19	run 181	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 19	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	19	run 182	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 19	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	0	19	run 183	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 19	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	19	run 184	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 19	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	19	run 185	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N		0.02 Da	10 ppm	1	4	95	female	Alzheimer's Disease
-Sample 19	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	19	run 186	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C		0.02 Da	10 ppm	1	4	84	female	Alzheimer's Disease
-Sample 19	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	19	run 187	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N		0.02 Da	10 ppm	1	2	85	female	Normal
-Sample 19	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	B	19	run 188	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C		0.02 Da	10 ppm	1	2	92	female	Normal
-Sample 19	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	not avilable	19	run 189	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N		0.02 Da	10 ppm	1	1	88	male	Normal
-Sample 19	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	1	C	19	run 190	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131		0.02 Da	10 ppm	1	4	94	male	Alzheimer's Disease
-Sample 27	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	20	run 191	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 27	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	20	run 192	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 27	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	0	20	run 193	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 27	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	20	run 194	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 27	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	20	run 195	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N		0.02 Da	10 ppm	1	4	95	female	Alzheimer's Disease
-Sample 27	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	20	run 196	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C		0.02 Da	10 ppm	1	4	84	female	Alzheimer's Disease
-Sample 27	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	20	run 197	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N		0.02 Da	10 ppm	1	2	85	female	Normal
-Sample 27	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	B	20	run 198	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C		0.02 Da	10 ppm	1	2	92	female	Normal
-Sample 27	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	not avilable	20	run 199	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N		0.02 Da	10 ppm	1	1	88	male	Normal
-Sample 27	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	1	C	20	run 200	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131		0.02 Da	10 ppm	1	4	94	male	Alzheimer's Disease
-Sample 28	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	21	run 201	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 28	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	21	run 202	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 28	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	0	21	run 203	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 28	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	21	run 204	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 28	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	21	run 205	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N		0.02 Da	10 ppm	1	4	95	female	Alzheimer's Disease
-Sample 28	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	21	run 206	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C		0.02 Da	10 ppm	1	4	84	female	Alzheimer's Disease
-Sample 28	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	21	run 207	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N		0.02 Da	10 ppm	1	2	85	female	Normal
-Sample 28	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	B	21	run 208	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C		0.02 Da	10 ppm	1	2	92	female	Normal
-Sample 28	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	not avilable	21	run 209	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N		0.02 Da	10 ppm	1	1	88	male	Normal
-Sample 28	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	1	C	21	run 210	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131		0.02 Da	10 ppm	1	4	94	male	Alzheimer's Disease
-Sample 29	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	22	run 211	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 29	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	22	run 212	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 29	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	0	22	run 213	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 29	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	22	run 214	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 29	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	22	run 215	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N		0.02 Da	10 ppm	1	4	95	female	Alzheimer's Disease
-Sample 29	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	22	run 216	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C		0.02 Da	10 ppm	1	4	84	female	Alzheimer's Disease
-Sample 29	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	22	run 217	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N		0.02 Da	10 ppm	1	2	85	female	Normal
-Sample 29	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	B	22	run 218	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C		0.02 Da	10 ppm	1	2	92	female	Normal
-Sample 29	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	not avilable	22	run 219	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N		0.02 Da	10 ppm	1	1	88	male	Normal
-Sample 29	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	1	C	22	run 220	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131		0.02 Da	10 ppm	1	4	94	male	Alzheimer's Disease
-Sample 30	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	23	run 221	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 30	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	23	run 222	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 30	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	0	23	run 223	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 30	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	23	run 224	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 30	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	23	run 225	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N		0.02 Da	10 ppm	1	4	95	female	Alzheimer's Disease
-Sample 30	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	23	run 226	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C		0.02 Da	10 ppm	1	4	84	female	Alzheimer's Disease
-Sample 30	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	23	run 227	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N		0.02 Da	10 ppm	1	2	85	female	Normal
-Sample 30	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	B	23	run 228	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C		0.02 Da	10 ppm	1	2	92	female	Normal
-Sample 30	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	not avilable	23	run 229	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N		0.02 Da	10 ppm	1	1	88	male	Normal
-Sample 30	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	1	C	23	run 230	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131		0.02 Da	10 ppm	1	4	94	male	Alzheimer's Disease
-Sample 31	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	24	run 231	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 31	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	24	run 232	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 31	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	0	24	run 233	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 31	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	24	run 234	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 31	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	24	run 235	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N		0.02 Da	10 ppm	1	4	95	female	Alzheimer's Disease
-Sample 31	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	24	run 236	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C		0.02 Da	10 ppm	1	4	84	female	Alzheimer's Disease
-Sample 31	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	24	run 237	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N		0.02 Da	10 ppm	1	2	85	female	Normal
-Sample 31	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	B	24	run 238	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C		0.02 Da	10 ppm	1	2	92	female	Normal
-Sample 31	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	not avilable	24	run 239	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N		0.02 Da	10 ppm	1	1	88	male	Normal
-Sample 31	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	1	C	24	run 240	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131		0.02 Da	10 ppm	1	4	94	male	Alzheimer's Disease
-Sample 36	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	25	run 241	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 36	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	25	run 242	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 36	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	0	25	run 243	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 36	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	25	run 244	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 36	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	25	run 245	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N		0.02 Da	10 ppm	1	4	95	female	Alzheimer's Disease
-Sample 36	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	25	run 246	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C		0.02 Da	10 ppm	1	4	84	female	Alzheimer's Disease
-Sample 36	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	25	run 247	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N		0.02 Da	10 ppm	1	2	85	female	Normal
-Sample 36	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	B	25	run 248	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C		0.02 Da	10 ppm	1	2	92	female	Normal
-Sample 36	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	not avilable	25	run 249	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N		0.02 Da	10 ppm	1	1	88	male	Normal
-Sample 36	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	1	C	25	run 250	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131		0.02 Da	10 ppm	1	4	94	male	Alzheimer's Disease
-Sample 37	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	26	run 251	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 37	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	26	run 252	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 37	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	0	26	run 253	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 37	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	26	run 254	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 37	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	26	run 255	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N		0.02 Da	10 ppm	1	4	95	female	Alzheimer's Disease
-Sample 37	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	26	run 256	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C		0.02 Da	10 ppm	1	4	84	female	Alzheimer's Disease
-Sample 37	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	26	run 257	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N		0.02 Da	10 ppm	1	2	85	female	Normal
-Sample 37	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	B	26	run 258	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C		0.02 Da	10 ppm	1	2	92	female	Normal
-Sample 37	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	not avilable	26	run 259	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N		0.02 Da	10 ppm	1	1	88	male	Normal
-Sample 37	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	1	C	26	run 260	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131		0.02 Da	10 ppm	1	4	94	male	Alzheimer's Disease
-Sample 38	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	27	run 261	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 38	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	27	run 262	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 38	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	0	27	run 263	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 38	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	27	run 264	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 38	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	27	run 265	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N		0.02 Da	10 ppm	1	4	95	female	Alzheimer's Disease
-Sample 38	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	27	run 266	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C		0.02 Da	10 ppm	1	4	84	female	Alzheimer's Disease
-Sample 38	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	27	run 267	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N		0.02 Da	10 ppm	1	2	85	female	Normal
-Sample 38	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	B	27	run 268	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C		0.02 Da	10 ppm	1	2	92	female	Normal
-Sample 38	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	not avilable	27	run 269	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N		0.02 Da	10 ppm	1	1	88	male	Normal
-Sample 38	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	1	C	27	run 270	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131		0.02 Da	10 ppm	1	4	94	male	Alzheimer's Disease
-Sample 39	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	28	run 271	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 39	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	28	run 272	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 39	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	0	28	run 273	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 39	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	28	run 274	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 39	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	28	run 275	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N		0.02 Da	10 ppm	1	4	95	female	Alzheimer's Disease
-Sample 39	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	28	run 276	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C		0.02 Da	10 ppm	1	4	84	female	Alzheimer's Disease
-Sample 39	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	28	run 277	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N		0.02 Da	10 ppm	1	2	85	female	Normal
-Sample 39	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	B	28	run 278	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C		0.02 Da	10 ppm	1	2	92	female	Normal
-Sample 39	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	not avilable	28	run 279	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N		0.02 Da	10 ppm	1	1	88	male	Normal
-Sample 39	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	1	C	28	run 280	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131		0.02 Da	10 ppm	1	4	94	male	Alzheimer's Disease
-Sample 40	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	29	run 281	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 40	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	29	run 282	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 40	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	0	29	run 283	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 40	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	29	run 284	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 40	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	29	run 285	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N		0.02 Da	10 ppm	1	4	95	female	Alzheimer's Disease
-Sample 40	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	29	run 286	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C		0.02 Da	10 ppm	1	4	84	female	Alzheimer's Disease
-Sample 40	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	29	run 287	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N		0.02 Da	10 ppm	1	2	85	female	Normal
-Sample 40	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	B	29	run 288	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C		0.02 Da	10 ppm	1	2	92	female	Normal
-Sample 40	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	not avilable	29	run 289	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N		0.02 Da	10 ppm	1	1	88	male	Normal
-Sample 40	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	1	C	29	run 290	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131		0.02 Da	10 ppm	1	4	94	male	Alzheimer's Disease
-Sample 41	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	30	run 291	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 41	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	30	run 292	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 41	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	0	30	run 293	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 41	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	30	run 294	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 41	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	30	run 295	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N		0.02 Da	10 ppm	1	4	95	female	Alzheimer's Disease
-Sample 41	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	30	run 296	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C		0.02 Da	10 ppm	1	4	84	female	Alzheimer's Disease
-Sample 41	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	30	run 297	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N		0.02 Da	10 ppm	1	2	85	female	Normal
-Sample 41	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	B	30	run 298	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C		0.02 Da	10 ppm	1	2	92	female	Normal
-Sample 41	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	not avilable	30	run 299	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N		0.02 Da	10 ppm	1	1	88	male	Normal
-Sample 41	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	1	C	30	run 300	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131		0.02 Da	10 ppm	1	4	94	male	Alzheimer's Disease
-Sample 42	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	31	run 301	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 42	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	31	run 302	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 42	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	0	31	run 303	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 42	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	31	run 304	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 42	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	31	run 305	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N		0.02 Da	10 ppm	1	4	95	female	Alzheimer's Disease
-Sample 42	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	31	run 306	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C		0.02 Da	10 ppm	1	4	84	female	Alzheimer's Disease
-Sample 42	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	31	run 307	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N		0.02 Da	10 ppm	1	2	85	female	Normal
-Sample 42	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	B	31	run 308	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C		0.02 Da	10 ppm	1	2	92	female	Normal
-Sample 42	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	not avilable	31	run 309	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N		0.02 Da	10 ppm	1	1	88	male	Normal
-Sample 42	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	1	C	31	run 310	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131		0.02 Da	10 ppm	1	4	94	male	Alzheimer's Disease
-Sample 50	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	32	run 311	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 50	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	32	run 312	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 50	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	0	32	run 313	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 50	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	32	run 314	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 50	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	32	run 315	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N		0.02 Da	10 ppm	1	4	95	female	Alzheimer's Disease
-Sample 50	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	32	run 316	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C		0.02 Da	10 ppm	1	4	84	female	Alzheimer's Disease
-Sample 50	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	32	run 317	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N		0.02 Da	10 ppm	1	2	85	female	Normal
-Sample 50	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	B	32	run 318	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C		0.02 Da	10 ppm	1	2	92	female	Normal
-Sample 50	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	not avilable	32	run 319	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N		0.02 Da	10 ppm	1	1	88	male	Normal
-Sample 50	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	1	C	32	run 320	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131		0.02 Da	10 ppm	1	4	94	male	Alzheimer's Disease
-Sample 51	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	33	run 321	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 51	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	33	run 322	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 51	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	0	33	run 323	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 51	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	33	run 324	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 51	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	33	run 325	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N		0.02 Da	10 ppm	1	4	95	female	Alzheimer's Disease
-Sample 51	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	33	run 326	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C		0.02 Da	10 ppm	1	4	84	female	Alzheimer's Disease
-Sample 51	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	33	run 327	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N		0.02 Da	10 ppm	1	2	85	female	Normal
-Sample 51	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	B	33	run 328	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C		0.02 Da	10 ppm	1	2	92	female	Normal
-Sample 51	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	not avilable	33	run 329	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N		0.02 Da	10 ppm	1	1	88	male	Normal
-Sample 51	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	1	C	33	run 330	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131		0.02 Da	10 ppm	1	4	94	male	Alzheimer's Disease
-Sample 52	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	34	run 331	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 52	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	34	run 332	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 52	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	0	34	run 333	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 52	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	34	run 334	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 52	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	34	run 335	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N		0.02 Da	10 ppm	1	4	95	female	Alzheimer's Disease
-Sample 52	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	34	run 336	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C		0.02 Da	10 ppm	1	4	84	female	Alzheimer's Disease
-Sample 52	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	34	run 337	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N		0.02 Da	10 ppm	1	2	85	female	Normal
-Sample 52	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	B	34	run 338	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C		0.02 Da	10 ppm	1	2	92	female	Normal
-Sample 52	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	not avilable	34	run 339	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N		0.02 Da	10 ppm	1	1	88	male	Normal
-Sample 52	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	1	C	34	run 340	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131		0.02 Da	10 ppm	1	4	94	male	Alzheimer's Disease
-Sample 53	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	35	run 341	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 53	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	35	run 342	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 53	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	0	35	run 343	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 53	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	35	run 344	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 53	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	35	run 345	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N		0.02 Da	10 ppm	1	4	95	female	Alzheimer's Disease
-Sample 53	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	35	run 346	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C		0.02 Da	10 ppm	1	4	84	female	Alzheimer's Disease
-Sample 53	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	35	run 347	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N		0.02 Da	10 ppm	1	2	85	female	Normal
-Sample 53	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	B	35	run 348	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C		0.02 Da	10 ppm	1	2	92	female	Normal
-Sample 53	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	not avilable	35	run 349	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N		0.02 Da	10 ppm	1	1	88	male	Normal
-Sample 53	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	1	C	35	run 350	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131		0.02 Da	10 ppm	1	4	94	male	Alzheimer's Disease
-Sample 64	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1		36	run 351	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 64	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	36	run 352	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 64	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	0	36	run 353	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 64	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	36	run 354	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 64	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	36	run 355	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N		0.02 Da	10 ppm	1	4	95	female	Alzheimer's Disease
-Sample 64	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	36	run 356	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C		0.02 Da	10 ppm	1	4	84	female	Alzheimer's Disease
-Sample 64	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	36	run 357	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N		0.02 Da	10 ppm	1	2	85	female	Normal
-Sample 64	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	B	36	run 358	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C		0.02 Da	10 ppm	1	2	92	female	Normal
-Sample 64	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	not avilable	36	run 359	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N		0.02 Da	10 ppm	1	1	88	male	Normal
-Sample 64	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	1	C	36	run 360	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131		0.02 Da	10 ppm	1	4	94	male	Alzheimer's Disease
-Sample 65	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	37	run 361	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 65	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	37	run 362	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 65	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	0	37	run 363	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 65	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	37	run 364	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 65	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	37	run 365	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N		0.02 Da	10 ppm	1	4	95	female	Alzheimer's Disease
-Sample 65	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	37	run 366	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C		0.02 Da	10 ppm	1	4	84	female	Alzheimer's Disease
-Sample 65	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	37	run 367	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N		0.02 Da	10 ppm	1	2	85	female	Normal
-Sample 65	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	B	37	run 368	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C		0.02 Da	10 ppm	1	2	92	female	Normal
-Sample 65	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	not avilable	37	run 369	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N		0.02 Da	10 ppm	1	1	88	male	Normal
-Sample 65	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	1	C	37	run 370	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131		0.02 Da	10 ppm	1	4	94	male	Alzheimer's Disease
-Sample 66	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	38	run 371	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 66	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	38	run 372	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 66	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	0	38	run 373	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 66	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	38	run 374	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 66	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	38	run 375	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N		0.02 Da	10 ppm	1	4	95	female	Alzheimer's Disease
-Sample 66	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	38	run 376	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C		0.02 Da	10 ppm	1	4	84	female	Alzheimer's Disease
-Sample 66	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	38	run 377	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N		0.02 Da	10 ppm	1	2	85	female	Normal
-Sample 66	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	B	38	run 378	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C		0.02 Da	10 ppm	1	2	92	female	Normal
-Sample 66	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	not avilable	38	run 379	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N		0.02 Da	10 ppm	1	1	88	male	Normal
-Sample 66	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	1	C	38	run 380	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131		0.02 Da	10 ppm	1	4	94	male	Alzheimer's Disease
-Sample 71	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	39	run 381	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 71	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	39	run 382	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 71	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	0	39	run 383	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 71	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	39	run 384	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 71	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	39	run 385	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N		0.02 Da	10 ppm	1	4	95	female	Alzheimer's Disease
-Sample 71	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	39	run 386	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C		0.02 Da	10 ppm	1	4	84	female	Alzheimer's Disease
-Sample 71	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	39	run 387	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N		0.02 Da	10 ppm	1	2	85	female	Normal
-Sample 71	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	B	39	run 388	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C		0.02 Da	10 ppm	1	2	92	female	Normal
-Sample 71	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	not avilable	39	run 389	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N		0.02 Da	10 ppm	1	1	88	male	Normal
-Sample 71	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	1	C	39	run 390	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131		0.02 Da	10 ppm	1	4	94	male	Alzheimer's Disease
-Sample 72	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	40	run 391	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 72	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	40	run 392	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 72	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	0	40	run 393	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N		0.02 Da	10 ppm	1	0	72	female	Normal
-Sample 72	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	40	run 394	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C		0.02 Da	10 ppm	1	4	91	female	Alzheimer's Disease
-Sample 72	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	40	run 395	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N		0.02 Da	10 ppm	1	4	95	female	Alzheimer's Disease
-Sample 72	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	1	C	40	run 396	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C		0.02 Da	10 ppm	1	4	84	female	Alzheimer's Disease
-Sample 72	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	not avilable	40	run 397	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N		0.02 Da	10 ppm	1	2	85	female	Normal
-Sample 72	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	1	B	40	run 398	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C		0.02 Da	10 ppm	1	2	92	female	Normal
-Sample 72	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	not avilable	40	run 399	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N		0.02 Da	10 ppm	1	1	88	male	Normal
-Sample 72	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	1	C	40	run 400	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131		0.02 Da	10 ppm	1	4	94	male	Alzheimer's Disease
\ No newline at end of file
+source name	characteristics[organism]	characteristics[organism part]	characteristics[organism part]	characteristics[cell type]	characteristics[age]	characteristics[ancestry category]	characteristics[sex]	characteristics[disease]	characteristics[developmental stage]	characteristics[BRAAK]	characteristics[Age at Death]	characteristics[biological replicate]	comment[Amyloid stage]	characteristics[individual]	assay name	technology type	comment[proteomexchange accession number]	comment[data file]	comment[file uri]	comment[fraction identifier]	comment[instrument]	comment[modification parameters]	comment[modification parameters]	comment[cleavage agent details]	comment[label]	comment[fragment mass tolerance]	comment[precursor mass tolerance]	comment[technical replicate]	factor value[sex]	factor value[disease]
+Sample 1	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	not avilable	1	run 1	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126	0.02 Da	10 ppm	1	female	Normal
+Sample 1	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	1	run 2	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 1	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	0	1	run 3	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N	0.02 Da	10 ppm	1	female	Normal
+Sample 1	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	1	run 4	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 1	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	95	1	C	1	run 5	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 1	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	84	1	C	1	run 6	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 1	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	85	1	not avilable	1	run 7	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N	0.02 Da	10 ppm	1	female	Normal
+Sample 1	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	92	1	B	1	run 8	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C	0.02 Da	10 ppm	1	female	Normal
+Sample 1	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	88	1	not avilable	1	run 9	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N	0.02 Da	10 ppm	1	male	Normal
+Sample 1	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	4	94	1	C	1	run 10	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131	0.02 Da	10 ppm	1	male	Alzheimer's Disease
+Sample 2	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	not avilable	2	run 11	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126	0.02 Da	10 ppm	1	female	Normal
+Sample 2	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	2	run 12	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 2	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	0	2	run 13	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N	0.02 Da	10 ppm	1	female	Normal
+Sample 2	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	2	run 14	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 2	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	95	1	C	2	run 15	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 2	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	84	1	C	2	run 16	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 2	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	85	1	not avilable	2	run 17	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N	0.02 Da	10 ppm	1	female	Normal
+Sample 2	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	92	1	B	2	run 18	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C	0.02 Da	10 ppm	1	female	Normal
+Sample 2	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	88	1	not avilable	2	run 19	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N	0.02 Da	10 ppm	1	male	Normal
+Sample 2	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	4	94	1	C	2	run 20	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131	0.02 Da	10 ppm	1	male	Alzheimer's Disease
+Sample 3	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	not avilable	3	run 21	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126	0.02 Da	10 ppm	1	female	Normal
+Sample 3	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	3	run 22	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 3	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	0	3	run 23	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N	0.02 Da	10 ppm	1	female	Normal
+Sample 3	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	3	run 24	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 3	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	95	1	C	3	run 25	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 3	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	84	1	C	3	run 26	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 3	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	85	1	not avilable	3	run 27	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N	0.02 Da	10 ppm	1	female	Normal
+Sample 3	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	92	1	B	3	run 28	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C	0.02 Da	10 ppm	1	female	Normal
+Sample 3	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	88	1	not avilable	3	run 29	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N	0.02 Da	10 ppm	1	male	Normal
+Sample 3	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	4	94	1	C	3	run 30	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131	0.02 Da	10 ppm	1	male	Alzheimer's Disease
+Sample 4	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	not avilable	4	run 31	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126	0.02 Da	10 ppm	1	female	Normal
+Sample 4	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	4	run 32	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 4	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	0	4	run 33	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N	0.02 Da	10 ppm	1	female	Normal
+Sample 4	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	4	run 34	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 4	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	95	1	C	4	run 35	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 4	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	84	1	C	4	run 36	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 4	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	85	1	not avilable	4	run 37	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N	0.02 Da	10 ppm	1	female	Normal
+Sample 4	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	92	1	B	4	run 38	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C	0.02 Da	10 ppm	1	female	Normal
+Sample 4	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	88	1	not avilable	4	run 39	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N	0.02 Da	10 ppm	1	male	Normal
+Sample 4	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	4	94	1	C	4	run 40	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131	0.02 Da	10 ppm	1	male	Alzheimer's Disease
+Sample 5	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	not avilable	5	run 41	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126	0.02 Da	10 ppm	1	female	Normal
+Sample 5	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	5	run 42	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 5	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	0	5	run 43	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N	0.02 Da	10 ppm	1	female	Normal
+Sample 5	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	5	run 44	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 5	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	95	1	C	5	run 45	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 5	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	84	1	C	5	run 46	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 5	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	85	1	not avilable	5	run 47	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N	0.02 Da	10 ppm	1	female	Normal
+Sample 5	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	92	1	B	5	run 48	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C	0.02 Da	10 ppm	1	female	Normal
+Sample 5	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	88	1	not avilable	5	run 49	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N	0.02 Da	10 ppm	1	male	Normal
+Sample 5	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	4	94	1	C	5	run 50	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131	0.02 Da	10 ppm	1	male	Alzheimer's Disease
+Sample 6	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	not avilable	6	run 51	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126	0.02 Da	10 ppm	1	female	Normal
+Sample 6	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	6	run 52	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 6	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	0	6	run 53	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N	0.02 Da	10 ppm	1	female	Normal
+Sample 6	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	6	run 54	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 6	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	95	1	C	6	run 55	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 6	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	84	1	C	6	run 56	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 6	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	85	1	not avilable	6	run 57	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N	0.02 Da	10 ppm	1	female	Normal
+Sample 6	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	92	1	B	6	run 58	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C	0.02 Da	10 ppm	1	female	Normal
+Sample 6	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	88	1		6	run 59	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N	0.02 Da	10 ppm	1	male	Normal
+Sample 6	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	4	94	1	C	6	run 60	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131	0.02 Da	10 ppm	1	male	Alzheimer's Disease
+Sample 7	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	not avilable	7	run 61	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126	0.02 Da	10 ppm	1	female	Normal
+Sample 7	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	7	run 62	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 7	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	0	7	run 63	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N	0.02 Da	10 ppm	1	female	Normal
+Sample 7	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	7	run 64	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 7	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	95	1	C	7	run 65	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 7	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	84	1	C	7	run 66	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 7	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	85	1		7	run 67	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N	0.02 Da	10 ppm	1	female	Normal
+Sample 7	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	92	1	B	7	run 68	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C	0.02 Da	10 ppm	1	female	Normal
+Sample 7	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	88	1	not avilable	7	run 69	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N	0.02 Da	10 ppm	1	male	Normal
+Sample 7	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	4	94	1	C	7	run 70	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131	0.02 Da	10 ppm	1	male	Alzheimer's Disease
+Sample 8	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	not avilable	8	run 71	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126	0.02 Da	10 ppm	1	female	Normal
+Sample 8	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	8	run 72	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 8	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	0	8	run 73	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N	0.02 Da	10 ppm	1	female	Normal
+Sample 8	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	8	run 74	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 8	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	95	1	C	8	run 75	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 8	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	84	1	C	8	run 76	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 8	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	85	1	not avilable	8	run 77	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N	0.02 Da	10 ppm	1	female	Normal
+Sample 8	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	92	1	B	8	run 78	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C	0.02 Da	10 ppm	1	female	Normal
+Sample 8	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	88	1	not avilable	8	run 79	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N	0.02 Da	10 ppm	1	male	Normal
+Sample 8	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	4	94	1	C	8	run 80	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131	0.02 Da	10 ppm	1	male	Alzheimer's Disease
+Sample 9	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	not avilable	9	run 81	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126	0.02 Da	10 ppm	1	female	Normal
+Sample 9	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	9	run 82	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 9	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	0	9	run 83	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N	0.02 Da	10 ppm	1	female	Normal
+Sample 9	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	9	run 84	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 9	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	95	1	C	9	run 85	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 9	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	84	1	C	9	run 86	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 9	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	85	1	not avilable	9	run 87	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N	0.02 Da	10 ppm	1	female	Normal
+Sample 9	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	92	1	B	9	run 88	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C	0.02 Da	10 ppm	1	female	Normal
+Sample 9	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	88	1	not avilable	9	run 89	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N	0.02 Da	10 ppm	1	male	Normal
+Sample 9	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	4	94	1	C	9	run 90	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131	0.02 Da	10 ppm	1	male	Alzheimer's Disease
+Sample 10	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	not avilable	10	run 91	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126	0.02 Da	10 ppm	1	female	Normal
+Sample 10	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	10	run 92	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 10	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	0	10	run 93	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N	0.02 Da	10 ppm	1	female	Normal
+Sample 10	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	10	run 94	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 10	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	95	1	C	10	run 95	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 10	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	84	1	C	10	run 96	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 10	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	85	1	not avilable	10	run 97	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N	0.02 Da	10 ppm	1	female	Normal
+Sample 10	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	92	1	B	10	run 98	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C	0.02 Da	10 ppm	1	female	Normal
+Sample 10	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	88	1	not avilable	10	run 99	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N	0.02 Da	10 ppm	1	male	Normal
+Sample 10	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	4	94	1	C	10	run 100	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131	0.02 Da	10 ppm	1	male	Alzheimer's Disease
+Sample 11	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	not avilable	11	run 101	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126	0.02 Da	10 ppm	1	female	Normal
+Sample 11	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	11	run 102	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 11	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	0	11	run 103	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N	0.02 Da	10 ppm	1	female	Normal
+Sample 11	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	11	run 104	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 11	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	95	1	C	11	run 105	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 11	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	84	1	C	11	run 106	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 11	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	85	1	not avilable	11	run 107	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N	0.02 Da	10 ppm	1	female	Normal
+Sample 11	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	92	1	B	11	run 108	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C	0.02 Da	10 ppm	1	female	Normal
+Sample 11	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	88	1	not avilable	11	run 109	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N	0.02 Da	10 ppm	1	male	Normal
+Sample 11	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	4	94	1	C	11	run 110	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131	0.02 Da	10 ppm	1	male	Alzheimer's Disease
+Sample 12	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	not avilable	12	run 111	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126	0.02 Da	10 ppm	1	female	Normal
+Sample 12	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	12	run 112	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 12	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	0	12	run 113	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N	0.02 Da	10 ppm	1	female	Normal
+Sample 12	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	12	run 114	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 12	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	95	1	C	12	run 115	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 12	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	84	1	C	12	run 116	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 12	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	85	1	not avilable	12	run 117	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N	0.02 Da	10 ppm	1	female	Normal
+Sample 12	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	92	1	B	12	run 118	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C	0.02 Da	10 ppm	1	female	Normal
+Sample 12	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	88	1	not avilable	12	run 119	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N	0.02 Da	10 ppm	1	male	Normal
+Sample 12	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	4	94	1	C	12	run 120	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131	0.02 Da	10 ppm	1	male	Alzheimer's Disease
+Sample 13	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	not avilable	13	run 121	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126	0.02 Da	10 ppm	1	female	Normal
+Sample 13	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	13	run 122	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 13	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	0	13	run 123	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N	0.02 Da	10 ppm	1	female	Normal
+Sample 13	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	13	run 124	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 13	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	95	1	C	13	run 125	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 13	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	84	1	C	13	run 126	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 13	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	85	1	not avilable	13	run 127	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N	0.02 Da	10 ppm	1	female	Normal
+Sample 13	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	92	1	B	13	run 128	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C	0.02 Da	10 ppm	1	female	Normal
+Sample 13	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	88	1	not avilable	13	run 129	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N	0.02 Da	10 ppm	1	male	Normal
+Sample 13	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	4	94	1	C	13	run 130	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131	0.02 Da	10 ppm	1	male	Alzheimer's Disease
+Sample 14	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	not avilable	14	run 131	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126	0.02 Da	10 ppm	1	female	Normal
+Sample 14	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	14	run 132	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 14	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	0	14	run 133	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N	0.02 Da	10 ppm	1	female	Normal
+Sample 14	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	14	run 134	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 14	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	95	1	C	14	run 135	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 14	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	84	1	C	14	run 136	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 14	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	85	1	not avilable	14	run 137	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N	0.02 Da	10 ppm	1	female	Normal
+Sample 14	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	92	1	B	14	run 138	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C	0.02 Da	10 ppm	1	female	Normal
+Sample 14	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	88	1	not avilable	14	run 139	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N	0.02 Da	10 ppm	1	male	Normal
+Sample 14	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	4	94	1	C	14	run 140	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131	0.02 Da	10 ppm	1	male	Alzheimer's Disease
+Sample 15	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	not avilable	15	run 141	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126	0.02 Da	10 ppm	1	female	Normal
+Sample 15	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	15	run 142	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 15	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	0	15	run 143	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N	0.02 Da	10 ppm	1	female	Normal
+Sample 15	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	15	run 144	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 15	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	95	1	C	15	run 145	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 15	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	84	1	C	15	run 146	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 15	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	85	1	not avilable	15	run 147	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N	0.02 Da	10 ppm	1	female	Normal
+Sample 15	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	92	1	B	15	run 148	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C	0.02 Da	10 ppm	1	female	Normal
+Sample 15	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	88	1	not avilable	15	run 149	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N	0.02 Da	10 ppm	1	male	Normal
+Sample 15	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	4	94	1	C	15	run 150	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131	0.02 Da	10 ppm	1	male	Alzheimer's Disease
+Sample 16	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	not avilable	16	run 151	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126	0.02 Da	10 ppm	1	female	Normal
+Sample 16	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	16	run 152	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 16	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	0	16	run 153	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N	0.02 Da	10 ppm	1	female	Normal
+Sample 16	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	16	run 154	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 16	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	95	1	C	16	run 155	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 16	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	84	1	C	16	run 156	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 16	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	85	1	not avilable	16	run 157	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N	0.02 Da	10 ppm	1	female	Normal
+Sample 16	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	92	1	B	16	run 158	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C	0.02 Da	10 ppm	1	female	Normal
+Sample 16	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	88	1	not avilable	16	run 159	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N	0.02 Da	10 ppm	1	male	Normal
+Sample 16	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	4	94	1	C	16	run 160	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131	0.02 Da	10 ppm	1	male	Alzheimer's Disease
+Sample 17	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	not avilable	17	run 161	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126	0.02 Da	10 ppm	1	female	Normal
+Sample 17	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	17	run 162	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 17	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	0	17	run 163	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N	0.02 Da	10 ppm	1	female	Normal
+Sample 17	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	17	run 164	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 17	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	95	1	C	17	run 165	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 17	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	84	1	C	17	run 166	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 17	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	85	1	not avilable	17	run 167	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N	0.02 Da	10 ppm	1	female	Normal
+Sample 17	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	92	1	B	17	run 168	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C	0.02 Da	10 ppm	1	female	Normal
+Sample 17	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	88	1	not avilable	17	run 169	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N	0.02 Da	10 ppm	1	male	Normal
+Sample 17	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	4	94	1	C	17	run 170	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131	0.02 Da	10 ppm	1	male	Alzheimer's Disease
+Sample 18	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	not avilable	18	run 171	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126	0.02 Da	10 ppm	1	female	Normal
+Sample 18	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	18	run 172	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 18	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	0	18	run 173	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N	0.02 Da	10 ppm	1	female	Normal
+Sample 18	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	18	run 174	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 18	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	95	1	C	18	run 175	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 18	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	84	1	C	18	run 176	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 18	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	85	1	not avilable	18	run 177	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N	0.02 Da	10 ppm	1	female	Normal
+Sample 18	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	92	1	B	18	run 178	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C	0.02 Da	10 ppm	1	female	Normal
+Sample 18	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	88	1	not avilable	18	run 179	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N	0.02 Da	10 ppm	1	male	Normal
+Sample 18	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	4	94	1	C	18	run 180	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131	0.02 Da	10 ppm	1	male	Alzheimer's Disease
+Sample 19	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	not avilable	19	run 181	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126	0.02 Da	10 ppm	1	female	Normal
+Sample 19	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	19	run 182	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 19	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	0	19	run 183	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N	0.02 Da	10 ppm	1	female	Normal
+Sample 19	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	19	run 184	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 19	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	95	1	C	19	run 185	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 19	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	84	1	C	19	run 186	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 19	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	85	1	not avilable	19	run 187	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N	0.02 Da	10 ppm	1	female	Normal
+Sample 19	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	92	1	B	19	run 188	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C	0.02 Da	10 ppm	1	female	Normal
+Sample 19	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	88	1	not avilable	19	run 189	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N	0.02 Da	10 ppm	1	male	Normal
+Sample 19	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	4	94	1	C	19	run 190	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131	0.02 Da	10 ppm	1	male	Alzheimer's Disease
+Sample 27	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	not avilable	20	run 191	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126	0.02 Da	10 ppm	1	female	Normal
+Sample 27	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	20	run 192	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 27	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	0	20	run 193	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N	0.02 Da	10 ppm	1	female	Normal
+Sample 27	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	20	run 194	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 27	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	95	1	C	20	run 195	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 27	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	84	1	C	20	run 196	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 27	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	85	1	not avilable	20	run 197	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N	0.02 Da	10 ppm	1	female	Normal
+Sample 27	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	92	1	B	20	run 198	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C	0.02 Da	10 ppm	1	female	Normal
+Sample 27	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	88	1	not avilable	20	run 199	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N	0.02 Da	10 ppm	1	male	Normal
+Sample 27	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	4	94	1	C	20	run 200	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131	0.02 Da	10 ppm	1	male	Alzheimer's Disease
+Sample 28	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	not avilable	21	run 201	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126	0.02 Da	10 ppm	1	female	Normal
+Sample 28	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	21	run 202	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 28	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	0	21	run 203	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N	0.02 Da	10 ppm	1	female	Normal
+Sample 28	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	21	run 204	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 28	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	95	1	C	21	run 205	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 28	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	84	1	C	21	run 206	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 28	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	85	1	not avilable	21	run 207	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N	0.02 Da	10 ppm	1	female	Normal
+Sample 28	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	92	1	B	21	run 208	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C	0.02 Da	10 ppm	1	female	Normal
+Sample 28	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	88	1	not avilable	21	run 209	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N	0.02 Da	10 ppm	1	male	Normal
+Sample 28	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	4	94	1	C	21	run 210	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131	0.02 Da	10 ppm	1	male	Alzheimer's Disease
+Sample 29	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	not avilable	22	run 211	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126	0.02 Da	10 ppm	1	female	Normal
+Sample 29	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	22	run 212	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 29	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	0	22	run 213	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N	0.02 Da	10 ppm	1	female	Normal
+Sample 29	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	22	run 214	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 29	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	95	1	C	22	run 215	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 29	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	84	1	C	22	run 216	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 29	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	85	1	not avilable	22	run 217	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N	0.02 Da	10 ppm	1	female	Normal
+Sample 29	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	92	1	B	22	run 218	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C	0.02 Da	10 ppm	1	female	Normal
+Sample 29	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	88	1	not avilable	22	run 219	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N	0.02 Da	10 ppm	1	male	Normal
+Sample 29	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	4	94	1	C	22	run 220	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131	0.02 Da	10 ppm	1	male	Alzheimer's Disease
+Sample 30	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	not avilable	23	run 221	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126	0.02 Da	10 ppm	1	female	Normal
+Sample 30	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	23	run 222	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 30	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	0	23	run 223	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N	0.02 Da	10 ppm	1	female	Normal
+Sample 30	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	23	run 224	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 30	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	95	1	C	23	run 225	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 30	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	84	1	C	23	run 226	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 30	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	85	1	not avilable	23	run 227	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N	0.02 Da	10 ppm	1	female	Normal
+Sample 30	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	92	1	B	23	run 228	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C	0.02 Da	10 ppm	1	female	Normal
+Sample 30	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	88	1	not avilable	23	run 229	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N	0.02 Da	10 ppm	1	male	Normal
+Sample 30	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	4	94	1	C	23	run 230	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131	0.02 Da	10 ppm	1	male	Alzheimer's Disease
+Sample 31	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	not avilable	24	run 231	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126	0.02 Da	10 ppm	1	female	Normal
+Sample 31	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	24	run 232	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 31	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	0	24	run 233	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N	0.02 Da	10 ppm	1	female	Normal
+Sample 31	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	24	run 234	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 31	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	95	1	C	24	run 235	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 31	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	84	1	C	24	run 236	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 31	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	85	1	not avilable	24	run 237	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N	0.02 Da	10 ppm	1	female	Normal
+Sample 31	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	92	1	B	24	run 238	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C	0.02 Da	10 ppm	1	female	Normal
+Sample 31	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	88	1	not avilable	24	run 239	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N	0.02 Da	10 ppm	1	male	Normal
+Sample 31	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	4	94	1	C	24	run 240	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131	0.02 Da	10 ppm	1	male	Alzheimer's Disease
+Sample 36	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	not avilable	25	run 241	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126	0.02 Da	10 ppm	1	female	Normal
+Sample 36	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	25	run 242	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 36	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	0	25	run 243	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N	0.02 Da	10 ppm	1	female	Normal
+Sample 36	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	25	run 244	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 36	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	95	1	C	25	run 245	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 36	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	84	1	C	25	run 246	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 36	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	85	1	not avilable	25	run 247	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N	0.02 Da	10 ppm	1	female	Normal
+Sample 36	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	92	1	B	25	run 248	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C	0.02 Da	10 ppm	1	female	Normal
+Sample 36	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	88	1	not avilable	25	run 249	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N	0.02 Da	10 ppm	1	male	Normal
+Sample 36	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	4	94	1	C	25	run 250	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131	0.02 Da	10 ppm	1	male	Alzheimer's Disease
+Sample 37	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	not avilable	26	run 251	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126	0.02 Da	10 ppm	1	female	Normal
+Sample 37	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	26	run 252	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 37	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	0	26	run 253	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N	0.02 Da	10 ppm	1	female	Normal
+Sample 37	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	26	run 254	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 37	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	95	1	C	26	run 255	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 37	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	84	1	C	26	run 256	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 37	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	85	1	not avilable	26	run 257	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N	0.02 Da	10 ppm	1	female	Normal
+Sample 37	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	92	1	B	26	run 258	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C	0.02 Da	10 ppm	1	female	Normal
+Sample 37	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	88	1	not avilable	26	run 259	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N	0.02 Da	10 ppm	1	male	Normal
+Sample 37	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	4	94	1	C	26	run 260	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131	0.02 Da	10 ppm	1	male	Alzheimer's Disease
+Sample 38	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	not avilable	27	run 261	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126	0.02 Da	10 ppm	1	female	Normal
+Sample 38	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	27	run 262	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 38	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	0	27	run 263	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N	0.02 Da	10 ppm	1	female	Normal
+Sample 38	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	27	run 264	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 38	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	95	1	C	27	run 265	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 38	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	84	1	C	27	run 266	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 38	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	85	1	not avilable	27	run 267	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N	0.02 Da	10 ppm	1	female	Normal
+Sample 38	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	92	1	B	27	run 268	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C	0.02 Da	10 ppm	1	female	Normal
+Sample 38	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	88	1	not avilable	27	run 269	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N	0.02 Da	10 ppm	1	male	Normal
+Sample 38	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	4	94	1	C	27	run 270	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131	0.02 Da	10 ppm	1	male	Alzheimer's Disease
+Sample 39	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	not avilable	28	run 271	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126	0.02 Da	10 ppm	1	female	Normal
+Sample 39	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	28	run 272	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 39	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	0	28	run 273	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N	0.02 Da	10 ppm	1	female	Normal
+Sample 39	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	28	run 274	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 39	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	95	1	C	28	run 275	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 39	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	84	1	C	28	run 276	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 39	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	85	1	not avilable	28	run 277	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N	0.02 Da	10 ppm	1	female	Normal
+Sample 39	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	92	1	B	28	run 278	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C	0.02 Da	10 ppm	1	female	Normal
+Sample 39	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	88	1	not avilable	28	run 279	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N	0.02 Da	10 ppm	1	male	Normal
+Sample 39	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	4	94	1	C	28	run 280	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131	0.02 Da	10 ppm	1	male	Alzheimer's Disease
+Sample 40	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	not avilable	29	run 281	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126	0.02 Da	10 ppm	1	female	Normal
+Sample 40	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	29	run 282	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 40	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	0	29	run 283	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N	0.02 Da	10 ppm	1	female	Normal
+Sample 40	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	29	run 284	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 40	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	95	1	C	29	run 285	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 40	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	84	1	C	29	run 286	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 40	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	85	1	not avilable	29	run 287	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N	0.02 Da	10 ppm	1	female	Normal
+Sample 40	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	92	1	B	29	run 288	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C	0.02 Da	10 ppm	1	female	Normal
+Sample 40	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	88	1	not avilable	29	run 289	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N	0.02 Da	10 ppm	1	male	Normal
+Sample 40	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	4	94	1	C	29	run 290	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131	0.02 Da	10 ppm	1	male	Alzheimer's Disease
+Sample 41	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	not avilable	30	run 291	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126	0.02 Da	10 ppm	1	female	Normal
+Sample 41	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	30	run 292	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 41	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	0	30	run 293	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N	0.02 Da	10 ppm	1	female	Normal
+Sample 41	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	30	run 294	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 41	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	95	1	C	30	run 295	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 41	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	84	1	C	30	run 296	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 41	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	85	1	not avilable	30	run 297	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N	0.02 Da	10 ppm	1	female	Normal
+Sample 41	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	92	1	B	30	run 298	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C	0.02 Da	10 ppm	1	female	Normal
+Sample 41	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	88	1	not avilable	30	run 299	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N	0.02 Da	10 ppm	1	male	Normal
+Sample 41	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	4	94	1	C	30	run 300	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131	0.02 Da	10 ppm	1	male	Alzheimer's Disease
+Sample 42	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	not avilable	31	run 301	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126	0.02 Da	10 ppm	1	female	Normal
+Sample 42	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	31	run 302	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 42	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	0	31	run 303	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N	0.02 Da	10 ppm	1	female	Normal
+Sample 42	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	31	run 304	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 42	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	95	1	C	31	run 305	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 42	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	84	1	C	31	run 306	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 42	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	85	1	not avilable	31	run 307	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N	0.02 Da	10 ppm	1	female	Normal
+Sample 42	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	92	1	B	31	run 308	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C	0.02 Da	10 ppm	1	female	Normal
+Sample 42	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	88	1	not avilable	31	run 309	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N	0.02 Da	10 ppm	1	male	Normal
+Sample 42	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	4	94	1	C	31	run 310	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131	0.02 Da	10 ppm	1	male	Alzheimer's Disease
+Sample 50	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	not avilable	32	run 311	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126	0.02 Da	10 ppm	1	female	Normal
+Sample 50	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	32	run 312	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 50	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	0	32	run 313	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N	0.02 Da	10 ppm	1	female	Normal
+Sample 50	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	32	run 314	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 50	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	95	1	C	32	run 315	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 50	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	84	1	C	32	run 316	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 50	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	85	1	not avilable	32	run 317	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N	0.02 Da	10 ppm	1	female	Normal
+Sample 50	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	92	1	B	32	run 318	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C	0.02 Da	10 ppm	1	female	Normal
+Sample 50	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	88	1	not avilable	32	run 319	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N	0.02 Da	10 ppm	1	male	Normal
+Sample 50	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	4	94	1	C	32	run 320	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131	0.02 Da	10 ppm	1	male	Alzheimer's Disease
+Sample 51	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	not avilable	33	run 321	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126	0.02 Da	10 ppm	1	female	Normal
+Sample 51	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	33	run 322	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 51	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	0	33	run 323	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N	0.02 Da	10 ppm	1	female	Normal
+Sample 51	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	33	run 324	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 51	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	95	1	C	33	run 325	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 51	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	84	1	C	33	run 326	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 51	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	85	1	not avilable	33	run 327	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N	0.02 Da	10 ppm	1	female	Normal
+Sample 51	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	92	1	B	33	run 328	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C	0.02 Da	10 ppm	1	female	Normal
+Sample 51	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	88	1	not avilable	33	run 329	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N	0.02 Da	10 ppm	1	male	Normal
+Sample 51	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	4	94	1	C	33	run 330	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131	0.02 Da	10 ppm	1	male	Alzheimer's Disease
+Sample 52	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	not avilable	34	run 331	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126	0.02 Da	10 ppm	1	female	Normal
+Sample 52	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	34	run 332	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 52	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	0	34	run 333	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N	0.02 Da	10 ppm	1	female	Normal
+Sample 52	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	34	run 334	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 52	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	95	1	C	34	run 335	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 52	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	84	1	C	34	run 336	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 52	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	85	1	not avilable	34	run 337	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N	0.02 Da	10 ppm	1	female	Normal
+Sample 52	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	92	1	B	34	run 338	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C	0.02 Da	10 ppm	1	female	Normal
+Sample 52	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	88	1	not avilable	34	run 339	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N	0.02 Da	10 ppm	1	male	Normal
+Sample 52	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	4	94	1	C	34	run 340	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131	0.02 Da	10 ppm	1	male	Alzheimer's Disease
+Sample 53	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	not avilable	35	run 341	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126	0.02 Da	10 ppm	1	female	Normal
+Sample 53	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	35	run 342	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 53	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	0	35	run 343	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N	0.02 Da	10 ppm	1	female	Normal
+Sample 53	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	35	run 344	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 53	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	95	1	C	35	run 345	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 53	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	84	1	C	35	run 346	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 53	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	85	1	not avilable	35	run 347	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N	0.02 Da	10 ppm	1	female	Normal
+Sample 53	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	92	1	B	35	run 348	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C	0.02 Da	10 ppm	1	female	Normal
+Sample 53	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	88	1	not avilable	35	run 349	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N	0.02 Da	10 ppm	1	male	Normal
+Sample 53	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	4	94	1	C	35	run 350	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131	0.02 Da	10 ppm	1	male	Alzheimer's Disease
+Sample 64	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1		36	run 351	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126	0.02 Da	10 ppm	1	female	Normal
+Sample 64	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	36	run 352	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 64	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	0	36	run 353	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N	0.02 Da	10 ppm	1	female	Normal
+Sample 64	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	36	run 354	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 64	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	95	1	C	36	run 355	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 64	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	84	1	C	36	run 356	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 64	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	85	1	not avilable	36	run 357	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N	0.02 Da	10 ppm	1	female	Normal
+Sample 64	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	92	1	B	36	run 358	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C	0.02 Da	10 ppm	1	female	Normal
+Sample 64	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	88	1	not avilable	36	run 359	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N	0.02 Da	10 ppm	1	male	Normal
+Sample 64	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	4	94	1	C	36	run 360	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131	0.02 Da	10 ppm	1	male	Alzheimer's Disease
+Sample 65	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	not avilable	37	run 361	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126	0.02 Da	10 ppm	1	female	Normal
+Sample 65	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	37	run 362	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 65	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	0	37	run 363	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N	0.02 Da	10 ppm	1	female	Normal
+Sample 65	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	37	run 364	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 65	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	95	1	C	37	run 365	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 65	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	84	1	C	37	run 366	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 65	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	85	1	not avilable	37	run 367	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N	0.02 Da	10 ppm	1	female	Normal
+Sample 65	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	92	1	B	37	run 368	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C	0.02 Da	10 ppm	1	female	Normal
+Sample 65	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	88	1	not avilable	37	run 369	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N	0.02 Da	10 ppm	1	male	Normal
+Sample 65	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	4	94	1	C	37	run 370	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131	0.02 Da	10 ppm	1	male	Alzheimer's Disease
+Sample 66	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	not avilable	38	run 371	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126	0.02 Da	10 ppm	1	female	Normal
+Sample 66	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	38	run 372	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 66	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	0	38	run 373	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N	0.02 Da	10 ppm	1	female	Normal
+Sample 66	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	38	run 374	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 66	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	95	1	C	38	run 375	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 66	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	84	1	C	38	run 376	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 66	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	85	1	not avilable	38	run 377	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N	0.02 Da	10 ppm	1	female	Normal
+Sample 66	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	92	1	B	38	run 378	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C	0.02 Da	10 ppm	1	female	Normal
+Sample 66	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	88	1	not avilable	38	run 379	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N	0.02 Da	10 ppm	1	male	Normal
+Sample 66	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	4	94	1	C	38	run 380	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131	0.02 Da	10 ppm	1	male	Alzheimer's Disease
+Sample 71	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	not avilable	39	run 381	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126	0.02 Da	10 ppm	1	female	Normal
+Sample 71	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	39	run 382	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 71	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	0	39	run 383	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N	0.02 Da	10 ppm	1	female	Normal
+Sample 71	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	39	run 384	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 71	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	95	1	C	39	run 385	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 71	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	84	1	C	39	run 386	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 71	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	85	1	not avilable	39	run 387	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N	0.02 Da	10 ppm	1	female	Normal
+Sample 71	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	92	1	B	39	run 388	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C	0.02 Da	10 ppm	1	female	Normal
+Sample 71	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	88	1	not avilable	39	run 389	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N	0.02 Da	10 ppm	1	male	Normal
+Sample 71	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	4	94	1	C	39	run 390	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131	0.02 Da	10 ppm	1	male	Alzheimer's Disease
+Sample 72	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	not avilable	40	run 391	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT126	0.02 Da	10 ppm	1	female	Normal
+Sample 72	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	40	run 392	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 72	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	0	72	1	0	40	run 393	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT127N	0.02 Da	10 ppm	1	female	Normal
+Sample 72	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	91	1	C	40	run 394	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 72	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	95	1	C	40	run 395	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT128N	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 72	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Alzheimer's Disease	not available	4	84	1	C	40	run 396	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129C	0.02 Da	10 ppm	1	female	Alzheimer's Disease
+Sample 72	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	85	1	not avilable	40	run 397	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT129N	0.02 Da	10 ppm	1	female	Normal
+Sample 72	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	female	Normal	not available	2	92	1	B	40	run 398	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130C	0.02 Da	10 ppm	1	female	Normal
+Sample 72	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Normal	not available	1	88	1	not avilable	40	run 399	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT130N	0.02 Da	10 ppm	1	male	Normal
+Sample 72	Homo sapiens	Brain	Hippocampus	not applicable	not available	not available	male	Alzheimer's Disease	not available	4	94	1	C	40	run 400	proteomic profiling by mass spectrometry	PXD014557	GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD014557/GMSFHH_human_microd_20171123_400ug_IPG3-10_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	TMT131	0.02 Da	10 ppm	1	male	Alzheimer's Disease
\ No newline at end of file
diff --git a/annotated-projects/PXD019185_PXD018883/PXD019185_PXD018883.sdrf.tsv b/annotated-projects/PXD019185_PXD018883/PXD019185_PXD018883.sdrf.tsv
index 30214d21..a928e278 100644
--- a/annotated-projects/PXD019185_PXD018883/PXD019185_PXD018883.sdrf.tsv
+++ b/annotated-projects/PXD019185_PXD018883/PXD019185_PXD018883.sdrf.tsv
@@ -1,14 +1,14 @@
 source name	characteristics[biological replicate]	characteristics[organism]	characteristics[organism part]	characteristics[age]	characteristics[ancestry category]	characteristics[cell type]	characteristics[disease]	characteristics[cell line]	characteristics[phenotype]	characteristics[genetic modification]	characteristics[individual]	characteristics[sex]	characteristics[pooled sample]	characteristics[xenograft]	characteristics[enrichment process]	assay name	technology type	comment[proteomexchange accession number]	comment[cleavage agent details]	comment[cleavage agent details]	comment[cleavage agent details]	comment[fraction identifier]	comment[fragment mass tolerance]	comment[instrument]	comment[label]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[precursor mass tolerance]	comment[technical replicate]	comment[tool metadata]	comment[data file]	factor value[genetic modification]	factor value[phenotype]
-D-HEp3 #1	1	homo sapiens	NT=head and neck;AC=MA:0000006	62Y	african american	squamous epitheliel cells	squamous cell carcinoma	NT=HEp-3 cell;AC=BTO:0005139	NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445	not applicable	not applicable	not available	pooled	cancer cell line grown in mice	NT=Extraction purification;AC=NCIT:C113061	run 1	proteomic profiling by mass spectrometry	PXD036453 	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002922	not applicable	0.015 Da	NT=LTQ Orbitrap Velos;AC=MS:1001742	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M', 'K', 'P	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N,Q	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Any N-term;TA=N	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Variable;PP=Any N-term;TA=Y', 'S', 'T	not applicable	10 ppm	1	lesSDRF v0.1.0	180615_554_AN_D1.raw	not applicable	NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445
-D-HEp3 #2	2	homo sapiens	NT=head and neck;AC=MA:0000006	62Y	african american	squamous epitheliel cells	squamous cell carcinoma	NT=HEp-3 cell;AC=BTO:0005139	NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445	not applicable	not applicable	not available	pooled	cancer cell line grown in mice	NT=Extraction purification;AC=NCIT:C113061	run 2	proteomic profiling by mass spectrometry	PXD036453 	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002922	not applicable	0.015 Da	NT=LTQ Orbitrap Velos;AC=MS:1001742	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M', 'K', 'P	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N,Q	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Any N-term;TA=N	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Variable;PP=Any N-term;TA=Y', 'S', 'T	not applicable	10 ppm	1	lesSDRF v0.1.0	180615_554_AN_D2.raw	not applicable	NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445
-T-HEp3 #1	1	homo sapiens	NT=head and neck;AC=MA:0000006	62Y	african american	squamous epitheliel cells	squamous cell carcinoma	NT=HEp-3 cell;AC=BTO:0005139	NT=proliferating cells;AC=CMPO:0000241	not applicable	not applicable	not available	not pooled	cancer cell line grown in mice	NT=Extraction purification;AC=NCIT:C113061	run 3	proteomic profiling by mass spectrometry	PXD036453	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002922	not applicable	0.015 Da	NT=LTQ Orbitrap Velos;AC=MS:1001742	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M', 'K', 'P	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N,Q	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Any N-term;TA=N	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Variable;PP=Any N-term;TA=Y', 'S', 'T	not applicable	10 ppm	1	lesSDRF v0.1.0	180615_554_AN_T1.raw	not applicable	NT=proliferating cells;AC=CMPO:0000241
-T-HEp3 #2	2	homo sapiens	NT=head and neck;AC=MA:0000006	62Y	african american	squamous epitheliel cells	squamous cell carcinoma	NT=HEp-3 cell;AC=BTO:0005139	NT=proliferating cells;AC=CMPO:0000241	not applicable	not applicable	not available	not pooled	cancer cell line grown in mice	NT=Extraction purification;AC=NCIT:C113061	run 4	proteomic profiling by mass spectrometry	PXD036453	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002922	not applicable	0.015 Da	NT=LTQ Orbitrap Velos;AC=MS:1001742	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M', 'K', 'P	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N,Q	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Any N-term;TA=N	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Variable;PP=Any N-term;TA=Y', 'S', 'T	not applicable	10 ppm	1	lesSDRF v0.1.0	180615_554_AN_T2.raw	not applicable	NT=proliferating cells;AC=CMPO:0000241
-T-HEp3 #4	3	homo sapiens	NT=head and neck;AC=MA:0000006	62Y	african american	squamous epitheliel cells	squamous cell carcinoma	NT=HEp-3 cell;AC=BTO:0005139	NT=proliferating cells;AC=CMPO:0000241	not applicable	not applicable	not available	not pooled	cancer cell line grown in mice	NT=Extraction purification;AC=NCIT:C113061	run 5	proteomic profiling by mass spectrometry	PXD036453	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002922	not applicable	0.015 Da	NT=LTQ Orbitrap Velos;AC=MS:1001742	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M', 'K', 'P	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N,Q	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Any N-term;TA=N	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Variable;PP=Any N-term;TA=Y', 'S', 'T	not applicable	10 ppm	1	lesSDRF v0.1.0	180615_554_AN_T4.raw	not applicable	NT=proliferating cells;AC=CMPO:0000241
-D-HEp3 shCTRL #1	1	homo sapiens	NT=head and neck;AC=MA:0000006	62Y	african american	squamous epitheliel cells	squamous cell carcinoma	NT=HEp-3 cell;AC=BTO:0005139	NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445	not applicable	not applicable	not available	not pooled	cancer cell line grown in mice	NT=Extraction purification;AC=NCIT:C113061	run 6	proteomic profiling by mass spectrometry	PXD018883	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002922	not applicable	0.1 Da	NT=LTQ Orbitrap Velos;AC=MS:1001742	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Any N-term;TA=N	not applicable	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P	10 ppm	1	lesSDRF v0.1.0	NabaC0-2-10X.raw	not applicable	NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445
-D-HEp3 shCTRL #2	2	homo sapiens	NT=head and neck;AC=MA:0000006	62Y	african american	squamous epitheliel cells	squamous cell carcinoma	NT=HEp-3 cell;AC=BTO:0005139	NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445	not applicable	not applicable	not available	not pooled	cancer cell line grown in mice	NT=Extraction purification;AC=NCIT:C113061	run 7	proteomic profiling by mass spectrometry	PXD018883	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002922	not applicable	0.1 Da	NT=LTQ Orbitrap Velos;AC=MS:1001742	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Any N-term;TA=N	not applicable	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P	10 ppm	1	lesSDRF v0.1.0	NabaC1-1-10X.raw	not applicable	NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445
-D-HEp3 shCTRL #3	3	homo sapiens	NT=head and neck;AC=MA:0000006	62Y	african american	squamous epitheliel cells	squamous cell carcinoma	NT=HEp-3 cell;AC=BTO:0005139	NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445	not applicable	not applicable	not available	not pooled	cancer cell line grown in mice	NT=Extraction purification;AC=NCIT:C113061	run 8	proteomic profiling by mass spectrometry	PXD018883	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002922	not applicable	0.1 Da	NT=LTQ Orbitrap Velos;AC=MS:1001742	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Any N-term;TA=N	not applicable	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P	10 ppm	1	lesSDRF v0.1.0	Naba-1-10x_180123194318.raw	not applicable	NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445
-D-HEp3 shCTRL #4	4	homo sapiens	NT=head and neck;AC=MA:0000006	62Y	african american	squamous epitheliel cells	squamous cell carcinoma	NT=HEp-3 cell;AC=BTO:0005139	NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445	not applicable	not applicable	not available	not pooled	cancer cell line grown in mice	NT=Extraction purification;AC=NCIT:C113061	run 9	proteomic profiling by mass spectrometry	PXD018883	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002922	not applicable	0.1 Da	NT=LTQ Orbitrap Velos;AC=MS:1001742	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Any N-term;TA=N	not applicable	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P	10 ppm	1	lesSDRF v0.1.0	Naba-2-10x.raw	not applicable	NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445
-D-HEp3 shDDR1 #1	1	homo sapiens	NT=head and neck;AC=MA:0000006	62Y	african american	squamous epitheliel cells	squamous cell carcinoma	NT=HEp-3 cell;AC=BTO:0005139	NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445	NT=gene knockdown;AC=OBI:0002625	not applicable	not available	not pooled	cancer cell line grown in mice	NT=Extraction purification;AC=NCIT:C113061	run 10	proteomic profiling by mass spectrometry	PXD018883	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002922	not applicable	0.1 Da	NT=LTQ Orbitrap Velos;AC=MS:1001742	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Any N-term;TA=N	not applicable	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P	10 ppm	1	lesSDRF v0.1.0	NabaSh2-4-10X.raw	NT=gene knockdown;AC=OBI:0002625	NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445
-D-HEp3 shDDR1 #2	2	homo sapiens	NT=head and neck;AC=MA:0000006	62Y	african american	squamous epitheliel cells	squamous cell carcinoma	NT=HEp-3 cell;AC=BTO:0005139	NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445	NT=gene knockdown;AC=OBI:0002625	not applicable	not available	not pooled	cancer cell line grown in mice	NT=Extraction purification;AC=NCIT:C113061	run 11	proteomic profiling by mass spectrometry	PXD018883	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002922	not applicable	0.1 Da	NT=LTQ Orbitrap Velos;AC=MS:1001742	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Any N-term;TA=N	not applicable	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P	10 ppm	1	lesSDRF v0.1.0	NabaSh3-2-10X.raw	NT=gene knockdown;AC=OBI:0002625	NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445
-D-HEp3 shDDR1 #3	3	homo sapiens	NT=head and neck;AC=MA:0000006	62Y	african american	squamous epitheliel cells	squamous cell carcinoma	NT=HEp-3 cell;AC=BTO:0005139	NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445	NT=gene knockdown;AC=OBI:0002625	not applicable	not available	not pooled	cancer cell line grown in mice	NT=Extraction purification;AC=NCIT:C113061	run 12	proteomic profiling by mass spectrometry	PXD018883	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002922	not applicable	0.1 Da	NT=LTQ Orbitrap Velos;AC=MS:1001742	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Any N-term;TA=N	not applicable	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P	10 ppm	1	lesSDRF v0.1.0	Naba-3-10x.raw	NT=gene knockdown;AC=OBI:0002625	NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445
-D-HEp3 shDDR1 #4	4	homo sapiens	NT=head and neck;AC=MA:0000006	62Y	african american	squamous epitheliel cells	squamous cell carcinoma	NT=HEp-3 cell;AC=BTO:0005139	NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445	NT=gene knockdown;AC=OBI:0002625	not applicable	not available	not pooled	cancer cell line grown in mice	NT=Extraction purification;AC=NCIT:C113061	run 13	proteomic profiling by mass spectrometry	PXD018883	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002922	not applicable	0.1 Da	NT=LTQ Orbitrap Velos;AC=MS:1001742	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Any N-term;TA=N	not applicable	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P	10 ppm	1	lesSDRF v0.1.0	Naba-4-10x.raw	NT=gene knockdown;AC=OBI:0002625	NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445
\ No newline at end of file
+D-HEp3 #1	1	homo sapiens	NT=head and neck;AC=MA:0000006	62Y	african american	squamous epitheliel cells	squamous cell carcinoma	NT=HEp-3 cell;AC=BTO:0005139	NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445	not applicable	not applicable	not available	pooled	cancer cell line grown in mice	NT=Extraction purification;AC=NCIT:C113061	run 1	proteomic profiling by mass spectrometry	PXD036453 	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002922	not applicable	0.015 Da	NT=LTQ Orbitrap Velos;AC=MS:1001742	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M', 'K', 'P	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N,Q	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Variable;PP=Any N-term;TA=Y', 'S', 'T	not applicable	10 ppm	1	lesSDRF v0.1.0	180615_554_AN_D1.raw	not applicable	NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445
+D-HEp3 #2	2	homo sapiens	NT=head and neck;AC=MA:0000006	62Y	african american	squamous epitheliel cells	squamous cell carcinoma	NT=HEp-3 cell;AC=BTO:0005139	NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445	not applicable	not applicable	not available	pooled	cancer cell line grown in mice	NT=Extraction purification;AC=NCIT:C113061	run 2	proteomic profiling by mass spectrometry	PXD036453 	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002922	not applicable	0.015 Da	NT=LTQ Orbitrap Velos;AC=MS:1001742	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M', 'K', 'P	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N,Q	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Variable;PP=Any N-term;TA=Y', 'S', 'T	not applicable	10 ppm	1	lesSDRF v0.1.0	180615_554_AN_D2.raw	not applicable	NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445
+T-HEp3 #1	1	homo sapiens	NT=head and neck;AC=MA:0000006	62Y	african american	squamous epitheliel cells	squamous cell carcinoma	NT=HEp-3 cell;AC=BTO:0005139	NT=proliferating cells;AC=CMPO:0000241	not applicable	not applicable	not available	not pooled	cancer cell line grown in mice	NT=Extraction purification;AC=NCIT:C113061	run 3	proteomic profiling by mass spectrometry	PXD036453	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002922	not applicable	0.015 Da	NT=LTQ Orbitrap Velos;AC=MS:1001742	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M', 'K', 'P	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N,Q	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Variable;PP=Any N-term;TA=Y', 'S', 'T	not applicable	10 ppm	1	lesSDRF v0.1.0	180615_554_AN_T1.raw	not applicable	NT=proliferating cells;AC=CMPO:0000241
+T-HEp3 #2	2	homo sapiens	NT=head and neck;AC=MA:0000006	62Y	african american	squamous epitheliel cells	squamous cell carcinoma	NT=HEp-3 cell;AC=BTO:0005139	NT=proliferating cells;AC=CMPO:0000241	not applicable	not applicable	not available	not pooled	cancer cell line grown in mice	NT=Extraction purification;AC=NCIT:C113061	run 4	proteomic profiling by mass spectrometry	PXD036453	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002922	not applicable	0.015 Da	NT=LTQ Orbitrap Velos;AC=MS:1001742	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M', 'K', 'P	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N,Q	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Variable;PP=Any N-term;TA=Y', 'S', 'T	not applicable	10 ppm	1	lesSDRF v0.1.0	180615_554_AN_T2.raw	not applicable	NT=proliferating cells;AC=CMPO:0000241
+T-HEp3 #4	3	homo sapiens	NT=head and neck;AC=MA:0000006	62Y	african american	squamous epitheliel cells	squamous cell carcinoma	NT=HEp-3 cell;AC=BTO:0005139	NT=proliferating cells;AC=CMPO:0000241	not applicable	not applicable	not available	not pooled	cancer cell line grown in mice	NT=Extraction purification;AC=NCIT:C113061	run 5	proteomic profiling by mass spectrometry	PXD036453	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002922	not applicable	0.015 Da	NT=LTQ Orbitrap Velos;AC=MS:1001742	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M', 'K', 'P	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N,Q	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N	NT=Carbamyl;AC=5;CF=H C N O;MM=43.005814;MT=Variable;PP=Any N-term;TA=Y', 'S', 'T	not applicable	10 ppm	1	lesSDRF v0.1.0	180615_554_AN_T4.raw	not applicable	NT=proliferating cells;AC=CMPO:0000241
+D-HEp3 shCTRL #1	1	homo sapiens	NT=head and neck;AC=MA:0000006	62Y	african american	squamous epitheliel cells	squamous cell carcinoma	NT=HEp-3 cell;AC=BTO:0005139	NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445	not applicable	not applicable	not available	not pooled	cancer cell line grown in mice	NT=Extraction purification;AC=NCIT:C113061	run 6	proteomic profiling by mass spectrometry	PXD018883	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002922	not applicable	0.1 Da	NT=LTQ Orbitrap Velos;AC=MS:1001742	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N	not applicable	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P	10 ppm	1	lesSDRF v0.1.0	NabaC0-2-10X.raw	not applicable	NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445
+D-HEp3 shCTRL #2	2	homo sapiens	NT=head and neck;AC=MA:0000006	62Y	african american	squamous epitheliel cells	squamous cell carcinoma	NT=HEp-3 cell;AC=BTO:0005139	NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445	not applicable	not applicable	not available	not pooled	cancer cell line grown in mice	NT=Extraction purification;AC=NCIT:C113061	run 7	proteomic profiling by mass spectrometry	PXD018883	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002922	not applicable	0.1 Da	NT=LTQ Orbitrap Velos;AC=MS:1001742	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N	not applicable	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P	10 ppm	1	lesSDRF v0.1.0	NabaC1-1-10X.raw	not applicable	NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445
+D-HEp3 shCTRL #3	3	homo sapiens	NT=head and neck;AC=MA:0000006	62Y	african american	squamous epitheliel cells	squamous cell carcinoma	NT=HEp-3 cell;AC=BTO:0005139	NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445	not applicable	not applicable	not available	not pooled	cancer cell line grown in mice	NT=Extraction purification;AC=NCIT:C113061	run 8	proteomic profiling by mass spectrometry	PXD018883	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002922	not applicable	0.1 Da	NT=LTQ Orbitrap Velos;AC=MS:1001742	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N	not applicable	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P	10 ppm	1	lesSDRF v0.1.0	Naba-1-10x_180123194318.raw	not applicable	NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445
+D-HEp3 shCTRL #4	4	homo sapiens	NT=head and neck;AC=MA:0000006	62Y	african american	squamous epitheliel cells	squamous cell carcinoma	NT=HEp-3 cell;AC=BTO:0005139	NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445	not applicable	not applicable	not available	not pooled	cancer cell line grown in mice	NT=Extraction purification;AC=NCIT:C113061	run 9	proteomic profiling by mass spectrometry	PXD018883	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002922	not applicable	0.1 Da	NT=LTQ Orbitrap Velos;AC=MS:1001742	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N	not applicable	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P	10 ppm	1	lesSDRF v0.1.0	Naba-2-10x.raw	not applicable	NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445
+D-HEp3 shDDR1 #1	1	homo sapiens	NT=head and neck;AC=MA:0000006	62Y	african american	squamous epitheliel cells	squamous cell carcinoma	NT=HEp-3 cell;AC=BTO:0005139	NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445	NT=gene knockdown;AC=OBI:0002625	not applicable	not available	not pooled	cancer cell line grown in mice	NT=Extraction purification;AC=NCIT:C113061	run 10	proteomic profiling by mass spectrometry	PXD018883	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002922	not applicable	0.1 Da	NT=LTQ Orbitrap Velos;AC=MS:1001742	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N	not applicable	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P	10 ppm	1	lesSDRF v0.1.0	NabaSh2-4-10X.raw	NT=gene knockdown;AC=OBI:0002625	NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445
+D-HEp3 shDDR1 #2	2	homo sapiens	NT=head and neck;AC=MA:0000006	62Y	african american	squamous epitheliel cells	squamous cell carcinoma	NT=HEp-3 cell;AC=BTO:0005139	NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445	NT=gene knockdown;AC=OBI:0002625	not applicable	not available	not pooled	cancer cell line grown in mice	NT=Extraction purification;AC=NCIT:C113061	run 11	proteomic profiling by mass spectrometry	PXD018883	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002922	not applicable	0.1 Da	NT=LTQ Orbitrap Velos;AC=MS:1001742	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N	not applicable	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P	10 ppm	1	lesSDRF v0.1.0	NabaSh3-2-10X.raw	NT=gene knockdown;AC=OBI:0002625	NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445
+D-HEp3 shDDR1 #3	3	homo sapiens	NT=head and neck;AC=MA:0000006	62Y	african american	squamous epitheliel cells	squamous cell carcinoma	NT=HEp-3 cell;AC=BTO:0005139	NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445	NT=gene knockdown;AC=OBI:0002625	not applicable	not available	not pooled	cancer cell line grown in mice	NT=Extraction purification;AC=NCIT:C113061	run 12	proteomic profiling by mass spectrometry	PXD018883	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002922	not applicable	0.1 Da	NT=LTQ Orbitrap Velos;AC=MS:1001742	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N	not applicable	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P	10 ppm	1	lesSDRF v0.1.0	Naba-3-10x.raw	NT=gene knockdown;AC=OBI:0002625	NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445
+D-HEp3 shDDR1 #4	4	homo sapiens	NT=head and neck;AC=MA:0000006	62Y	african american	squamous epitheliel cells	squamous cell carcinoma	NT=HEp-3 cell;AC=BTO:0005139	NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445	NT=gene knockdown;AC=OBI:0002625	not applicable	not available	not pooled	cancer cell line grown in mice	NT=Extraction purification;AC=NCIT:C113061	run 13	proteomic profiling by mass spectrometry	PXD018883	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002922	not applicable	0.1 Da	NT=LTQ Orbitrap Velos;AC=MS:1001742	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N	not applicable	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P	10 ppm	1	lesSDRF v0.1.0	Naba-4-10x.raw	NT=gene knockdown;AC=OBI:0002625	NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445
\ No newline at end of file
diff --git a/annotated-projects/PXD023707/PXD023707.sdrf.tsv b/annotated-projects/PXD023707/PXD023707.sdrf.tsv
index cb8c52bc..45535be7 100644
--- a/annotated-projects/PXD023707/PXD023707.sdrf.tsv
+++ b/annotated-projects/PXD023707/PXD023707.sdrf.tsv
@@ -1,4 +1,4 @@
 source name	characteristics[biological replicate]	characteristics[organism]	characteristics[organism part]	characteristics[cell type]	characteristics[age]	characteristics[ancestry category]	characteristics[sex]	characteristics[disease]	characteristics[individual]	characteristics[enrichment process]	assay name	technology type	comment[cleavage agent details]	comment[cleavage agent details]	comment[cleavage agent details]	comment[fractionation method]	comment[fraction identifier]	comment[fragment mass tolerance]	comment[precursor mass tolerance]	comment[technical replicate]	comment[instrument]	comment[label]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[tool metadata]	comment[file uri]	comment[data file]	factor value[disease]
-fallopian tube sample	1	homo sapiens	fallopian tube	fallopian tube ciliated cell	43Y	caucasian	F	cancer or benign tumor	1	NT= Extraction purification;AC=NCIT:C113061	run 1	proteomic profilling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	not applicable	not applicable	0.20 Da	10 ppm	1	NT=Q Exactive HF;AC=MS:1002523	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N','Q	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M,K,P	NT=Lys-> Pyl ;MT=Fixed;PP=Anywhere;TA=K;CF=C12H21N3O3;MM=-110	NT=Delta: S(-1)Se(1);MT=Fixed;PP=Anywhere;TA=C;CF=C3H7NO2Se;MM=49; PMID= 12148805	lesSDRF v0.1.0	https://ftp.pride.ebi.ac.uk/pride/data/archive/2021/11/PXD023707/20201009_MSC419_1.raw	20201009_MSC419_1.raw	cancer or benign tumor
-fallopian tube sample	1	homo sapiens	fallopian tube	fallopian tube ciliated cell	43Y	caucasian	F	cancer or benign tumor	1	NT= Extraction purification;AC=NCIT:C113061	run 2	proteomic profilling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	not applicable	not applicable	0.20 Da	10 ppm	2	NT=Q Exactive HF;AC=MS:1002523	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N','Q	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M,K,P	NT=Lys-> Pyl ;MT=Fixed;PP=Anywhere;TA=K;CF=C12H21N3O3;MM=-110	NT=Delta: S(-1)Se(1);MT=Fixed;PP=Anywhere;TA=C;CF=C3H7NO2Se;MM=49; PMID= 12148805	lesSDRF v0.1.0	https://ftp.pride.ebi.ac.uk/pride/data/archive/2021/11/PXD023707/20201114_MSC419_1-2.raw	20201114_MSC419_1-2.raw	cancer or benign tumor
-fallopian tube sample	1	homo sapeins	fallopian tube	fallopian tube ciliated cell	43Y	caucasian	F	cancer or benign tumor	1	NT= Extraction purification;AC=NCIT:C113061	run 3	proteomic profilling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	not applicable	not applicable	0.20 Da	10 ppm	3	NT=Q Exactive HF;AC=MS:1002523	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=N','Q	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=M,K,P	NT=Lys-> Pyl ;MT=Fixed;PP=Anywhere;TA=K;CF=C12H21N3O3;MM=-110	NT=Delta: S(-1)Se(1);MT=Fixed;PP=Anywhere;TA=C;CF=C3H7NO2Se;MM=49; PMID= 12148805	lesSDRF v0.1.0	https://ftp.pride.ebi.ac.uk/pride/data/archive/2021/11/PXD023707/20201114_MSC419_1-3.raw	20201114_MSC419_1-3.raw	cancer or benign tumor
\ No newline at end of file
+fallopian tube sample	1	homo sapiens	fallopian tube	fallopian tube ciliated cell	43Y	caucasian	F	cancer or benign tumor	1	NT= Extraction purification;AC=NCIT:C113061	run 1	proteomic profilling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	not applicable	not applicable	0.20 Da	10 ppm	1	NT=Q Exactive HF;AC=MS:1002523	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N','Q	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M,K,P	NT=Lys-> Pyl ;MT=Fixed;PP=Anywhere;TA=K;CF=C12H21N3O3;MM=-110	NT=Delta: S(-1)Se(1);MT=Fixed;PP=Anywhere;TA=C;CF=C3H7NO2Se;MM=49; PMID= 12148805	lesSDRF v0.1.0	https://ftp.pride.ebi.ac.uk/pride/data/archive/2021/11/PXD023707/20201009_MSC419_1.raw	20201009_MSC419_1.raw	cancer or benign tumor
+fallopian tube sample	1	homo sapiens	fallopian tube	fallopian tube ciliated cell	43Y	caucasian	F	cancer or benign tumor	1	NT= Extraction purification;AC=NCIT:C113061	run 2	proteomic profilling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	not applicable	not applicable	0.20 Da	10 ppm	2	NT=Q Exactive HF;AC=MS:1002523	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N','Q	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M,K,P	NT=Lys-> Pyl ;MT=Fixed;PP=Anywhere;TA=K;CF=C12H21N3O3;MM=-110	NT=Delta: S(-1)Se(1);MT=Fixed;PP=Anywhere;TA=C;CF=C3H7NO2Se;MM=49; PMID= 12148805	lesSDRF v0.1.0	https://ftp.pride.ebi.ac.uk/pride/data/archive/2021/11/PXD023707/20201114_MSC419_1-2.raw	20201114_MSC419_1-2.raw	cancer or benign tumor
+fallopian tube sample	1	homo sapeins	fallopian tube	fallopian tube ciliated cell	43Y	caucasian	F	cancer or benign tumor	1	NT= Extraction purification;AC=NCIT:C113061	run 3	proteomic profilling by mass spectrometry	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=N-glycosidase F;AC=CHMO:0002921	not applicable	not applicable	0.20 Da	10 ppm	3	NT=Q Exactive HF;AC=MS:1002523	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=C	NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Protein N-term;TA=Q	NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N','Q	NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M,K,P	NT=Lys-> Pyl ;MT=Fixed;PP=Anywhere;TA=K;CF=C12H21N3O3;MM=-110	NT=Delta: S(-1)Se(1);MT=Fixed;PP=Anywhere;TA=C;CF=C3H7NO2Se;MM=49; PMID= 12148805	lesSDRF v0.1.0	https://ftp.pride.ebi.ac.uk/pride/data/archive/2021/11/PXD023707/20201114_MSC419_1-3.raw	20201114_MSC419_1-3.raw	cancer or benign tumor
\ No newline at end of file